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It	 is	 well	 established	 that	 adenoviruses	 degrade	 components	 of	 the	 cellular	 DNA	
damage	response,	such	as	p53,	DNA	ligase	IV	and	Mre11,	 in	order	to	avoid	detection	from	
the	 host	 cell	 and	 thus,	 promote	 viral	 replication.	 Here	 we	 show	 TAB182,	 a	 protein	 of	
previously	unknown	function,	is	degraded	following	adenovirus	serotype	5	and	12	infection.	
Similarly	 to	 other	DNA	 damage	 proteins,	 the	 degradation	 of	 TAB182	 is	 dependent	 on	 the	
adenoviral	 E1B55K	 and	 E4orf6	 proteins,	 together	 with	 the	 cellular	 Cullin	 5	 (during	 Ad5	
infection)	and	Cullin	2	(during	Ad12	infection).	Interestingly,	siRNA-mediated	knockdown	of	
TAB182	 appears	 to	 be	 beneficial	 for	 adenovirus	 infection,	 as	 denoted	 by	 an	 increased	
expression	of	the	adenoviral	E1A	protein	and	Cyclin	E	during	adenovirus	infection.	Together	
with	 other	 studies,	 we	 confirm	 that	 TAB182	 interacts	 with	 the	 large,	multi-subunit	 CNOT	
complex.	This	complex	has	no	defined	function	 in	mammalian	cells,	but	 is	known	to	play	a	
role	 in	 gene	 regulation	 in	 yeast.	 Interestingly,	 components	 of	 the	 CNOT	 complex	 are	 also	
degraded	 during	 adenovirus	 infection,	 whether	 adenovirus	 degrades	 TAB182	 as	 well	 as	
CNOT	for	the	same	advantage	is	currently	unknown.		
Cells	 deficient	 in	 TAB182	 are	 hypersensitive	 to	 agents	 that	 induce	DNA	 replication	
stress	and	also	exhibit	abnormal	 replication	dynamics	 following	release	 from	hydroxyurea-
induced	 fork	 stalling.	 In	 particular,	 they	 display	 increased	 fork	 restart	 and	 elevated	 new	
origin	firing	following	release	from	hydroxyurea	treatment,	suggesting	that	TAB182	prevents	
fork	 recovery	 and	 suppresses	 new	 origin	 firing	 following	 replication	 stress.	 Depletion	 of	
some	 components	 of	 the	 CNOT	 complex	 is	 able	 to	 rescue	 the	 phenotypes	 observed	 in	
TAB182	deficient	cells,	suggesting	that	TAB182	and	the	CNOT	complex	may	act	in	concert	at	
the	replication	fork.	TAB182	deficient	cells	display	 less	DNA	gaps	and	breaks	but	 increased	
	levels	 of	 53BP1	 bodies	 in	 G1	 and	 micronuclei,	 which	 are	 markers	 of	 genome	 instability,	
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	 	 	 	Table	4.1	 GST-TAB182C	Non-Interacting	Proteins	
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later,	 a	 number	 of	 publications	 presented	 evidence	 to	 suggest	 a	 novel	 ‘agent’	 was	
responsible	for	patients	diagnosed	with	‘acute	respiratory	illness’	that	was	not	attributed	to	





tumours	 in	 new-born	 rodents,	 adenovirus	 can	 also	 transform	mammalian	 cells	 in	 culture;	
every	adenovirus	serotype	is	known	to	have	the	capacity	to	transform	primary	rodent	cells	in	
vitro	(McBride	and	Wiener	1964,	Pope	and	Rowe	1964).		
The	 adenoviridae	 family	 contains	 five	 accepted	 genera	 comprised	 of	
Mastadenoviridae,	 Atadenoviridae,	 Aviadenoviridae,	 Siadenoviridae	 and	 Ictadenoviridae.	
These	 genera	 encompass	 a	 wide	 range	 of	 host	 vertebrate	 species	 from	 humans	 in	 the	
Mastadenoviridae	genus,	to	fish	in	the	Ictadenoviridae	genus.	Mastadenoviridae	is	the	genus	









A" 12,"18,"31" High" Yes"
B1" 3,"7,"16,"21,"50"" Moderate" Yes"
B2" 11,"14,"34,"35,"55" Moderate" Yes"




E" 4" Low/None" Yes"
F" 40,"41" Not"reported" Yes"







G	(Table	1.1).	The	species	to	which	each	serotype	 is	grouped	 is	 largely	dependent	on	their	
oncogenicity	 in	 rodents,	 their	 ability	 to	 agglutinate	 erythrocytes	 and	 their	 DNA	 sequence	
(Russell	2009).	
Certain	 adenovirus	 serotypes	 are	 known	 to	 cause	 gastrointestinal,	 respiratory	 and	
ocular	disease	(Bennett,	Hamilton	et	al.	1957,	Brandt,	Kim	et	al.	1969,	Uhnoo,	Wadell	et	al.	
1984).	 The	 incidence	of	 adenovirus	 infection	 in	 immunocompromised	hosts	 is	 significantly	
increased,	particularly	in	patients	receiving	allogeneic	stem	cell	transplantations.	Adenovirus	







of	 252	 subunits;	 240	 hexons	 and	 12	 pentons	 (Horne,	 Brenner	 et	 al.	 1959).	 Six	 years	 later	
further	 imaging	 by	 electron	 microscopy	 revealed	 fibres	 that	 protruded	 from	 the	 penton	
bases	 of	 the	 capsid	 of	 the	 virus	 (Valentine	 and	 Pereira	 1965).	 More	 recently,	 X-ray	
crystallography	 has	 revealed	 the	 atomic	 structure	 of	 most	 of	 the	 adenovirus	 structural	
proteins	(Roberts,	White	et	al.	1986,	Athappilly,	Murali	et	al.	1994,	Zubieta,	Schoehn	et	al.	
2005).	 Each	virion	 is	 composed	of	multiple	 copies	of	 a	 total	of	11	 structural	proteins.	 The	
icosahedral	capsid	is	formed	from	the	structural	proteins	hexon	(II),	penton	base	(III)	and	the	
protruding	knob	fibre	(IV),	which	are	known	to	be	essential	for	binding	to	the	coxsackievirus	
and	Ad	 receptor	 (CAR)	of	 the	host	 cell	 (Bergelson,	Cunningham	et	 al.	 1997).	 The	 capsid	 is	
		 4	
also	 composed	 of	 the	more	minor	 structural	 capsid	 proteins	 IIIa,	 IV,	 VIII	 and	 IX.	 The	 core	
complex	 contains	 the	 proteins	 V,	 VII,	Mu	 and	 the	 terminal	 protein	 (TP).	 Each	 adenovirus	
virion	also	contains	10	copies	of	the	adenovirus	protease	protein	(Anderson	1990).	
The	adenoviral	genome	is	a	linear,	double-stranded	deoxyribonucleic	acid	(dsDNA)	of	
approximately	35kbp	 in	 size.	 The	adenoviral	 genome	 is	 characterised	by	 inverted	 terminal	
repeats	 (ITRs)	 which	 are	 approximately	 100	 bp	 long	 (actual	 length	 varies	 between	
serotypes).	The	TP	 is	 covalently	 linked	 to	each	5’	end	via	 the	 ITR	 region	of	 the	adenovirus	
genome,	its	function	being	to	prime	the	genome	for	DNA	replication	(Rekosh,	Russell	et	al.	











the	viral	 capsid	 in	preparation	 for	exit	of	 the	viral	DNA	 (Greber,	Webster	et	al.	1996).	The	
virus	 is	 then	 transported	 from	 the	 cytoplasm	 to	 the	 nucleus,	 a	 process	 thought	 to	 be	
achieved	 through	 the	 association	with	 the	 cellular	 protein	 p32.	 p32	 shuttles	 between	 the	
mitochondria	and	nucleus	as	part	of	the	cellular	transport	system,	a	system	that	is	believed	
		 5	
to	 be	 hijacked	 by	 the	 virus	 in	 order	 to	 enter	 the	 host	 cell	 nucleus	 (Matthews	 and	Russell	
1998).	
The	 adenovirus	 infectious	 cycle	 can	 be	 categorised	 into	 the	 early	 and	 late	 phase,	
which	 is	 separated	 by	 adenoviral	 DNA	 replication.	 The	 early	 phase	 of	 the	 adenovirus	
infectious	cycle	takes	6-8	hours	and	involves	the	transcription	of	the	early	proteins	E1,	E2,	E3	
and	 E4	 (see	 Sections	 1.1.4,	 1.1.5	 and	 1.1.6	 for	 a	 detailed	 discussion	 on	 the	 E1	 and	 E4	
proteins).	 In	 order	 to	 replicate	 its	 genome,	 adenovirus	 uses	 three	 viral	 proteins	 produced	
from	 transcription	 of	 its	 early	 E2	 genes.	 These	 are	 the	 TP	 precursor	 (pTP),	 Adv	 DNA	
polymerase	 (Adv	 Pol)	 and	 the	DNA	 binding	 protein	 (DBP)	 (van	 der	 Vliet	 and	 Levine	 1973,	
Coombs,	Robinson	et	al.	1979).	Adenovirus	also	utilises	 three	cellular	proteins	during	DNA	
replication,	two	transcription	factors:	nuclear	factor	1	(NF1)	and	octamer-binding	protein	1	
(Oct-1),	 as	 well	 as	 the	 type	 1	 topoisomerase	 (TOP)	 nuclear	 factor	 2	 (NF2)	 (Nagata,	
Guggenheimer	et	al.	1982,	Nagata,	Guggenheimer	et	al.	1983,	Pruijn,	van	Driel	et	al.	1986).	
Adenovirus	DNA	replication	begins	from	both	ends	of	the	DNA	termini	whereby	a	covalent	
bond	 is	 formed	between	 the	5’	 terminal	nucleotide	deoxycitidine	monophosphate	 (dCMP)	
and	a	serine	residue	of	pTP,	in	a	reaction	catalysed	by	Ad	pol.	This	dCMP/pTP	complex	then	
acts	as	a	primer	for	nascent	DNA	synthesis.	DBP	stimulates	the	binding	of	the	transcription	
factor	 NF1	 to	 AdV	 Pol,	 whilst	 the	 transcription	 factor	 Oct-1	 interacts	 with	 pTP;	 together	
these	proteins	form	the	pre-initiation	complex	required	for	the	initiation	of	DNA	replication	
(Nagata,	Guggenheimer	et	al.	1982).	DBP	also	promotes	DNA	elongation	and	together	with	
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Figure	 1.1:	 Adenovirus	 Genome	 Organisation.	 	 Schematic	 to	 outline	 the	
organisation	 of	 the	 adenovirus	 genome.	 Early	 adenovirus	 transcripts	 are	
indicated	 in	 green,	 late	 adenovirus	 transcripts	 are	 indicated	 in	 blue.	









The	 adenovirus	 E1A	 protein	 is	 the	 first	 messenger	 RNA	 (mRNA)	 to	 be	 transcribed	
following	entry	of	the	virus	into	the	nucleus	and	produces	two	major	mRNA	products	of	289	
and	 243	 amino	 acid	 residues	 in	 length	 in	 adenovirus	 serotype	 5.	 E1As	 from	 other	 virus	
serotypes	vary	in	length	(Avvakumov,	Sahbegovic	et	al.	2002).	These	proteins	contain	three	
conserved	 regions	 (CRs)	 known	 as	 CR1,	 CR2	 and	 CR4,	 whilst	 the	 289	 amino	 acid	 protein	





in	 gene	 expression	 and	 cell	 growth,	 with	 the	 ultimate	 aim	 of	 replicating	 the	 adenoviral	
genome.	 These	 genes	 include	 transcriptional	 co-repressors,	 co-activators,	 cell	 cycle	
regulatory	 proteins	 and	 the	 transcriptional	 machinery	 (Gallimore	 and	 Turnell	 2001,	 Berk	
2005).		
The	 first	 E1A-binding	 protein	 to	 be	 characterised	 was	 the	 retinoblastoma	 protein	
(pRB)	tumour	suppressor	(Whyte,	Buchkovich	et	al.	1988).	The	CR1	and	CR2	regions	of	E1A	




























Figure	 1.2:	 Representation	 of	 Ad5	 E1A13S.	 Schematic	 shows	 the	Ad5	 E1A13S	 protein	
and	 the	 four	 conserved	 regions	 (CR1-4)	 of	 the	 protein.	 Protein	 binding	 partners	 are	




transcription	of	 the	viral	 gene	E2	and	a	number	of	 cellular	 genes,	 the	end	 result	of	which	
being	 S	phase	entry,	which	drives	 viral	DNA	 replication	 (Bagchi,	 Raychaudhuri	 et	 al.	 1990,	
Grand,	 Ibrahim	 et	 al.	 1998).	 In	 adenovirus	 transformed	 cells	 where	 there	 is	 no	 viral	
replication,	 the	 role	 of	 AdE1A	 is	 to	 drive	 cellular	 proliferation,	 largely	 through	 interaction	
with	the	same	proteins	(Gallimore	and	Turnell	2001).	
Another	 way	 in	 which	 the	 adenovirus	 E1A	 protein	 is	 able	 to	 drive	 cell	 cycle	
progression	is	through	the	interaction	with	the	transcriptional	co-activators	p300	and	CREB-
binding	 protein	 (CBP)	 (Eckner,	 Ewen	 et	 al.	 1994,	 Arany,	 Newsome	 et	 al.	 1995).	 These	
transcriptional	 co-activators	 possess	 histone	 acetyltransferase	 (HAT)	 activity	 which	 is	
thought	 to	 control	 the	 transcriptional	 activation	 of	 other	 key	 cell	 cycle	mediator	 proteins	
such	as	p53	and	nuclear	 factor-kappa	B	 (NF-κB),	again	with	 the	ultimate	aim	to	drive	cells	
into	S	phase	(Ogryzko,	Schiltz	et	al.	1996,	Lill,	Grossman	et	al.	1997).		
Other	 E1A	 interacting	 proteins	 include	 the	 transcriptional	 co-repressor	 C-terminal	
binding	protein	(CtBP)	and	components	of	the	general	transcription	machinery	such	as	the	
TATA-binding	protein	 (TBP)	 and	 a	 number	of	 TBP-associated	 factors	 (TAFs),	 as	well	 as	 the	
transcription	 factors	 AMP-dependent	 transcription	 factor	 2	 (ATF2)	 and	 cJUN	 (Figure	 1.2)	














its	mobility	and	therefore	 its	 function	 (Muller	and	Dobner	2008,	Pennella,	Liu	et	al.	2010).	
The	E1B55K	protein	then	facilitates	nuclear	export	and	the	subsequent	degradation	of	p53	
(Figure	1.3)	(Muller	and	Dobner	2008).	
In	 addition	 to	 E1B55K	 acting	 alone,	 E1B55K	 also	 interacts	 with	 the	 E4orf6	 viral	
protein,	 the	 results	 of	 which	 are	 two-fold:	 firstly,	 the	 E1B55K	 and	 E4orf6	 proteins	 act	
together	to	induce	the	degradation	of	a	number	of	cellular	proteins	which	would	otherwise	
be	 detrimental	 to	 viral	 DNA	 replication.	 Secondly,	 the	 E1B55K	 and	 E4orf6	 proteins	 inhibit	
cellular	mRNA	 export	 and	 translation	whilst	 facilitating	 the	 transport	 of	 late	 viral	mRNAs.	
Ad5E1B55K	 and	Ad5E4orf6,	 together	with	 the	 cellular	 proteins	 RING-box	 1	 (Rbx1),	 Cullin5	
(Cul5)	and	Elongins	B	and	C	form	an	E3	ubiquitin	ligase	complex	that	is	able	to	ubiquitinate	
target	 proteins	 and	 thus	 direct	 them	 for	 proteasomal-mediated	 degradation	 (Querido,	
Blanchette	 et	 al.	 2001).	 Such	 targets	 include	 p53	 and	 various	 DNA	 damage	 and	 repair	
proteins	 (see	 Section	 1.3.2).	 The	 E1B55K	 and	 E4orf6	 proteins	 also	 have	 roles	 in	 the	 late	














Figure	 1.3:	 Representation	 of	 Ad5	 E1B55K.	 Schematic	 shows	 the	Ad5	E1B55K	protein	









for	 viral	 mRNA	 export	 (Ornelles	 and	 Shenk	 1991,	 Dobbelstein,	 Roth	 et	 al.	 1997).	 Indeed,	
E1B55K	 is	known	to	be	required	for	the	transport	of	viral	mRNAs	from	the	nucleus	via	the	
chromosome	 region	maintenance	 1	 (CRM1)	 export	 pathway,	 but	 the	 precise	 roles	 of	 the	
ubiquitin	E3	ligase	complex	in	viral	mRNA	export	is	yet	to	be	defined	(Babiss,	Ginsberg	et	al.	
1985,	Dosch,	Horn	 et	 al.	 2001,	 Kindsmuller,	Groitl	 et	 al.	 2007,	Woo	 and	Berk	 2007).	 Both	










BCL2-associated	X	 (BAX)	pro-apoptotic	protein,	 resulting	 in	 the	 formation	of	mitochondrial	
membrane	 pores	 from	 which	 the	 pro-apoptotic	 proteins	 that	 activate	 caspases,	 such	 as	
cytochrome	c	and	second	mitochondria-derived	activator	of	caspases	(SMAC),	are	released.	














et	al.	 1985).	 It	was	 later	 revealed	 that	mutations	 in	orf3	or	orf6	 can	compensate	 for	each	
other,	perhaps	explaining	the	previous	result	 (Bridge	and	Ketner	1989,	Huang	and	Hearing	
1989).	 The	 E4	 proteins	 have	 a	 diverse	 range	 of	 functions	 during	 adenovirus	 infection	
including	 the	 regulation	 of	 transcription,	 mRNA	 nucleocytoplasmic	 transport,	 DNA	
replication,	virion	assembly	and	host-cell	shut	off.			
E4orf4	 has	 a	 number	 of	 roles	 during	 adenovirus	 infection	 including	 the	 negative	




subunit	 of	 PP2A,	 leading	 to	 the	 hypophosphorylation	 of	 a	 number	 of	 viral	 and	 cellular	
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proteins	 including	 E1A	 and	 the	 c-Fos	 component	 of	 the	 activating	 protein	 1	 (AP1)	





viral	and	cellular	proteins.	This	negative	 feedback	 loop	 is	 thought	 to	exist	 in	order	 to	 limit	
the	 toxicity	 of	 viral	 infection	 and	 in	 turn	 increase	 viral	 efficiency.	 The	 adenovirus	 E4orf4	
protein	 has	 also	 been	 shown	 to	 induce	 apoptosis,	 the	 expression	 of	 E4orf4	 protein	 was	
shown	 to	 induce	 apoptosis	 independently	 of	 p53	 (Marcellus,	 Lavoie	 et	 al.	 1998).	
Interestingly,	 the	 induction	 of	 apoptosis	 was	 seen	 exclusively	 in	 transformed	 cell	 lines,	
suggesting	that	E4orf4	may	be	a	potential	therapeutic	target	(Shtrichman,	Sharf	et	al.	1999).		
Apart	 from	 the	 adenovirus	 E1A	 and	 E1B	 proteins,	 E4orf1	 is	 the	 only	 other	 known	
adenovirus	protein	to	confer	transforming	capabilities	in	rodent	cells,	albeit	only	during	Ad9	
infection	(Javier,	Raska	et	al.	1992,	Javier	1994).	




The	 E4orf6/7	 gene	 product	 is	 a	 fusion	 protein	 with	 known	 roles	 as	 a	 viral	
transactivator	 together	with	 E1A.	 The	 E4orf6/7	 protein	 is	 known	 to	 bind	 to	 E2F,	where	 it	
dimerises	and	associates	with	E2F	binding	sites	 in	the	viral	Ad5	E2	early	promoter	and	the	





As	 previously	 discussed	 (see	 Section	 1.1.5),	 E4orf6	 cooperates	 with	 the	 E1B55K	







The	 adenovirus	 E4orf3	 protein	 has	 a	 number	 of	 roles	 during	 adenovirus	 infection.	
E4orf3	 is	 involved	 in	the	splicing	of	the	viral	major	 late	transcript	 (Nordqvist,	Ohman	et	al.	
1994).	E4orf3	has	also	been	shown	to	be	responsible	for	the	reorganisation	of	a	number	of	
cellular	 proteins	 to	 discrete	 nuclear	 structures	 known	 as	 PML	 nuclear	 bodies	 or	 PML	
oncogenic	 domains	 (PODs).	 A	 number	 of	 proteins	 are	 known	 to	 associate	 with	 these	
structures,	 the	most	notable	of	which	 is	 the	PML	protein,	 the	 recruitment	of	a	number	of	
PML	 nuclear	 bodies	 is	 dependent	 on	 this	 protein.	 During	 adenovirus	 infection,	 E4orf3	 is	
responsible	 for	 the	 rapid	 reorganisation	 of	 PODs	 into	 track-like	 structures	 through	 the	
interaction	with	the	PML	isoform	PMLII	(Hoppe,	Beech	et	al.	2006).	The	precise	function	of	




and	 Bazett-Jones	 2004,	 Takahashi,	 Lallemand-Breitenbach	 et	 al.	 2004).	 E4orf3	 is	 also	
responsible	for	the	localisation	of	E4orf6	to	PML	nuclear	bodies	(Leppard	and	Everett	1999).	
E4orf3	also	stimulates	the	reorganisation	of	p53	to	PML	bodies	where	it	 induces	H3K9me3	
heterochromatin	 formation	 at	 p53	 target	 promoter	 regions,	 silencing	 p53	 target	 genes	
(Soria,	Estermann	et	al.	2010).	Finally,	as	well	as	E1B55K,	E4orf3	has	been	shown	to	also	bind	
to	 p53,	 relocating	 it	 from	 the	 nucleus	 to	 the	 cytoplasm.	 The	 function	 of	 the	 E4orf3	
interaction	with	p53	is	thought	to	‘liberate’	p53	from	E1B55K,	subsequently	allowing	it	to	be	
degraded	by	the	E1B55K/E4orf6	E3	ubiquitin	ligase	complex	(Konig,	Roth	et	al.	1999).	E4orf3	




DNA.	 DNA	 damage	 occurs	 from	 both	 exogenous	 agents	 as	 well	 as	 endogenous	 cellular	
processes.	 Examples	 of	 exogenous	 agents	 that	 are	 able	 to	 induce	 DNA	 damage	 include	
exposure	 to	ultra-violet	C	 (UV-C)	 irradiation,	which	 leads	 to	 the	 formation	of	bulky	 lesions	




damage	 include	 heterocyclic	 amines	 and	 aflatoxins	 which	 can	 be	 found	 in	 contaminated	














































can	 be	 generated	 from	 both	 exogenous	 agents	 as	 well	 as	 endogenous	 cellular	 processes.	
Activation	of	the	DNA	damage	response	induces	cell	cycle	arrest	to	prevent	DNA	replication	
until	 the	 damage	 is	 repaired.	 In	 the	 event	 of	 irreparable	 DNA	 damage,	 apoptosis	
mechanisms	are	triggered.	DNA	damage	includes	the	generation	of	DNA	strand	breaks,	bulky	






‘nicks’	 in	 the	DNA	during	DNA	 replication	or	 transcription,	 such	as	 topoisomerase	 I	 (TOPI)	
and	 topoisomerase	 II	 (TOPII),	 leading	 to	 SSBs	 and	 DSBs	 respectively,	 and	 the	 erroneous	
action	of	DNA	polymerases	during	DNA	replication,	leading	to	DNA	base	mismatches	(Weiss,	
King	et	al.	1977,	Ward,	Evans	et	al.	1987).		




coordinated	 set	 of	 signalling	 networks	 and	 repair	 pathways	 exist	 in	 order	 to	 protect	 the	





can	 occur	 both	 endogenously	 and	 from	 environmental	 sources.	 DSBs	 can	 occur	
endogenously	through	the	abortive	activity	of	TOPII,	the	collapse	of	stalled	replication	forks	
and	 from	 the	 collision	of	 an	elongating	 replication	 fork	with	 a	 SSB	during	DNA	 replication	





be	 detrimental	 to	 genome	 integrity	 if	 these	 breaks	 were	 not	 efficiently	 repaired	 (Lieber	
2010).		
The	MRN	complex,	 comprising	Mre11,	Rad51	and	Nbs1	proteins,	 is	 responsible	 for	
the	rapid	detection	of	DSBs.	Following	detection,	the	transducer	kinase	ataxia	telangiectasia	
mutated	(ATM)	is	rapidly	recruited	to	the	site	of	the	break	(Falck,	Coates	et	al.	2005,	Lee	and	
Paull	2005).	Two	events	are	 required	 for	 the	complete	activation	of	ATM:	 firstly,	 the	MRN	
complex	 is	 required	 to	 activate	ATM,	 secondly,	ATM	 is	 acetylated	by	HIV-1	 tat	 interacting	
protein	 60kDa	 (Tip60)	 (Sun,	 Jiang	 et	 al.	 2005).	 In	 its	 inactive	 form,	 ATM	 resides	 in	
homodimers	 but,	 following	 its	 activation,	 it	 becomes	 autophosphorylated	 whereby	 it	
dissociates	to	form	active	monomers	(Bakkenist	and	Kastan	2003).	Following	the	complete	
activation	 of	 ATM	 by	 the	 MRN	 complex	 and	 Tip60,	 ATM	 is	 then	 able	 to	 phosphorylate	
downstream	 components	 of	 the	 DNA	 damage	 response	 (DDR)	 such	 as	 H2AX,	 and	
components	of	 the	 cell	 cycle	 checkpoint	 such	as	p53	and	Chk2,	ultimately	 resulting	 in	 the	




Following	 DSB	 formation,	 the	 histone	 H2A	 variant	 H2AX,	 a	 minor	 chromatin	
constituent	 composed	 of	 approximately	 2-25%	 of	 the	 total	 H2A	 pool,	 becomes	 rapidly	









subsequently	 phosphorylated	 by	 ATM.	 MDC1	 recruits	 additional	 ATM	 to	 the	 site	 of	 the	
break,	propagating	the	DNA	damage	signal,	and	also	recruits	RNF8	to	the	site	of	the	break.	
RNF8,	together	with	MDC1	catalyses	the	formation	of	ubiquitin	chains	onto	γH2AX.	RNF168	
is	 then	 recruited	 to	 the	 site	 of	 the	 break	 and	 further	 ubiquitinates	 γH2AX.	 At	 this	 point	
repair	 factors	 such	 as	 53BP1	 and	 BRCA1	 are	 recruited	 to	 the	 site	 of	 the	 break.	 RPA	 is	
responsible	 for	 the	 rapid	 detection	 of	 ssDNA.	 Binding	 of	 RPA	 to	 ssDNA	 recruits	 the	 ATR	
kinase	 through	 its	 association	 with	 ATRIP.	 TOPBP1	 localises	 to	 the	 region	 through	 9-1-1	




































where	 it	 is	 subsequently	 phosphorylated	 by	 ATM	 (Goldberg,	 Stucki	 et	 al.	 2003).	MDC1	 is	
then	able	to	associate	with	γH2AX,	ATM	and	the	MRN	complex,	the	results	of	which	are	two-
fold	 (Stucki,	Clapperton	et	al.	2005).	Firstly,	MDC1	 is	able	 to	 recruit	additional	ATM	to	 the	
site	 of	 the	 damage,	 where	 it	 is	 able	 to	 propagate	 the	 DNA	 damage	 signal	 through	 the	
phosphorylation	 of	 additional	H2AX	 (Lou,	Minter-Dykhouse	 et	 al.	 2006).	 It	 is	 thought	 that	
this	 action	 is	 able	 to	 ‘spread’	 the	 DNA	 damage	 signal	 along	 up	 to	 2	 megabases	 of	 DNA	
(Celeste,	Petersen	et	al.	2002).	Secondly,	MDC1	is	able	to	form	a	‘scaffold’	onto	which	other	
proteins	involved	in	the	DDR	can	access	the	site	of	the	break.	Following	the	recruitment	and	




are	 responsible	 for	 the	 addition	 of	 K63	 ubiquitin	 chains	 onto	 γH2AX,	 amplifying	 the	 DNA	




ubiquitination	of	γH2AX	at	 the	site	of	 the	DSB	also	 leads	to	the	recruitment	of	DNA	repair	
proteins	such	as	receptor-associated	protein	80	(RAP80),	breast	cancer	type	1	susceptibility	






to	 activate	 ATR	 being	 single-stranded	 DNA	 (ssDNA)(Figure	 1.5)(Zou	 and	 Elledge	 2003,	
Jazayeri,	 Falck	 et	 al.	 2006).	 The	 ssDNA	 binding	 protein,	 replication	 protein	 A	 (RPA),	 is	
responsible	for	the	rapid	coating	of	regions	of	ssDNA,	which	subsequently	recruits	the	ATR	
kinase	 to	 the	 ssDNA	 site	 through	 the	 interaction	 with	 the	 ATR	 binding	 partner	 ATR-
interacting	protein	(ATRIP)(Zou	and	Elledge	2003).	The	Rad9-Rad1-Hus1	(9-1-1)	complex	and	
the	Rad17-replication	factor	C	2	(RFC2)	clamp	loader	complex	are	subsequently	recruited	to	
the	 ssDNA-RPA	 complex,	 which	 results	 in	 topoisomerase	 II	 binding	 protein	 1	 (TOPBP1)	
recruitment	to	the	site	of	ssDNA	(Bermudez,	Lindsey-Boltz	et	al.	2003,	Zou	and	Elledge	2003,	
Parrilla-Castellar,	 Arlander	 et	 al.	 2004).	 TOPBP1	 is	 then	 able	 to	 activate	 ATR	 through	
associations	with	ATRIP	and	the	Rad9	component	of	the	9-1-1-	complex	(Kumagai,	Lee	et	al.	
2006,	 Mordes,	 Glick	 et	 al.	 2008).	 Activated	 ATR	 is	 subsequently	 able	 to	 phosphorylate	









DSB	 repair	 is	 essential	 for	 the	 maintenance	 of	 genome	 integrity	 since	 failure	 to	
efficiently	 repair	DNA	damage	 can	 lead	 to	 gross	 chromosomal	 translocations	 and	 genome	
instability.	 There	 are	 two	main	 DSB	 repair	mechanisms	 in	 place	 to	 rapidly	 and	 efficiently	
repair	 DSBs	 when	 they	 arise;	 these	 repair	 mechanisms	 are	 non-homologous	 end-joining	
(NHEJ)	and	homologous	recombination	(HR)	repair	(Weibezahn	and	Coquerelle	1981).	NHEJ	






end	 processing	 (end-resection)	 followed	 by	 a	 ‘search’	 for	 homologous	 regions	 in	 the	
undamaged,	 sister	 strand	 of	 the	 DNA;	 once	 found,	 this	 region	 of	 homology	 is	 used	 as	 a	
template	 for	 DNA	 repair.	 Since	 HR	 repair	 involves	 end-processing	with	 no	 loss	 of	 genetic	
information,	 HR	 is	 considered	 to	 be	 an	 error-free	 form	 of	 DSB	 repair.	 However,	 since	 HR	








heterodimer,	 which	 forms	 a	 ring-like	 structure	 around	 each	 end	 of	 the	 DSB	 (Figure	 1.6)	
(Blier,	 Griffith	 et	 al.	 1993,	 Walker,	 Corpina	 et	 al.	 2001).	 The	 formation	 of	 the	 ring-like	
structure	around	the	DNA	allows	the	structure	to	translocate	along	the	DNA	away	from	the	
break,	 which	 allows	 other	 NHEJ	 proteins	 access	 to	 the	 site	 of	 the	 break	 (Yoo	 and	 Dynan	
1999).	 Following	 the	 recruitment	 of	 the	 Ku70/80	 heterodimer	 to	 the	 break,	 the	 catalytic	
subunit	 of	 the	 DNA-dependent	 protein	 kinase	 (DNA-PKcs)	 associates	 with	 the	 Ku70/80	
heterodimer,	 together	 forming	 the	 DNA-PK	 holoenzyme	 (Suwa,	 Hirakata	 et	 al.	 1994).	 The	
active	DNA-PK	holoenzyme	autophosphorylates	 itself,	as	well	as	phosphorylating	a	number	







termini	 before	 they	 can	 be	 re-ligated	 by	 NHEJ.	 The	 end-processing	 enzymes	 used	 in	 this	
process	 are	 dependent	 on	 the	 termini	 created	 during	 the	DNA	damage.	 For	 example,	 the	
major	processing	enzyme	during	NHEJ	is	believed	to	be	Artemis,	which	is	responsible	for	the	

































the	 detection	 of	 DSBs	 during	 NHEJ.	 Following	 initial	 detection,	 the	 Ku70/Ku80	
heterodimer	translocates	along	the	DNA	allowing	access	to	the	break	for	other	DSB	repair	
machinery.	 DNA-PK	 is	 then	 recruited	 to	 the	 site	 of	 the	 break	 and	 together	 with	
Ku70/Ku80,	forms	the	DNA-PK	holoenzyme.	The	autophosphorylation	of	DNA-PK	results	in	
the	accumulation	of	other	DSB	 repair	proteins	at	 the	 site	of	 the	break	 such	as	Artemis,	
DNA	 ligase	IV,	XRCC4	and	XLF.	A	variety	of	end-processing	factors	including	Artemis,	are	










protein	 (CtIP)	 (Figure	 1.7)	 (Sartori,	 Lukas	 et	 al.	 2007,	 Huertas	 and	 Jackson	 2009).	 The	 E3	
ubiquitin	 ligase	BRCA1	 is	 responsible	 for	the	targeting	of	CtIP	to	the	DSB	site	 (Yu,	Fu	et	al.	
2006).	The	helicase	BLM	and	 the	exonucleases:	exonuclease	1	 (EXO1)	and	DNA	replication	
helicase/nuclease	 2	 (DNA2)	 are	 responsible	 for	 the	 further	 resection	 of	 the	 DNA	 ends	
(Nimonkar,	Genschel	et	al.	2011).	The	3’	ssDNA	overhang	created	from	resection	of	the	DNA	
ends	is	rapidly	coated	with	RPA,	with	two	major	consequences.	Firstly,	the	coating	of	RPA	on	
the	 ssDNA	 activates	 ATR	 and	 its	 downstream	 proteins.	 Secondly,	 RPA	 binding	 to	 ssDNA	
induces	the	next	steps	in	the	HR	process.	RPA	is	displaced	from	the	ssDNA-RPA	by	Rad51	in	a	
breast	 cancer	 type	 2	 susceptibility	 protein	 (BRCA2)-dependent	 manner,	 which	 forms	 a	
nucleoprotein	 filament	with	the	ssDNA	(Wong,	Pero	et	al.	1997,	Pellegrini,	Yu	et	al.	2002).	
The	 ssDNA-Rad51	 nucleoprotein,	 then	 invades	 the	 undamaged,	 sister	 chromatid	 strand,	
displacing	the	DNA,	which	forms	a	displacement	loop	(D-loop)(Baumann,	Benson	et	al.	1996,	
Sugiyama	and	Kowalczykowski	2002).	The	nucleoprotein	 filament	 then	undergoes	a	search	






























Figure	 1.7:	 Homologous	 Recombination	 Repair.	 During	 homologous	 recombination	
repair,	 MRN	 in	 conjunction	 with	 CtIP	 and	 BRCA1,	 are	 responsible	 for	 the	 initial	 5’-3’	






whereby	 the	 D-loop	 captures	 the	 second	 DNA	 end,	 or	 by	 synthesis-dependent	 strand	
annealing	 (SDSA),	 where	 the	 D-loop	 is	 dissolved	 before	 second-end	 capture,	 resulting	
exclusively	in	non-crossover	events.	The	classical	recombination	repair	pathway	results	in	




junction	 is	 formed	 which	 can	 be	 resolved	 by	 the	 endonucleases	 MUS81	 endonuclease	
homologue	(MUS81)/	essential	meiotic	endonuclease	1	homologue	1	(EME1),	SLX1/SLX4	and	
GEN1	 (Boddy,	Gaillard	et	 al.	 2001,	 Ip,	Rass	 et	 al.	 2008,	 Fekairi,	 Scaglione	et	 al.	 2009).	 The	
endonucleases	 are	 responsible	 for	 the	 cleavage	 of	 the	 junction	 and	 depending	 on	 the	
endonuclease	employed,	this	results	in	either	a	chromatid	crossover	event,	whereby	genetic	









occur	 in	 the	 genome,	with	 approximately	 10,000	 endogenously-induced	 SSBs	 per	 cell	 per	
day	 (Lindahl	1993).	 SSBs	are	not	 the	most	genotoxic	DNA	 lesion	 to	 the	cell;	however,	 it	 is	

























repair.	Alternatively,	 single-strand	breaks	 can	be	generated	directly	and	are	 recognised	by	
PARP1.	As	with	DSBs,	SSBs	possess	damaged	termini	which	need	to	be	processed	before	SSB	
repair	 can	 proceed.	 A	 number	 of	 end-processing	 factors	 exist	 to	 process	 the	 termini,	 one	
example	 being	 PNPK.	 Following	 DNA	 end-processing,	 DNA	 gap	 filling	 can	 occur	 either	





alkylated,	 deaminated	 and	 oxidised	 bases	 from	 the	 DNA	 backbone.	 Nucleotide	 excision	
repair	(NER)	also	leads	to	the	indirect	formation	of	SSBs	through	the	removal	of	bulky,	helix	
distorting	 lesions	from	the	DNA	backbone.	SSBs	can	also	occur	from	abortive	TOP1	activity	
during	 DNA	 replication	 and	 transcription.	 The	 function	 of	 TOP1	 is	 to	 reduce	 super-helical	







or	 incorrect	 bases	 during	 BER	 (Lindahl	 1974).	 During	 BER,	 DNA	 base	 modifications	 are	
excised	 by	 DNA	 glycosylases	 which	 act	 to	 excise	 these	 modifications	 leaving	 an	 apurinic-
apyrimidinic	 (AP)	 site	 (Figure	 1.8).	 There	 are	 known	 to	 be	 two	 types	 of	DNA	 glycosylases;	
mono-functional	 glycosylases	 which	 possess	 glycosylase	 activity	 alone,	 and	 bi-functional	
glycosylases	which	possess	glycosylase	activity	and	AP	lyase	activities	(Lindahl	1974).	Mono-
functional	 glycosylases	excise	 the	damaged	base	 leaving	an	AP	 site,	which	 is	 subsequently	
incised	 by	 AP	 endonuclease	 I	 (APE1),	 leaving	 a	 SSB	 (Demple,	 Herman	 et	 al.	 1991).	 The	
intrinsic	 AP	 lyase	 activities	 of	 the	 bi-functional	 glycosylases	 cleave	 abasic	 sites	 in	 a	 β-
elimination	or	β,δ-	elimination	reaction,	leading	to	a	single	nucleotide	gap	containing	a	5’-P	
and	3’-αβ	unsaturated	aldehyde	or	5’	and	3’-P,	respectively	(O'Connor	and	Laval	1989).		
Poly	 (ADP-ribose)	 polymerase	 1	 (PARP1)	 is	 responsible	 for	 the	 recognition	 of	 SSBs	
that	 have	 occurred	 directly	 (e.g	 through	 sugar	 damage);	 upon	 recognition	 and	 binding	 of	
		 31	
PARP1	to	the	SSB,	PARP1	becomes	activated	(Figure	1.8)	(Benjamin	and	Gill	1980,	Alkhatib,	
Chen	 et	 al.	 1987,	 Gradwohl,	 Menissier	 de	 Murcia	 et	 al.	 1990,	 Satoh	 and	 Lindahl	 1992,	
Weinfeld,	Chaudhry	et	al.	1997).	The	activation	of	PARP1	induces	its	poly	(ADP-ribose)(PAR)	









5’P	 ends.	 This	 is	 achieved	 by	 various	 end-processing	 proteins,	 the	 protein	 involved	 in	 the	
end-processing	 is	 dependent	 on	 the	 type	 of	 damage	 to	 the	 termini.	 For	 example,	
polynucleotide	kinase	phosphatase	 (PNKP)	 is	necessary	 for	 the	processing	of	3’P	and	5’OH	
termini	 induced	by	ROS,	 and	 so	 is	 a	 particularly	 important	processing	 enzyme	 considering	
the	abundance	of	these	lesions	(Jilani,	Ramotar	et	al.	1999,	Whitehouse,	Taylor	et	al.	2001).		
Following	the	restoration	of	the	DNA	termini	to	their	conventional	forms,	single-strand	gap	
filling	 can	 occur	which	 can	 either	 incorporate	 one	 nucleotide	 (short-patch	 repair)	 or	 2-12	
nucleotides	 (long-patch	repair)(Dianov,	Price	et	al.	1992,	Klungland	and	Lindahl	1997).	The	
removal	 of	 displaced	 5’	 nucleotides	 produced	 during	 long-patch	 repair	 are	
resolved/removed	 by	 flap	 endonuclease	 1	 (FEN1)	 (Prasad,	 Dianov	 et	 al.	 2000).	 The	 DNA	
polymerases	 involved	 in	 short-patch	 and	 long-patch	 repair	 are	 numerous	 and	 are	
		 32	
responsible	for	DNA	gap	filling	during	BER.	Finally,	the	end	step	of	SSB	repair	is	the	ligation	of	
the	 newly	 synthesised	 DNA	which	 is	 performed	 by	 DNA	 ligase	 III	 (usually	 associated	with	





caused	 during	 exposure	 to	 chemicals	 which	 cause	 bulky	 chemical-induced	 adducts,	 and	
agents	 such	 as	 UV-C,	 which	 induce	 CPDs	 and	 6-4	 photoproducts	 (Wood	 1999,	 Douki	 and	
Cadet	2001).		
There	 are	 two	 forms	 of	 NER	 termed	 global-genome	 repair	 (GGR)	 NER	 and	





detected	 by	 the	 XPC	 complex,	 there	 is	 the	 UV	 DNA	 damage	 binding	 protein	 (UV-DDB)	
composed	 of	 DDB1	 and	 DDB2/XPE	 to	 facilitate	 their	 recognition	 (Payne	 and	 Chu	 1994,	
Hwang,	Toering	et	al.	1998).	The	recognition	of	bulky	lesions	during	TCR	is	performed	by	the	
elongating	 polymerase	 II	 (RNAPII),	 the	 recognition	 involves	 the	 stalling	 of	 the	 polymerase	





































are	responsible	 for	the	detection	of	bulky	DNA	 lesions	during	global-genome	repair	 (GGR),	
whilst	 RNA	 polymerase	 II	 detects	 bulky	 DNA	 lesions	 during	 transcription-coupled	 repair	
(TCR).	 Following	 initial	 detection	 the	 two	 pathways	 of	 nucleotide	 excision	 (NER)	 repair	
converge.	 The	 multi-subunit	 TFIIH	 transcription	 factor	 associates	 with	 the	 lesion	 and	 this	
stimulates	 the	 helicase	 activity	 of	 two	 of	 its	 subunits;	 XPB	 and	 XPD,	 resulting	 in	 the	
unwinding	 of	 the	 DNA	 to	 allow	 access	 for	 the	 repair	 machinery.	 XPA	 associates	with	 the	
lesion	 present	 on	 the	 single	 stranded	 DNA	 coated	with	 RPA.	 This	 then	 activates	 the	 XPF-




Following	 the	 recognition	 of	 the	 bulky	 lesion,	 the	 two	 helicase	 subunits	 of	 the	
transcription	 factor	 TFIIH,	 termed	 xeroderma	 pigmentosum	 (XP)	 XPB	 and	 XPD,	 are	
responsible	 for	 the	unwinding	of	 the	DNA,	which	allows	access	of	 the	 repair	machinery	 to	
the	 DNA	 lesion	 (Volker,	 Mone	 et	 al.	 2001,	 Tapias,	 Auriol	 et	 al.	 2004).	 	 TFIIH	 is	 then	
responsible	 for	 recruiting	 XPA	 and	 RPA	 which	 activate	 XPF-	 excision	 repair	 cross-
complementation	 group	 1	 (ERCC1)	 and	 XPG	 (5’	 endonuclease	 and	 3’	 endonuclease,	
respectively)	 which	 are	 responsible	 for	 the	 excision	 of	 the	 22-30nt	 long	 DNA	 strand	
containing	the	bulky	 lesion	(Li,	Elledge	et	al.	1994,	Odonovan,	Davies	et	al.	1994,	Park	and	
Sancar	1994,	Saijo,	Kuraoka	et	al.	1996,	Volker,	Mone	et	al.	2001).	The	DNA	polymerases	Pol	
δ,	 Pol	 ε	 and	 Pol	 κ	 are	 responsible	 for	 filling	 the	 gap	 in	 the	 DNA	 left	 behind	 from	 the	
endonucleases	 together	 with	 proliferating	 cell	 nuclear	 antigen	 (PCNA)(Shivji,	 Kenny	 et	 al.	
1992).	 The	 ligase	 III-XRCC1	 complex	 facilitates	 the	 ligation	 step	 in	NER	 (Figure	 1.9)	 (Shivji,	
Kenny	et	al.	1992,	Moser,	Kool	et	al.	2007).		
1.2.2.3	Mismatch	Repair	
DNA	base	mismatching	 occurs	 from	 errors	made	 by	DNA	 polymerases	 during	DNA	


























Figure	 1.10:	 Mismatch	 Repair.	 DNA	 mismatches	 are	 detected	 by	 MSH2-MSH6	
heterodimer	 and	 deletion/insertion	 loops	 by	 the	 MSH2-MSH3	 complex.	
MLH1/PMS2	 is	 then	 recruited	 to	 the	 mismatch	 where	 it	 forms	 a	 complex	 with	
MSH2-MSH6	or	MSH2-MSH3,	respectively.		PMS2	has	endonuclease	activity	which	






1990,	 Thomas,	 Roberts	 et	 al.	 1991).	 DNA	 base-pair	mismatches	 and	 IDLs	 are	 detected	 by	
MSH2-MSH6	(MutSα)	and	MSH2-MSH3	(MutSβ),	respectively	(Figure	1.10)	(Drummond,	Li	et	
al.	1995,	Acharya,	Wilson	et	al.	1996,	Palombo,	 Iaccarino	et	al.	1996,	McCulloch,	Gu	et	al.	
2003).	 Following	 the	 detection	 of	 the	 mismatch	 by	 MutSα	 and	 MutSβ,	 the	 MLH1/PMS2	
(MutLα)	 complex	 is	 recruited	which	 forms	a	 ternary	 complex	with	MutSα	and	MutSβ.	The	
formation	of	the	ternary	complex	induces	a	change	in	the	conformation	which	is	necessary	
for	the	movement	of	the	complex	away	from	the	site	of	the	mismatch	(Gradia,	Acharya	et	al.	











is	 responsible	 for	 the	 resolution	 of	 ICLs	 (Raschle,	 Knipscheer	 et	 al.	 2008).	 FANCM	 is	
responsible	 for	 recognition	 of	 ICLs	 during	 DNA	 replication.	 FANCM	 forms	 a	 heterodimeric	























































enzyme	 UBE2T,	 is	 responsible	 for	 the	 monoubiquitination	 of	 FANCI	 (I)	 and	 FANCD2	 (D),	
which	 together	 form	 the	 ID	 complex	 (Machida,	 Machida	 et	 al.	 2006).	 The	
monoubiquitination	 of	 FANCI	 and	 FANCD2	 leads	 to	 the	 retention	 of	 these	 proteins	 at	





Translesion	 synthesis	 then	 occurs	 over	 the	 ICL	 on	 the	 intact	 strand,	 followed	 by	 further	
incisions	to	remove	the	lesion	and	homologous	recombination	to	repair	the	DSB	formed	by	
the	incision	events	(Moldovan,	Madhavan	et	al.	2010).	The	downstream	FA	proteins	BRCA1	




There	 are	 four	 phases	 of	 the	 cell	 cycle;	 gap-phase	 1	 (G1),	 DNA	 synthesis	 (S),	 gap-
phase	2	(G2)	and	mitosis	(M)	(Figure	1.12).	Progression	through	the	cell	cycle	is	controlled	by	





























of	 the	 cell	 cycle	 (G1,	 S,	 G2	 and	 M)	 is	 controlled	 by	 Cyclin-CDK	 complexes.	 Progression	
through	G1	is	governed	by	Cyclin	D-CDK4/6	and	Cyclin	E-CDK2	complexes.	The	formation	of	
the	 Cyclin	 A-CDK2	 complex	 marks	 the	 S/G2	 transition.	 Formation	 of	 the	 Cyclin	 A-CDK1	
complex	promotes	the	G2/M	transition.	Finally,	the	Cyclin	B-CDK1	complex	marks	the	G2/M	
transition.	 The	 CDC25	 phosphatases	 are	 responsible	 for	 the	 removal	 of	 inhibitory	







and	 Harlow	 1994).	 The	 formation	 of	 the	 active	 Cyclin	 D-CDK4/6	 complexes	 leads	 to	 the	




phosphorylated	 form	 (Chellappan,	 Hiebert	 et	 al.	 1991).	 Free	 E2F	 is	 able	 to	 stimulate	 the	
transcription	of,	amongst	a	number	of	proteins,	Cyclin	E	that	associates	with	CDK2	(Ohtani,	
DeGregori	 et	 al.	 1995).	 The	 Cyclin	 E-CDK2	 complex	 also	 phosphorylates	 pRB	 leading	 to	
further	dissociation	of	pRB	from	E2F,	which	leads	to	the	transcriptional	activation	of	S	phase	




then	 associates	with	 CDK1,	 promoting	 the	 G2/M	 transition	where	 it	 is	 then	 subsequently	
degraded.	 During	 G2,	 Cyclin	 B1-CDK1	 complexes	 remain	 inactive	 through	 the	
phosphorylation	of	CDK1	on	Tyr15	and	Tyr14	by	the	Wee1	and	myelin	transcription	factor	1	
(Myt1)	kinases,	respectively	(Parker	and	Piwnicaworms	1992,	Liu,	Stanton	et	al.	1997).	The	
cell	 division	 cycle	 25	 C	 (CDC25C)	 phosphatase	 is	 responsible	 for	 the	 dephosphorylation	 of	
CDK1,	 thus	 activating	 the	 Cyclin	 B1-CDK1	 complex	 which	 triggers	 the	 G2/M	 transition	
(Malumbres	 and	 Barbacid	 2009).	 Active	 Cyclin	 B1-CDK1	 complexes	 are	 then	 able	 to	












Subsequently	 p53	 becomes	 transcriptionally	 activated	 and	 stabilised	 through	 the	
phosphorylation-mediated	 disruption	 of	 p53	 mouse	 double	 minute	 2	 (MDM2)	 binding,	
which	prevents	MDM2-mediated	nuclear	export	and	degradation	of	p53	(Dumaz	and	Meek	
1999,	 Schon,	 Friedler	 et	 al.	 2002).	 The	 activation	 and	 stabilisation	 of	 p53	 leads	 to	 the	
transcriptional	 activation	 of	 a	 number	 of	 target	 genes	 including	 p21,	 which	 inhibits	 G1/S	
entry	 through	 its	 role	 as	 a	CDK	 inhibitor,	 subsequently	 inhibiting	 the	Cyclin	D-CDK4/6	and	
Cyclin	D-CDK2	complexes	and	preventing	the	transition	into	S	phase	(He,	Siddik	et	al.	2005).	
ATM-mediated	 Chk2	 activation	 also	 leads	 to	 the	 removal	 of	 CDC25A,	 a	 phosphatase	 that	
normally	acts	to	remove	the	inhibitory	phosphatases	from	CDK2	and	thus	inhibit	the	Cyclin	
E-CDK2	 complexes,	 preventing	 the	G1/S	 transition.	 There	 is	 also	 evidence	 to	 suggest	 that	
ATR	is	able	to	directly	phosphorylate	p53	to	induce	cell	cycle	arrest	following	DNA	damage,	




The	 S	 phase	 checkpoint	 exists	 to	 ensure	 that	 damaged	 DNA	 is	 not	 replicated.	
Activation	of	 the	S	phase	checkpoint	 through	 the	ATR/Chk1	signalling	pathway	 targets	 the	
Cyclin-CDK	and	CDC7-DBF4	protein	kinase	(DDK)	complexes	which	act	to	inhibit	the	firing	of	
primed	 origins	 (Heffernan,	 Unsal-Kacmaz	 et	 al.	 2007,	 Zegerman	 and	 Diffley	 2010).	 The	
checkpoint	 also	 exists	 in	 order	 to	 preserve	 the	 integrity	 of	 the	 replication	 forks	 following	
replication	 stress,	 allowing	 time	 for	DNA	 repair	 before	 it	 is	met	 by	 an	ongoing	 replication	
fork	 (see	 Section	 1.2.4.2.2	 for	 a	 detailed	 discussion	 of	 the	 S	 phase	 checkpoint	 during	
replication).	The	S	phase	checkpoint	also	detects	DSBs	that	occur	during	S	phase	that	are	not	
associated	 with	 active	 replicons.	 DSBs	 that	 occur	 during	 S	 phase	 are	 recognised	 by	 the	
ATM/Chk2	signalling	pathway	 (see	Section	1.2.1.1),	which	 is	ultimately	activated	 to	 induce	




complexes	 (see	Section	1.2.4.1),	 and	 therefore	 inhibits	 firing	of	 any	 remaining	origins	 that	
have	 been	 primed	 for	 replication	 initiation	 (Falck,	Mailand	 et	 al.	 2001).	 Activation	 of	 the	
ATR/Chk1	 pathway	 also	 leads	 to	 the	 proteasome-mediated	 degradation	 of	 CDC25A,	 thus	







leading	 to	 the	 inactivation	 of	 the	 Cyclin	 B1-CDK1	 complex	 which	 is	 necessary	 for	 the	




complex	 (Kumagai	 and	 Dunphy	 1999,	 Lopez-Girona,	 Furnari	 et	 al.	 1999).	 Proteins	 of	 the	
mitogen-activated	 protein	 kinase	 (MAPK)	 pathway	 have	 also	 been	 shown	 to	 be	 able	 to	
phosphorylate	 CDC25A,	 CDC25B	 and	 CDC25C,	 also	 leading	 to	 14-3-3	 binding	 and	
sequestering	 of	 these	 proteins	 to	 the	 cytoplasm	 (Bulavin,	 Higashimoto	 et	 al.	 2001,	
Reinhardt,	Aslanian	et	 al.	 2007).	ATM/ATR-mediated	phosphorylation	of	polo-like	 kinase	3	
(Plk3)	has	also	been	 shown	 to	 further	 inhibit	CDC25	 function	during	 the	G2/M	checkpoint	
(Bahassi,	Hennigan	et	al.	2004).	p53	is	also	involved	in	G2/M	checkpoint	arrest	through	the	
transcriptional	activation	of	cell	cycle	inhibitors	such	as	p21,	14-3-3σ	and	growth	arrest	and	
DNA	damage	 inducible	45	alpha	 (GADD45).	p21	 is	 able	 to	 inhibit	CDK1	directly,	 14-3-3σ	 is	





The	 initiation	 of	 DNA	 replication	 is	 a	 two-step	 process	 involving	 origin	 licensing	
followed	 by	 origin	 firing.	 Origin	 licensing	 begins	 during	 the	 late	 phases	 of	 mitosis	 and	
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continues	 through	 to	 the	 G1	 phase	 of	 the	 cell	 cycle.	 The	 onset	 of	 origin	 licensing	 occurs	
when	the	hexameric	origin	recognition	complex	1-6	(ORC	1-6)	recruits	cell	division	cycle	10-
dependent	transcript	1	(Cdt1)	and	cell	division	cycle	6	(Cdc6)	proteins	to	replication	origins	
(Bell	 and	 Stillman	 1992,	 Gavin,	 Hidaka	 et	 al.	 1995,	 Piatti,	 Lengauer	 et	 al.	 1995,	 Nishitani,	
Lygerou	 et	 al.	 2000).	 Together,	 these	 proteins	 load	 the	 helicase	 component,	 mini	
chromosome	 maintenance	 (MCM)	 2-7	 protein	 complexes	 onto	 origins	 of	 replication;	 the	
proteins	 loaded	 at	 these	 origins	 together	 form	 a	 complex	 termed	 the	 pre-replicative	
complexes	(pre-RCs)	(Evrin,	Clarke	et	al.	2009).		Cyclin	A/CDK2	activity	marks	the	G1/S	phase	
transition	where	origin	 firing	 is	 initiated.	 In	mammalian	 cells,	 the	pre-RC	 component	Cdc6	
becomes	 phosphorylated	 upon	 S	 phase	 entry,	 leading	 to	 its	 dissociation	 from	 the	 pre-RC	
complex	 into	 the	cytoplasm	 (Petersen,	 Lukas	et	al.	1999).	Origin	 firing	during	S	phase	also	
involves	 the	 activation	 of	 the	 MCM	 2-7	 hexamer	 and	 is	 achieved	 by	 the	 subsequent	
association	of	Cdc45	and	MCM10	with	the	pre-RC	complex,	which	then	associates	with	GINS	













Replication	 stress	 can	 be	 defined	 as	 any	 perturbation	 in	 the	 process,	 coordination	
and	timing	of	DNA	synthesis.	One	way	of	inducing	replication	stress	is	the	slowing	or	stalling	
of	 the	 replication	 fork	 during	 DNA	 synthesis	 in	 response	 to	 a	 particular	 replication	 fork	
barrier	(RFB).	There	are	a	number	of	RFBs	that	have	the	capacity	to	lead	to	replication	stress,	
including	 unresolved	 DNA	 lesions,	 DNA-bound	 proteins	 and	 secondary	 structures	 (Zeman	
and	 Cimprich	 2014).	 A	 number	 of	 exogenous	 agents	 can	 also	 induce	 replication	 stress	
including	 agents	 that	 inhibit	 DNA	 elongation	 such	 as	 the	 DNA	 polymerase	 inhibitor	
aphidicolin,	 and	 the	 ribonucleotide	 reductase	 (RNR)	 inhibitor	 hydroxyurea	 (HU)	 (Yarbro	
1968,	Krokan,	Wist	et	al.	1981).	RNR	catalyses	the	conversion	of	NDPs	into	dNDPs,	which	is	
the	rate	limiting	step	in	the	production	of	dNTPs	(Jordan	and	Reichard	1998).	HU	treatment	




Replication	 fork	 stalling	 can	 be	 defined	 as	 a	 temporary	 ‘pause’	 in	 replication	 fork	
progression	 in	response	to	a	RFB.	Following	the	removal	of	the	RFB,	the	stalled	replication	
fork	 is	 able	 to	 resume	 fork	progression.	 Fork	 collapse	 can	be	defined	as	 a	 replication	 fork	








this	 instance,	 global	new	origin	 firing	 is	 responsible	 for	 the	 completion	of	DNA	 replication	
(Woodward,	Gohler	et	al.	2006,	Ge,	Jackson	et	al.	2007,	Petermann,	Orta	et	al.	2010).		
The	 replication	 fork	 has	 a	 number	 of	 defence	mechanisms	 that	 act	 to	 resolve	 replication	
stress.	 Firstly,	 the	 simplest	 mechanism	 to	 avoid	 replication	 stress	 is	 to	 resolve	 any	 DNA	
lesions	before	they	are	met	by	the	replication	fork.	This	can	be	performed	by	any	number	of	
DNA	 repair	 mechanisms	 depending	 on	 the	 type	 of	 damage	 incurred	 (see	 Section	 1.2.2).	
Secondly,	 if	 the	 damage	 is	 not	 resolved	 before	 association	 with	 the	 replication	 fork,	
activation	 of	 the	 replication	 checkpoint	 can	 act	 to	 temporarily	 stall	 the	 replication	 fork,	
which	can	then	be	stabilised	and	restarted	following	clearance	of	the	damage.	Finally,	if	the	






most	 commonly	 results	 in	 the	 formation	 of	 ssDNA	 as	 a	 result	 of	 DNA	 helicase	 activity	
continuing	 to	 unwind	 the	 double	 helix	 when	 the	 polymerase	 has	 stalled.	 The	 type	 of	














































































Figure	 1.13:	 Sources	 of	 Replication	 Stress.	 There	 are	 a	 number	 of	 replication	 fork	
barriers	that	can	perturb	the	progression	of	DNA	synthesis	and	lead	to	replication	stress.	
These	 include	 limited	 nucleotide	 pools,	 DNA	 lesions,	 fragile	 sites,	 ribonucleotide	
incorporation,	 DNA	 secondary	 structures,	 repetitive	 DNA	 and	 transcription/RNA-DNA	




One	common	unresolved	RFB	 is	DNA	damage,	which	 includes	 lesions	such	as	bulky	
adducts,	alkylated	bases,	pyrimidine	dimers	and	abasic	sites.	These	unresolved	lesions	pose	
a	problem	for	the	replicating	polymerases,	since	they	cannot	replicate	past	these	sites.	The	
translesion	 synthesis	 (TLS)	 pathway	 acts	 to	 resolve	 this	 problem	by	 employing	 a	 group	 of	
‘error-prone’	 polymerases,	 termed	 TLS	 polymerases,	 which	 are	 able	 to	 incorporate	
nucleotides	 opposite	 the	 damaged	 base	 allowing	 replication	 to	 proceed	 (Cordeiro-Stone,	
Zaritskaya	et	al.	1997,	Gibbs,	McGregor	et	al.	1998,	Gerlach,	Aravind	et	al.	1999).	Blocking	of	
the	 replication	 machinery	 resulting	 in	 uncoupling	 of	 polymerase	 and	 helicase	 activities	
induces	 the	 monoubiquitination	 of	 PCNA	 on	 lysine	 164	 which	 is	 catalysed	 by	 the	 E2	
ubiquitin-conjugating	enzyme	Rad6	and	the	E3	ubiquitin	ligase	Rad18	(Hoege,	Pfander	et	al.	
2002,	 Stelter	 and	 Ulrich	 2003).	 The	 ubiquitination	 of	 PCNA	 aids	 the	 association	 with	 TLS	
polymerases	 which	 are	 then	 able	 to	 by-pass	 the	 lesion,	 but	 sometimes	 at	 the	 cost	 of	
mutagenesis	 (Hoege,	 Pfander	 et	 al.	 2002,	 Stelter	 and	Ulrich	 2003,	 Kannouche,	Wing	et	 al.	
2004).	 	 Poly-ubiquitination	 of	 PCNA	 leads	 to	 a	 mode	 of	 damage	 by-pass	 that	 is	 less	
characterised	but	is	considered	to	be	error-free	(Moldovan,	Pfander	et	al.	2007).		
Single-strand	 gaps	 and	 DSBs	 also	 pose	 a	 serious	 threat	 to	 DNA	 replication.	 The	
consequence	 of	 a	 replication	 fork	meeting	 a	 single-strand	 gap	 or	 DSB	 is	 thought	 to	 be	 a	
broken	fork	with	one	arm	becoming	a	DSB,	and	two	double-strand	ends	respectively	(Cortes-
Ledesma	 and	 Aguilera	 2006).	 As	 a	 defence	 mechanism	 against	 the	 generation	 of	 passive	
DSBs,	 there	 is	 some	evidence	 to	 suggest	 that	 the	 replication	 fork	 is	 able	 to	 slow	down,	 in	
order	to	allow	for	DNA	repair	mechanisms	to	clear	the	damage	before	the	fork	arrives,	which	




replication	 stress.	 Sometimes,	 the	 replicative	 polymerases,	 Pol	 δ	 and	 Pol	 ε,	 erroneously	
incorporate	 ribonucleotides	 (rNTPs)	 instead	of	deoxyribonucleotides	 (dNTPs)	 into	 the	DNA	
backbone	 during	 DNA	 replication	 (McElhinny,	Watts	 et	 al.	 2010).	Mis-incorporated	 rNTPs	
must	be	 removed	 from	 the	DNA	backbone	 since	polymerases	 cannot	 replicate	past	 these.	
Mis-incorporated	rNTPs	are	removed	from	the	DNA	backbone	by	the	ribonucleotide	repair	
pathway,	 whereby	 RNase	 H2	 is	 responsible	 for	 the	 recognition	 and	 excision	 of	 the	 rNTP,	
together	with	the	endonucleases	FEN1	and	EXO1	(Sparks,	Chon	et	al.	2012).	In	the	absence	
of	 RNase	 H2-mediated	 excision	 of	 rNTPs,	 the	 TLS	 polymerases	 are	 able	 to	 bypass	 them	
(Lazzaro,	Novarina	et	al.	2012).		
Replication	stress	can	also	be	induced	by	DNA	structures	that	deviate	from	the	right-
handed	double	helix	B	 form	of	DNA.	Such	structures	 include	hairpins,	 triplexes,	cruciforms	
and	 G4	 quadruplexes	 (Gacy,	 Goellner	 et	 al.	 1995,	 Paeschke,	 Bochman	 et	 al.	 2013).	 The	
formation	of	these	structures	leads	to	a	significant	challenge	for	the	replication	fork.	These	
structures	 are	 thought	 to	 be	 resolved	by	 specific	 helicases,	which	 act	 to	 dissociate	 bound	
DNA	structures,	as	well	as	nucleases	(Mre11,	FEN1,	EXO1	and	DNA2)	which	are	thought	to	
cleave	 secondary	 structures	 (Sun,	 Karow	 et	 al.	 1998,	 Fry	 and	 Loeb	 1999,	 Ghosal	 and	
Muniyappa	 2005,	Masuda-Sasa,	 Polaczek	 et	 al.	 2008,	Wu,	 Shin-ya	 et	 al.	 2008,	 Vallur	 and	
Maizels	2010).		
Since	 both	 replication	 and	 transcription	occur	 on	DNA,	 it	 is	 not	 surprising	 that	 the	
two	machineries	have	 the	capacity	 to	collide.	Whilst	DNA	replication	 is	 restricted	 to	occur	
only	during	S	phase,	and	transcription	normally	occurs	during	G1	phase,	the	latter	can	also	
proceed	during	 S	phase.	 It	 is	 thought	 that	 replication	and	 transcription	occurring	during	 S	
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phase	 is	 spatially	 separated	 from	 the	 DNA	 replication	 machinery	 in	 order	 to	 prevent	
collision.	Interestingly,	there	are	a	number	of	human	genes	that	are	so	large	they	need	more	
than	 one	 cell	 cycle	 to	 be	 completely	 transcribed,	 in	 these	 cases	 the	 replication	 and	
transcriptional	machinery	are	known	to	associate	(Helmrich,	Ballarino	et	al.	2011).	Helicases	
and	 topoisomerases	 are	 known	 to	 unwind	 the	 DNA	 and	 ease	 the	 topological	 stress	
associated	 with	 replication	 and	 transcription	 machinery	 that	 are	 in	 close	 proximities	
(Bermejo,	Capra	et	al.	2009,	Tuduri,	Crabbe	et	al.	2009).		
The	 formation	 of	 R-loops	 can	 also	 cause	 significant	 replication	 stress;	 they	 can	 be	
defined	 as	 an	 RNA-DNA	 hybrid	 structure	with	 a	 displaced	 ssDNA	 strand.	 These	 structures	
cannot	 be	 replicated	 and	 are	 a	 significant	 barrier	 to	 the	 replication	 machinery.	 The	






(CFSs).	 ERFSs,	 as	 the	 name	 suggests,	 replicate	 early,	 have	 a	 high	G/C	 content	 and	 have	 a	
relaxed	 chromatin	 configuration	 (Barlow,	 Faryabi	 et	 al.	 2013).	 CFSs	 replicate	 late,	 are	 A/T	
rich	 and	 have	 a	 condensed	 chromatin	 state	 (Smeets	 and	 van	 de	 Klundert	 1990).	 Most	
significantly,	CFSs	are	prone	to	the	formation	of	secondary	structures	and	the	generation	of	
DSBs	 induced	by	replication	stress.	CFSs	are	thought	to	be	susceptible	to	replication	stress	
because	 they	 have	 a	 reduced	 number	 of	 replication	 origins,	 which	 leads	 to	 incomplete	
replication	due	 to	 lack	of	origin	 firing	upon	 replication	 stress.	 These	 regions	of	 replication	
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stress	 are	 targeted	 by	 the	 nucleases	 MUS81-EME1	 or	 ERCC1,	 resulting	 in	 controlled	 DSB	
events.	These	controlled	breaks	are	thought	to	maintain	genomic	stability	(Naim,	Wilhelm	et	
al.	2013,	Ying,	Minocherhomji	et	al.	2013).	 	More	recently,	 the	nuclease	activity	of	MUS81	






Jones,	 Mortusewicz	 et	 al.	 2013,	 Srinivasan,	 Dominguez-Sola	 et	 al.	 2013).	 Finally,	 limiting	
replication	factors	such	as	the	replication	machinery	itself,	nucleotides,	histones	and	histone	
deposition	machinery,	which	is	responsible	for	the	newly	replicated	DNA	packaging,	can	also	




damage,	DNA-protein	 adducts	 and	 secondary	 structures.	 If	 the	RFB	 is	 not	 resolved	before	
meeting	the	replication	fork,	the	next	mechanism	of	defence	to	protect	against	replication	
fork	collapse	is	to	activate	the	replication	checkpoint	which	prevents	further	replication	until	
the	 damage/lesion	 is	 repaired,	 only	 then	 will	 replication	 proceed.	 A	 common	 structure	
formed	from	replication	stress	is	ssDNA,	which	often	results	from	the	uncoupling	of	the	DNA	
polymerase	 and	 the	 DNA	 helicase,	 whereby	 the	 helicase	 continues	 to	 unwind	 the	 DNA	
following	 the	 stalling	 of	 the	DNA	polymerase	 (Pacek	 and	Walter	 2004).	 The	 generation	of	
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large	stretches	of	ssDNA	activates	the	replication	checkpoint	through	the	activation	of	ATR	
kinase,	 which	 acts	 to	 stall	 the	 cell	 cycle	 and	 thus	 prevent	 further	 DNA	 replication	 during	
replication	 stress	 (see	 Section	 1.2.1.2)	 (Byun,	 Pacek	 et	 al.	 2005).	 The	 active	 ATR	 kinase	
phosphorylates	 and	 activates	 Chk1,	 which,	 when	 activated,	 is	 able	 to	 phosphorylate	 the	





stalled	 replication	 fork	 and	 preventing	 fork	 collapse.	 A	 number	 of	 mechanisms	 of	 fork	




for	 the	 inhibition	 of	 late	 origin	 firing	 through	 a	 Chk1-mediated	 mechanism	 (Feijoo,	 Hall-
Jackson	et	al.	 2001).	 	 There	 is	 also	evidence	 to	 suggest	 that	 the	 suppression	of	 late	origin	
firing	 is	 controlled	 through	 the	 ATR-mediated	 repression	 of	 CDC45	 chromatin	 binding,	
although	 DDK	 activity	 remains	 (Liu,	 Barkley	 et	 al.	 2006,	 Tsuji,	 Lau	 et	 al.	 2008).	 The	 ATR-
mediated	 inhibition	 of	 CDK2	 and	 the	 phosphorylation	 of	 mixed	 lineage	 leukaemia	 (MLL)	
histone	methyltransferase	are	also	responsible	for	the	suppression	of	late	origin	firing	during	
replication	 stress	 (Liu,	 Takeda	 et	 al.	 2010).	 One	 mechanism	 involved	 in	 replication	 fork	
stabilisation	 was	 thought	 to	 be	 the	 stabilisation	 of	 components	 of	 the	 replisome	 by	 the	
checkpoint	 machinery.	 Studies	 in	 human	 cells	 showed	 that	 the	 amount	 of	 chromatin-
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associated	 replisome	 components	 PCNA,	 POLE,	 POLD2	 and	 CDC45	 was	 reduced	 in	 ATR-
deficient	 cells	 treated	 with	 replicative	 stress	 agents	 when	 compared	 to	 untreated	 cells,	
suggesting	that	the	checkpoint	is	necessary	for	replisome	stabilisation	(Ragland,	Patel	et	al.	
2013).	Furthermore,	the	association	of	the	replisome	component	PCNA	was	impeded	during	
early	 origin	 firing	 following	 inhibition	 of	 ATR	 in	mammalian	 cells	 when	 compared	 to	 ATR	
competent	 cells,	 also	 suggesting	 that	 the	 checkpoint	 is	 important	 for	 replisome	 stability	
(Dimitrova	and	Gilbert	2000).	There	is	also	evidence	to	suggest	that	the	S	phase	checkpoint	
during	replication	stress	is	not	important	for	replisome	stability	at	the	fork	(De	Piccoli,	Katou	
et	 al.	 2012).	 Furthermore,	 recent	 isolation	 of	 proteins	 on	 nascent	 DNA	 (iPOND),	 using	
checkpoint-deficient	 cells,	 showed	 that	 ATR	 signalling	 plays	 no	 significant	 role	 in	 the	
stabilisation	of	the	replisome	but	that	it	is	essential	for	fork	stability	(Dungrawala	and	Cortez,	
unpublished	 data).	 In	 addition	 to	 the	 inhibition	 of	 late	 origin	 firing,	 activation	 of	 the	
replication	 checkpoint	 is	 also	 thought	 to	 stabilise	 stalled	 forks	 through	 the	 ATR-mediated	
activation	of	 repair	proteins	 such	as	Werner	 syndrome	protein	 (WRN),	BLM	and	SWI/SNF-
related	matrix-associated	actin-dependent	regulator	of	chromatin	subfamily	A-like	protein	1	
(SMARCAL1)	(Pichierri,	Rosselli	et	al.	2003,	Davies,	North	et	al.	2004,	Couch,	Bansbach	et	al.	


























Figure	 1.14:	 A	 Model	 for	 Replication	 Fork	 Restart.	 In	 this	 model	 SMARCAL1	 is	
responsible	for	the	reannealing	of	ssDNA	that	has	formed	as	a	consequence	of	helicase	
polymerase	 uncoupling.	 BLM	 and	 WRN	 are	 responsible	 for	 the	 reversal	 of	 the	








ATR-mediated	 mechanisms.	 It	 is	 at	 this	 point	 that	 replication	 restart	 mechanisms	 are	
employed	in	order	to	ensure	the	complete	replication	of	the	genome.	The	exact	mechanism	
by	 which	 stalled	 replication	 forks	 are	 restarted	 is	 currently	 unknown.	 A	 number	 of	
mechanisms	 for	 fork	 restart	 have	 been	 postulated,	 however,	 including	 the	 enzymatic	
reversal	 of	 stalled	 forks	 into	 a	 ‘chicken-foot’	 structure	 that	 is	 competent	 for	 replication	
(Postow,	Ullsperger	et	 al.	 2001).	 The	 remodelling	of	 stalled	 forks	by	various	ATR-activated	
repair	 proteins	 has	 also	 been	 implicated	 in	 fork	 restart,	 although	 this	 mechanism	 may	
overlap	with	fork	reversal.	HR	as	a	mechanism	of	restart	has	also	been	hypothesised,	as	well	





comprises	 a	 typical	 three-way	 fork,	 into	 a	 four-way	 junction	 through	 the	 annealing	of	 the	




lesion	 into	 the	 double-stranded	 region	 of	 the	 DNA,	 allowing	 the	 lesion	 to	 be	 excised	 by	
conventional	excision	mechanisms.	Secondly,	annealing	of	 the	 two	newly	synthesised	DNA	
strands	limits	the	extent	of	exposed	ssDNA,	therefore	promoting	the	stabilisation	of	the	fork.	
Finally,	 fork	 regression	 allows	 lesion	 bypass	 through	 template	 switching.	 The	 concept	 of	
replication	fork	reversal	was	first	suggested	in	1976,	when	Higgins	and	colleagues	proposed	
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the	 formation	of	 the	 four-way	replication	 fork	 to	be	a	DNA	damage	tolerance	mechanism,	
whereby	the	newly	synthesised	strands	were	used	as	a	template	for	DNA	replication	in	order	
to	bypass	a	DNA	lesion	on	the	parental	strand	(Higgins,	Kato	et	al.	1976).	Although	there	has	




dependent	 on	 PARP1	 (Chaudhuri,	 Hashimoto	 et	 al.	 2012).	 Further	 work	 from	 this	 group	
demonstrated	 that	 the	 helicase	 RECQ1	 promotes	 the	 restart	 of	 reversed	 replication	 forks	
following	 TOP1	 inhibition.	 This	 RECQ1	 activity	 is	 inhibited	 by	 PARP1-mediated	 ADP	
ribosylation	(Berti,	Chaudhuri	et	al.	2013).	Further	evidence	for	fork	reversal	came	from	the	
work	of	Thangavel	 and	colleagues	who	 showed	 that	WRN	and	DNA2	were	 responsible	 for	
the	degradation	of	the	‘fourth	arm’	of	the	reversed	replication	fork	allowing	fork	restart	by	a	
novel	mechanism	(Thangavel,	Berti	et	al.	2015).	Recent	studies	have	demonstrated	that	fork	
reversal	 occurs	 not	 just	 in	 response	 to	 TOP1	 inhibitors,	 but	 also	 following	 treatment	with	
DNA	 synthesis	 inhibitors,	 interstrand	 cross-linking	 inducers	 and	 base-damaging	 agents,	
showing	 that	 fork	 reversal	 is	 a	 bona	 fide	 mechanism	 to	 respond	 to	 replication	 stress	
(Zellweger,	Dalcher	et	al.	2015).	In	addition,	this	work	showed	that	Rad51	was	essential	for	







Recent	 developments	 from	 in	 vivo	 studies	 of	 fork	 reversal	 have	 furthered	 our	
understanding	 of	 replication	 restart	 following	 replication	 stress.	 However,	 a	 number	 of	
proteins	have	been	implicated	in	replication	restart	via	 in	vitro	studies,	including	additional	
proteins	that	may	be	required	for	fork	reversal,	and	also	proteins	that	have	been	implicated	
in	 branch	 migration	 via	 fork	 remodelling.	 Of	 course,	 it	 is	 possible	 that	 fork	 reversal	 and	
branch	migration	are	interlinked	and	both	processes	are	necessary	to	carry	out	fork	restart.	
Indeed,	 Holliday	 junctions	 are	 structurally	 similar	 to	 reversed	 forks,	 and	 it	 could	 be	 that	
there	is	a	dual	function	for	these	proteins	both	in	HR	and	fork	reversal.	Other	proteins	that	
have	 been	 implicated	 in	 restart	 include	 the	 DNA	 helicases	 BLM,	 WRN,	 Fanconi	 anaemia	
complementation	 group	M	 (FANCM),	 SMARCAL1	 and	 F-box	 helicase	 1	 (FBH1)	 whose	 fork	
remodelling	activities	are	thought	to	promote	fork	restart.	Defects	in	BLM	and	WRN	proteins	
have	 been	 shown	 to	 slow	 fork	 progression,	 and	 cells	 deficient	 in	 these	 proteins	 undergo	
reduced	 fork	 restart	 following	 treatment	 with	 replication	 inhibitors	 (Davies,	 North	 et	 al.	
2007,	Sidorova,	Li	et	al.	2008).	It	is	possible	that	the	helicase	activity	of	these	proteins	may	
be	a	prerequisite	for	HR-mediated	fork	restart;	both	BLM	and	WRN	have	been	implicated	in	




helicase	 that	 may	 play	 a	 role	 in	 replication	 restart.	 It	 is	 an	 annealing	 helicase	 which	 is	
recruited	to	stalled	replication	forks	in	response	to	replication	stress.	Defects	in	SMARCAL1	
lead	to	replication	 fork	restart	problems	and	an	accumulation	of	ssDNA;	 this	suggests	 that	
		 58	
SMARCAL1	may	 restart	 stalled	 replication	 forks	 by	 re-annealing	 ssDNA	which	has	 resulted	
from	helicase	polymerase	uncoupling	(Bansbach,	Betous	et	al.	2009,	Ciccia,	Bredemeyer	et	
al.	2009).	Interestingly,	cells	lacking	functional	FANCM	exhibit	increased	replication	speeds	in	












There	 is	 increasing	 evidence	 to	 suggest	 that	 homologous	 recombination	 plays	 an	
important	 role	 in	 the	 restart	 of	 stalled	 forks.	 HR-mediated	 fork	 restart	 involves	 the	
processing	 of	 the	 stalled	 fork	 to	 form	 Holliday	 junctions	 and	 D-loop	 intermediates	 by	 a	
mechanism	 that	 is	 functionally	distinct	 from	HR-mediated	DSB	 repair.	 Indeed,	defects	 in	a	
number	 of	 HR	 proteins	 have	 been	 shown	 to	 induce	 replication-associated	 DSBs	 including	
BRCA2,	 Fanconi	 anaemia	 complementation	 group	 A	 (FANCA),	 Fanconi	 anaemia	
complementation	 group	 D2	 (FANCD2),	 Mre11	 and	 Rad51	 (Sonoda,	 Sasaki	 et	 al.	 1998,	
Costanzo,	Robertson	et	al.	2001,	Lomonosov,	Anand	et	al.	2003,	Sobeck,	Stone	et	al.	2006).	
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In	 addition,	 following	 treatment	 with	 various	 inhibitors	 of	 replication,	 the	 loss	 of	 the	 HR	
proteins	Mre11,	Rad51	and	X-ray	 repair	 cross-complementing	protein	3	 (XRCC3)	has	been	
shown	to	negatively	affect	replication	restart,	suggesting	that	these	proteins	are	necessary	
for	this	process	(Trenz,	Smith	et	al.	2006,	Bryant,	Petermann	et	al.	2009,	Petermann,	Orta	et	
al.	 2010).	 The	HR	 resection	protein	Mre11	 is	 known	 to	be	 recruited	 to	 the	 sites	of	 stalled	
replication	forks	(Franchitto	and	Pichierri	2002,	Mirzoeva	and	Petrini	2003,	Robison,	Elliott	et	
al.	2004).	Mre11	could,	therefore,	be	recruited	to	stalled	forks	to	process	them	to	produce	
the	 lagging	 strand	gap	or	3’	overhang	necessary	 for	 subsequent	Rad51	 loading	and	strand	
invasion.	The	Rad51	paralogue	XRCC3	has	also	been	shown	to	facilitate	fork	restart	following	
the	 release	 from	 replication	 blocks	 (Bishop,	 Ear	 et	 al.	 1998).	 In	 addition,	 PARP1	 has	 been	
shown	to	 facilitate	 replication	 restart	 through	 the	 recruitment	of	Mre11	 to	 the	 replication	
fork,	 where	 it	 is	 thought	 to	 promote	 restart	 through	 its	 resection	 activities	 (Bryant,	
Petermann	et	al.	2009).	 In	support	of	the	idea	of	HR-mediated	fork	restart,	Rad51	has	also	
been	 shown	 to	 be	 necessary	 for	 replication	 fork	 restart	 following	 long	 replication	 blocks	
which	lead	to	collapse	into	DSBs	(Petermann,	Orta	et	al.	2010).	Another	HR	protein,	BRCA2,	
has	 also	 been	 implicated	 in	 HR-mediated	 fork	 restart.	 BRCA2	was	 shown	 to	 limit	Mre11-
dependent	DNA	resection	at	stalled	forks,	and	also	to	regulate	Rad51	loading	and	filament	
formation	during	replication	restart	(Hashimoto,	Chaudhuri	et	al.	2010,	Schlacher,	Christ	et	
al.	 2011).	 During	 HR-mediated	 restart,	 the	 resulting	 Holliday	 Junction	 formed	 could	 be	
resolved	in	a	process	 involving	BLM	and	TOPIIIα,	which	would	allow	replication	to	proceed	







In	addition	 to	HR-mediated	 restart	 that	 is	 achieved	 in	 the	absence	of	 a	DSB,	 it	has	
been	suggested	that,	following	long	replication	blocks,	fork-associated	DSBs	are	created	by	
the	endonuclease	activity	of	MUS81-EME1	(Hanada,	Budzowska	et	al.	2007).	It	is	not	entirely	
clear	 whether	 these	 fork-associated	 DSBs	 are	 repaired	 by	 the	 canonical	 DSB	 repair	
machinery	or	whether	a	more	specific,	fork-associated	DSB	repair	mechanism	is	employed.	It	
is	 thought	 that	 fork-associated	 DSBs	 that	 occur	 passively,	 i.e.	 through	 replication	 and	
transcription	machinery	 collision	 rather	 than	 in	 an	MUS81-EME1	 dependent	 manner,	 are	
repaired	by	standard	DSB	repair	mechanisms.	Evidence	to	suggest	that	the	induction	of	DSBs	
promotes	 replication	 fork	 restart	 comes	 from	 a	 study	 using	MUS81-deficient	 cells,	 which,	
when	released	from	long	replication	blocks	(24	hours),	failed	to	restart	efficiently	(Hanada,	
Budzowska	 et	 al.	 2007).	 Conflicting	 reports	 suggest	 that	 replication	 cannot	 be	 restarted	
following	 the	 generation	 of	 DSBs	 induced	 by	 long	 replication	 blocks,	 and	 can	 only	 restart	
following	short	incubations	that	do	not	result	in	the	generation	of	DSBs	(Petermann,	Orta	et	






The	 first	 indication	 for	 a	 relationship	 between	 adenovirus	 and	 the	 DDR	 was	 seen	




levels	 of	 phosphorylated	 DDR	 proteins	 such	 as	 H2AX	 and	 RPA32	 (Carson,	 Schwartz	 et	 al.	
2003).	One	consequence	of	the	activation	of	the	cellular	DDR	is	the	‘repair’	of	viral	DNA	to	
form	viral	concatemers	which	can	no	longer	be	packaged	into	virions;	it	is	therefore	essential	
that	 adenovirus	 is	 able	 to	 circumvent	 the	 cellular	 DNA	 damage	 response	 (Weiden	 and	
Ginsberg	 1994).	 Adenovirus	 has	 evolved	 sophisticated	mechanisms	which	 lead	 to	 efficient	




efficient	viral	 infection,	 including	detection	by	the	host	cells	 immune	response	and	evasion	




activation	 of	 the	 DDR	 and	 subsequent	 ‘repair’	 of	 the	 double-stranded	 viral	 DNA	 ends	
through	the	DSB	repair	pathway	(Weiden	and	Ginsberg	1994).	
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The	 first	 study	 to	 document	 the	 ‘end-to-end’	 joining	 of	 viral	 double-stranded	
genomes	 showed	 that	 infection	 with	 Ad5	 mutant	 viruses	 containing	 large	 E4	 deletions	
resulted	 in	 the	 formation	of	 large	 concatemers	of	 viral	DNA	 (Weiden	and	Ginsberg	1994).	
Concatemers	can	be	defined	as	covalently	joined	monomers	of	DNA,	joined	in	a	non-specific	





IV,	 DNA-PKcs,	 and	 the	 MRN	 complex	 components	 Mre11	 and	 NBS1	 to	 be	 important	 for	
concatermisation	 of	 viral	 genomes	 (Boyer,	 Rohleder	 et	 al.	 1999,	 Riballo,	 Critchlow	 et	 al.	
1999,	 Stracker,	 Carson	 et	 al.	 2002).	 Significantly,	 studies	 using	 the	 Ad5	 E4	 mutant	 virus	
dl1004	showed	that	infection	with	this	mutant	exhibited	defective	viral	DNA	replication	and	
late	protein	synthesis	as	a	consequence	of	the	formation	of	concatemers	(Stracker,	Carson	
et	 al.	 2002).	 Since	 the	 process	 of	 viral	 concatermisation	 involves	 the	 direct	 end-to-end	
ligation	of	viral	genomes	with	some	loss	of	genetic	 information,	 it	was	speculated	that	the	
DDR,	 and	 more	 specifically	 NHEJ	 machinery,	 played	 an	 important	 role	 in	 viral	
concatermisation.	 Further	 investigations	 showed	 that	 dl1004	 infection	 in	 cell	 lines	
expressing	mutant	Mre11,	DNA	Ligase	IV	and	DNA-PKcs	were	able	to	rescue	the	formation	of	
viral	 concatemers,	 suggesting	 that	 these	 components	of	 the	NHEJ	machinery	 are	 required	
for	viral	concatemerisation	(Stracker,	Carson	et	al.	2002).	Later	studies	further	demonstrated	
the	 relationship	 between	 concatemer	 formation	 and	 defective	 DNA	 replication	 and	 late	
protein	synthesis,	showing	that	the	activity	of	the	MRN	complex	had	a	direct	effect	on	viral	
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DNA	 replication	 and	 not	 through	 the	 activation	 of	 the	 DDR	 and	 concatemer	 formation	
(Lakdawala,	Schwartz	et	al.	2008).		
1.3.2	Adenovirus-Mediated	Degradation	of	Cellular	Proteins	
In	 a	 cellular	 context,	 ubiquitin	 ligases	 are	 known	 to	 have	 important	 roles	 in	 the	
control	 of	 homeostasis	 through	 the	 addition	 of	 ubiquitin	 (Ub)	 onto	 target	 proteins.	 The	
proteins	 involved	 in	 this	 system	 include	 the	 E1	 activating	 enzymes,	 the	 E2	 conjugating	
enzymes	and	the	E3	 ligase	enzymes.	 In	brief,	 the	E1	activating	enzyme	binds	and	activates	
ubiquitin	in	an	ATP-dependent	manner,	which	is	then	passed	onto	a	specific	E2	conjugating	
enzyme	recruited	by	E1.	Together	with	the	E3	 ligase	enzyme,	E2	conjugates	ubiquitin	onto	
lysine	 residues	of	 target	proteins.	 The	end	 result	 is	 usually	being	marked	 for	proteasome-
mediated	degradation	 (reviewed	 in	 (Nakayama	and	Nakayama	2006).	 It	 is	well	established	
that	the	Ad5	and	Ad12	viral	proteins	E1B55K	and	E4orf6	 interact	with	the	cellular	proteins	
Rbx1,	 Cullin	 2/5	 and	 Elongins	 B	 and	 C	 to	 form	 an	 E3	 ubiquitin	 ligase	 complex	 (Querido,	
Blanchette	et	al.	2001).	It	is	thought	that	the	E1B55K	protein	acts	as	a	substrate	recognition	
unit	 whilst	 the	 E4orf6	 protein	 assembles	 the	 cellular	 proteins	 in	 the	 complex	 (Baker,	





The	 first	 indication	 that	 adenovirus	 employed	 cellular	 proteins	 to	 form	 an	 E3	
ubiquitin	 ligase	 complex	 came	 from	 Querido	 and	 colleagues	 who	 demonstrated	 that	 the	







targeted	 for	 proteasome-mediated	 degradation	 by	 adenovirus	 with	 the	 ultimate	 aim	 of	
destabilising	 the	 cellular	 DNA	 damage	 response	 and	 thus	 promoting	 viral	 replication	
(Stracker,	Carson	et	al.	2002).	Since	the	other	MRN	complex	components,	Rad50	and	NBS1,	
become	destabilised	 in	 the	absence	of	Mre11,	 targeting	Mre11	 for	degradation	essentially	
targets	 the	 entire	 complex	 (Stewart,	 Maser	 et	 al.	 1999,	 Zhong,	 Bryson	 et	 al.	 2005).	 	 As	
previously	 discussed,	 the	MRN	 complex	 recognises	DSBs	 and	 activates	 ATM,	 initiating	 the	
DDR	(Lee	and	Paull	2005).	Targeting	this	complex,	therefore,	prevents	the	activation	of	the	
DDR	and	thus	is	essential	for	viral	replication.		
Other	 DNA	 damage	 proteins	 known	 to	 be	 degraded	 during	 adenovirus	 infection	
include	 DNA	 ligase	 IV,	 BLM	 and	 TOPBP1.	 The	 NHEJ	 DSB	 repair	 pathway	 component	 DNA	




unclear	 (Forrester,	 Sedgwick	et	al.	2011).	BLM	 is	a	DDR	component	 that	 is	 known	 to	have	
DNA-end	 processing	 activity.	 BLM	 is	 degraded	 in	 a	 E1B55K/E4orf6/Cullin	 5-dependent	
manner	 during	 Ad5	 infection,	 although	 the	 precise	 function	 of	 the	 degradation	 of	 this	
protein	during	adenovirus	infection	is	unclear	(Orazio,	Naeger	et	al.	2011).	It	 is	known	that	
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degraded	 exclusively	 by	 Ad12	 in	 an	 E4orf6-dependent,	 E1B55K-independent	 manner,	
suggesting	 that	 E4orf6	 can	 in	 fact	 act	 as	 a	 substrate	 recognition	 unit	 as	well	 as	 a	 cellular	
linker	 protein	 (Blackford,	 Patel	 et	 al.	 2010).	 Quite	 why	 it	 is	 necessary	 for	 the	 group	 A	
adenoviruses	(which	includes	Ad12)	but	not	the	group	C	viruses	(Ad5)	to	degrade	TOPBP1	is	
unknown	at	present.			
Most	 recently,	 adenovirus	 has	 been	 shown	 to	 degrade	 the	 lysine	 acetyltransferase	
Tip60	in	an	E1B55K,	E4orf6	and	proteasome-dependent	manner.	Tip60	has	been	implicated	
in	the	DNA	damage	response	through	its	activation	of	the	ATM	and	ATR	kinases.	In	addition	
it	 is	also	able	to	 inhibit	the	DDR	through	promoting	the	dephosphorylation	of	H2AX.	 It	has	
been	 shown	 that	 Tip60	 is	 able	 to	 bind	 directly	 to	 the	 immediate	 early	 promoter	 of	 the	
adenovirus	E1A	gene,	thus	 inhibiting	 its	expression.	 It	 is,	therefore,	 important	that	Tip60	is	
degraded	 during	 adenovirus	 infection	 in	 order	 to	 evade	 the	 inhibition	 of	 E1A	 gene	
expression	(Gupta,	Jha	et	al.	2013).			
Adenovirus	 5	 has	 also	 been	 shown	 to	 degrade	 proteins	 not	 involved	 in	 the	 DDR	
including	 the	 cell	 surface	 receptor	 integrin	 α3	 (Dallaire,	 Blanchette	 et	 al.	 2009).	 This	





The	 death	 domain-associated	 protein	 (Daxx)	 is	 another	 target	 during	 adenovirus	
infection.	Daxx	is	thought	to	be	involved	in	the	regulation	of	a	number	of	functions	including	
apoptosis	and	transcription.	Daxx	is	degraded	during	Ad5	infection	in	an	E1B55K-dependent,	
E4orf6-independent	 manner	 (Schreiner,	 Wimmer	 et	 al.	 2011).	 Further	 studies	 from	 this	
group	showed	that	X-linked	α-thalassaemia	retardation	syndrome	protein	(ATRX),	which	has	
been	 previously	 shown	 to	 form	 a	 complex	 with	 Daxx	 and	 to	 be	 involved	 in	 chromatin	
remodelling,	 is	 also	 degraded	 during	 Ad5	 infection	 (Xue,	 Gibbons	 et	 al.	 2003,	 Schreiner,	
Burck	et	al.	2013).		







In	 addition	 to	 inhibiting	 the	 cellular	 DDR	 through	 the	 proteasome-mediated	




the	 role	 for	 adenoviral-mediated	 relocalisation	 to	 VRCs	 is	 currently	 unknown,	 it	 has	 been	





As	 well	 as	 relocalisation	 to	 VRCs,	 adenovirus	 infection	 can	 also	 induce	 the	
relocalisation	of	DDR	proteins	 into	nuclear	 track	 structures	which	derive	 from	PML	bodies	
(Puvion-Dutilleul,	Chelbi-Alix	et	al.	1995,	Everett	2001).	As	previously	discussed	(see	Section	
1.1.6),	 E4orf3	 is	 responsible	 for	 the	 rapid	 reorganisation	 of	 PML	 bodies	 into	 PML	 nuclear	
tracks,	where	 it	 is	 known	 to	 relocalise	p53	and	PML	 to	 these	 sites	 (Carvalho,	 Seeler	 et	 al.	
1995,	 Konig,	 Roth	 et	 al.	 1999).	 The	 function	 of	 this	 relocalisation	 is	 largely	 unknown,	
although	 it	 is	 thought	 that	 E4orf3-mediated	 p53	 relocalisation	 induces	 H3K9me3	
heterochromatin	 formation	 at	 p53	 target	 promoter	 regions,	 silencing	 p53	 target	 genes	
(Soria,	Estermann	et	al.	2010).	A	number	of	other	proteins,	which	associate	with	PML	bodies,	
are	 degraded	 during	 adenovirus	 infection	 and	 this	 is	 distinct	 from	 PML	 reorganisation.	
Examples	 include	the	MRN	complex	which	is	relocalised	to	PML	nuclear	tracks	following	IR	
exposure,	 and	 this	 is	 thought	 to	 inhibit	 the	 activation	 of	 ATR	 and	 ultimately	 promote	 the	
degradation	 of	 the	 MRN	 complex	 (see	 Section	 1.3.2)(Evans	 and	 Hearing	 2005).	 Another	
example	is	Daxx,	where	its	E4orf3-mediated	association	with	PML	nuclear	tracks	is	thought	
to	inhibit	its	repression	of	transcriptional	activity	(Li,	Leo	et	al.	2000).			
During	 adenovirus	 infection,	 DDR	 proteins	 can	 also	 be	 relocalised	 to	 aggresomes.	
Ordinarily,	misfolded	proteins	are	transported	along	microtubules	to	microtubule-organising	
centres,	 by	 the	 motor	 protein	 dynein,	 where	 they	 are	 sequestered	 into	 these	 large	
cytoplasmic	 bodies	 known	 as	 aggresomes.	 The	 proteins	 within	 these	 structures	 are	 then	





relocalised	 to	aggresomes	 together	with	adenoviral	proteins	where	Mre11	 is	 subsequently	
degraded	 (Liu,	 Shevchenko	 et	 al.	 2005).	 p53	 has	 also	 been	 shown	 to	 be	 relocalised	 to	
aggresomes	 in	an	E4orf3	dependent	manner,	 suggesting	 that	adenovirus	 is	 able	 to	exploit	
the	cellular	aggresome	system	 in	order	 to	 induce	degradation	of	DDR	proteins	 that	would	
otherwise	 be	 detrimental	 for	 viral	 DNA	 replication	 (Liu,	 Shevchenko	 et	 al.	 2005).	
Interestingly,	 not	 all	 E1B55K	 proteins	 from	 various	 adenovirus	 serotypes	 localises	 to	
aggresomes,	 suggesting	 that	 the	 relocalisation	 of	 E1B55K	 to	 these	 structures	 is	 not	
necessary	for	degradation	of	target	proteins	(Blanchette,	Wimmer	et	al.	2013).	In	the	case	of	
Ad4	 and	 Ad12	 infection,	 the	MRN	 complex	 is	 not	 relocalised	 into	 PML	 nuclear	 tracks	 by	
E4orf3	 and	 is	 instead	 relocalised	 to	 VRCs	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	 Orazio	 et	 al.	
2009).	 This	 could	 prove	 detrimental	 for	 viral	 DNA	 replication	 since	 the	 localisation	 of	 the	
MRN	 complex	 to	 VRCs	 could	 initiate	 a	 DDR.	 In	 order	 to	 circumvent	 this,	 Ad4	 and	 Ad12	






























transcription	 elongation,	 chromatin	modifications	 and	DNA	 repair.	 The	majority	 of	 studies	
on	 the	 CCR4-NOT	 complex	 have	 been	 performed	 in	 yeast	 (both	 S.	 cerevisiae	 and	 S.	
pombe),where	 the	 complex	 comprises	 9	 core	 subunits:	 CCR4,	 CAF1,	 CAF40,	 CAF130	 and	
NOT1-5.	Whilst	much	 less	 is	known	about	the	human	CCR4-NOT	complex,	 the	orthologues	
CCR4-NOT	 transcription	 complex	 (CNOT1-CNOT10)	 have	 been	 identified	 in	 human	 cells.	
Table	 1.2	 represents	 yeast	 CCR4-NOT	 complex	 components	 along	 with	 their	 human	
orthologues.				
Two	major	enzymatic	functions	of	the	CCR4-NOT	complex	have	been	identified	in	yeast	and	
mammals,	 deadenylation	 and	 ubiquitination.	 The	 ubiquitination	 activity	 of	 the	 CCR4-NOT	
complex	 is	performed	by	 the	NOT4	component	of	 the	complex,	which	has	been	shown	 to	
have	 E3	 ubiquitin	 ligase	 activity	 (Albert,	 Hanzawa	 et	 al.	 2002).	 In	 S.	 cerevisiae,	 NOT4	 has	
been	shown	to	stably	interact	with	the	CCR4-NOT	complex;	interestingly,	however,	in	human	
cells,	the	NOT4	(hCNOT4)	protein	has	been	shown	to	exist	in	a	protein	complex	distinct	from	
the	 CCR4-NOT	 complex	 (Lau,	 Kolkman	 et	 al.	 2009,	 Panasenko	 and	 Collart	 2011).	 The	
deadenylase	activity	of	 the	CCR4-NOT	complex	 is	achieved	 through	 the	CCR4	subunit	 in	S.	
cerevisiae,	 which	 has	 3’	 exoribonuclease	 activity	 that	 targets	 poly(A)	 substrates	 (Chen,	
Chiang	et	al.	2002).	The	S.	cerevisiae	CCR4-NOT	protein	Caf1	 is	 the	 linker	protein	between	
CCR4	and	the	core	complex	components	(Tucker,	Staples	et	al.	2002).	It	has	also	been	shown	
























subunits	 CNOT1,	 CNOT2,	 CNOT3,	 CNOT9,	 CNOT10,	 CNOT11	 and	 TAB182.	 CNOT4,	 the	 E3	








CNOT6L,	 CNOT7	 and	 CNOT8	 transiently	 associate	 with	 the	 core	 complex.	 Interestingly,	
studies	 by	 Lau	 and	 colleagues	 found	 that	 the	 deadenylases	 CNOT7	 and	 CNOT8	 do	 not	
associate	 with	 each	 other,	 suggesting	 that	 these	 proteins	 form	 distinct	 CNOT	 complexes.	
Furthermore,	 the	 deadenylases	 CNOT6	 and	 CNOT6L	 were	 found	 to	 stably	 interact	 with	
CNOT7	 but	 not	 CNOT8,	 and	 deadenylases	 CNOT6	 and	 CNOT6L	 do	 not	 interact	 with	 each	
other,	suggesting	that	these	deadenylases	are	mutually	exclusive.	Finally,	this	group	showed	
that	the	ubiquitin	ligase	component	of	the	CNOT	complex,	CNOT4,	does	not	stably	interact	




A	number	of	 studies	have	 implicated	 the	CCR4-NOT	complex	 in	 the	DDR	 in	both	S.	
cerevisiae	 and	 S.	 pombe.	 In	 the	 vast	 majority	 of	 these	 studies,	 sensitivity	 assays	 were	
performed	using	yeast	 strains	 that	were	mutant	 for	various	components	of	 the	CCR4-NOT	
complex.	 CCR4	 (hCNOT6/hCNOT6L)	 was	 shown	 to	 be	 sensitive	 to	 IR,	 UV-C,	 HU,	 4-









to	 a	 number	 of	 forms	 of	 DNA	 damage	 and/or	 replication	 stress.	 The	 mechanism	 for	
sensitivity	to	various	DNA	damaging	agents	in	CCR4-NOT	complex	mutant	strains	is	currently	
unclear	and	in	some	cases	conflicting.	There	have	been	reports	that	the	deadenylase	activity	








our	 knowledge,	only	one	publication	exists	by	Morita	and	colleagues	 to	 suggest	a	 role	 for	












TAB182	 was	 further	 validated	 by	 the	 transfection	 of	 labelled	 TAB182	 protein	 and	
endogenous	 TAB182	 targeting	 antibodies.	 Through	 immunofluorescence	 analysis	 of	 a	
synchronised	 cell	 population,	 TAB182	 was	 found	 to	 associate	 with	 mitotic	 chromosomes	
(Seimiya	and	Smith	2002).	The	TAB182	protein	is	known	to	have	a	tankyrase	binding	domain	


















Figure	 1.16:	 Schematic	 of	 TAB182	 Protein.	 Schematic	 of	 the	 full-length	 TAB182	 protein.	





Previous	 work	 in	 our	 laboratory	 has	 shown	 TAB182	 to	 be	 degraded	 following	 Ad5	
infection.	Since	more	than	80%	of	adenoviral	targets	are	known	to	be	DDR	proteins,	this	lead	
to	the	speculation	that	TAB182	may	also	be	involved	in	the	DDR.	Furthermore,	TAB182	was	
identified	 in	 a	 mass	 spectrometry	 screen	 as	 a	 potential	 substrate	 of	 ATM/ATR,	 further	
implicating	a	role	in	the	DDR	(Matsuoka,	Ballif	et	al.	2007).	Therefore	the	aims	of	this	study	
were	as	follows:	




























the	majority	 of	 the	 experiments	 throughout	 this	 study.	 HeLa	 cells	 respond	 to	 adenovirus	
infection	in	a	manner	similar	to	other	human	tumour	cell	lines,	such	as	A549	and	U2OS.	They	






Unless	 otherwise	 stated,	 all	 cell	 lines	were	 cultured	 in	Dulbecco’s	modified	 Eagle’s	





























Table	2.1:	Human	Cell	 Lines	 used	 throughout	 this	Study.	 The	human	cell	 lines	









with	DMEM	supplemented	with	10%	FCS.	Resuspended	cells	were	 transferred	 to	 cryovials	













































to	each	dish.	Following	 the	30	minute	 incubation,	 the	 transfection	mix	was	added	to	each	
dish	 and	 incubated	 at	 37°C	 for	 16	 to	 18	 hours.	 The	Opti-MEM	 transfection	mix	was	 then	




HeLa	 cells	 were	 transfected	 with	 plasmids	 containing	 the	 adenovirus	 genes	 as	





1.5ml	 eppendorf	 tube	 (per	 reaction).	 In	 another	 eppendorf	 tube,	 150μl	 of	Opti-MEM	was	
added	 to	 7.5μl	 of	 Lipofectamine	 2000	 (Invitrogen)	 (per	 reaction).	 The	 contents	 of	 both	




Target' siRNA' Sense'sequence' Supplier'
Non$silencing+
control+ Custom+ CGUACGCGGAAUACUUCGAdTdT+ Dharmacon+
CNOT4+ SMARTpool+ CCAAUUCUCUCAAUAGUAC+ Dharmacon+
++ ++ UAACAGAGUCACAGUCGUU+ ++
++ ++ CGUCUUUGUUGUAGGUUUA+ ++
++ ++ GGUAGUAGAUGGCAGAACA+ ++
CNOT6+ SMARTpool+ GAAAGAACGUGGCUAUAAU+ Dharmacon+
++ ++ GAGCACAGGUGGAGUAGAA+ ++
++ ++ GGGCAGAGCUUGAAAUAAG+ ++
++ ++ GCUAUAAUGUUCUUUGUGA+ ++
CNOT6L+ SMARTpool+ UGACAGCGCUGCACCUAAA+ Dharmacon+
++ ++ CCAAUUACACCUUUGAUUU+ ++
++ ++ GAGCAGGUAUGAAGCCUAU+ ++
++ ++ GGUAUUAGAGGUCCACAAA+ ++
TAB182+ SMARTpool+ GAGUUUGGGAAGAGCGCUU+ Dharmacon+
++ ++ AGGACCAGGAAUUCGGAAA+ ++
++ ++ CAGAAGCUUUGGAACGAGA+ ++
++ ++ CACCAAGGCCUGCGGUUGA+ ++
Table	 2.3:	 siRNAs	 used	 during	 this	 Study.	 The	 siRNAs	 used	 to	knockdown	 the	
















0.5μM	 of	 Bortezomib	 (LC	 Laboratories)	 was	 added	 to	 HeLa	 cells	 24	 hours	 prior	 to	
each	 harvesting	 point.	 4μM	 of	 MLN4924	 (Active	 Biochem	 Labs)	 was	 added	 to	 HeLa	 cells	
immediately	 after	 infecting	 with	 adenovirus	 and	 left	 throughout	 the	 duration	 of	 the	
infection.	 HU	 (Sigma-Aldrich)	 was	 dissolved	 at	 the	 required	 concentration	 in	 DMEM	 and	
added	at	different	time-points	prior	to	harvesting	depending	on	the	experiment.		5μM	of	the	
ATR	 inhibitor	 (VE-821	 Selleck)(in	 DMSO)	was	 added	 2	 hours	 prior	 to	 labelling	 DNA	 fibres.	
1μM	 of	 the	 Chk1	 inhibitor	 (Go6976	 Calbiochem)(in	 DMSO)	 was	 added	 2	 hours	 prior	 to	






were	 washed	 in	 PBS,	 and	 the	 PBS	 also	 added	 to	 the	 falcon	 tube	 (keeping	 all	 media	 and	
washes	ensures	no	mitotic	cells	are	lost).	Cells	were	trypsinised	as	previously	described	and	
the	harvested	cells	also	added	to	the	Falcon	tube.	All	cells	were	pelleted	by	centrifugation	at	
1400rpm	 for	 5	minutes.	 Cells	 were	 resuspended	 in	 PBS	 and	 pelleted	 by	 centrifugation	 at	
1400rpm	for	a	further	5	minutes.	Cells	were	resuspended	in	3mls	ice-cold	PBS,	followed	by	
the	addition	of	7mls	of	 ice-cold	100%	ethanol	drop-wise	whilst	 vortexing	 (preventing	 cells	
from	clumping).	Cells	were	stored	at	-20°C	for	at	least	1	hour	or	up	to	2	weeks.		
To	process	cells	for	propidium	iodide	(PI)	staining,	cells	were	washed	3	times	in	ice-








24	 hours	 prior	 to	 labelling,	 HeLa	 cells	 were	 plated	 in	 a	 6	 well	 plate	 at	 30-40%	


















minutes.	 Cells	 were	 washed	 once	 in	 PBS	 and	 again	 pelleted	 by	 centrifugation.	 Following	
resuspension	of	cell	pellets	in	1-2ml	PBS,	8-10mls	of	pre-warmed	0.03M	sodium	citrate	was	
added	drop-wise	with	gentle	agitation.	Cells	were	incubated	at	37°C	for	1	hour,	transferred	
to	 a	 polypropylene	 tube	 and	 pelleted	 by	 centrifugation	 at	 900rpm	 for	 5	 minutes.	 The	
supernatant	was	discarded	and	resuspended	 in	1-2mls	PBS,	 followed	by	 the	addition	of	6-





cells	onto	slides,	 slides	were	 immersed	 in	acetic	acid,	blotted	 to	 remove	any	excess	acetic	
acid,	and	using	a	pipette,	two	drops	of	fixed	cells	were	dropped	onto	the	slides.	Slides	were	
left	 to	 dry	 overnight.	 Slides	 were	 then	 stained	 in	 Giemsa	 diluted	 1:20	 with	 H20	 for	 15	
minutes,	followed	by	a	wash	in	H20	for	a	further	3	minutes.	The	slides	were	allowed	to	dry	








PBS	 was	 removed	 from	 the	 cell	 pellets	 and	 the	 pellet	 resuspended	 in	 80-200μl	 UTB	 lysis	
buffer	(8M	urea,	50mM	Tris	HCl,	150mM	β-mercaptoethanol,	pH	7.5).	Cells	were	sonicated	
twice	 for	10	seconds	and	 immediately	placed	on	 ice.	Cell	 lysates	were	 then	centrifuged	at	
16000	 rpm	 for	15	minutes	 to	 remove	 cell	 debris.	 Supernatants	were	 transferred	 to	a	pre-
chilled	Eppendorf	tube,	snap-frozen	in	liquid	nitrogen	and	stored	at	-80°C.		
Cell	 lysate	 preparation	 for	 glutathione	 S-transferase	 (GST)	 pull-downs	 and	 co-
immunoprecipitation	assays	was	performed	as	follows.	Cells	were	washed	two	times	in	ice-
cold	PBS,	in	the	final	PBS	wash,	cells	were	scraped	off	of	the	tissue	culture	dish	using	a	cell	
scraper	 and	 pooled	 into	 15ml	 Falcon	 tubes.	 Cells	were	 pelleted	 by	 centrifugation	 at	 2000	
rpm	at	4°C	 for	5	minutes.	Cells	were	washed	 in	 ice-cold	PBS	a	 further	two	times,	pelleting	
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the	cells	by	centrifugation	in	between	each	wash.	Cells	were	then	lysed	in	500-1000	μl	NETN	
buffer	 (0.5%	 NP-40	 (Sigma-Aldrich),	 150mM	NaCl	 (Sigma-Aldrich),	 50mM	 Tris	 HCl	 pH	 7.5,	
0.5mM	 EDTA	 (Sigma-Aldrich))	 depending	 on	 cell	 number.	 Cell	 lysates	 were	 homogenised	
using	a	Wheaton-Dounce	homogeniser	and	centrifuged	three	times	at	4°C,	first	at	3000	rpm	
for	5	minutes,	followed	by	13000	rpm	for	15	minutes,	and	finally	45000	rpm	for	30	minutes.	




Protein	 concentration	 of	 cell	 lysates	 were	 determined	 against	 a	 range	 of	 bovine	










were	prepared	 respectively	 (Table	2.4).	Gel	 apparatus	 (GE	Healthcare)	was	 constructed	as	
per	the	manufacturer’s	instructions.	Cell	lysates	were	prepared	for	loading	with	the	addition	
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of	 an	 equal	 volume	 of	 2x	 Laemmli	 sample	 buffer	 (Bio-Rad),	 boiled	 for	 5	 minutes	 and	
centrifuged	at	14,000	rpm	for	1	minute.	Typically	50μg	of	cell	 lysate	was	loaded	onto	each	






Coomassie	 blue	 solution	 (0.1%	 Coomassie	 Brilliant	 Blue	 R-250	 (Sigma-Aldrich),	 40%	






protocols	 followed	 until	 the	 point	 of	 the	 NETN	 washes	 (see	 Sections	 2.3.6	 and	 2.4.3,	
respectively).	 Beads	 were	 denatured	 by	 incubating	 in	 9M	 Urea/	 50mM	 ammonium	
bicarbonate	 at	 room	 temperature	 for	 1	 hour	 with	 agitation.	 Beads	 were	 pelleted	 by	
centrifugation	 at	 3000	 rpm	 at	 4°C	 for	 1	 minute	 and	 supernatant	 transferred	 to	 a	 fresh	
eppendorf	 tube.	 A	 final	 concentration	 of	 50mM	 dithiothreitol	 (DTT)	 was	 added	 to	 the	
















300μl	 of	 supernatant	 was	 added	 to	 FASP	 filters	 (Amicon,	 30K	 cut	 off)	 and	 centrifuged	 at	
14000	 rpm	 for	 15	 minutes	 at	 room	 temperature.	 Flow-through	 was	 discarded	 and	 the	
remaining	supernatant	added	to	the	FASP	filter	and	centrifuged	again	at	14000	rpm	for	15	
minutes	 at	 room	 temperature.	 Filters	 were	 washed	 four	 times	 with	 50mM	 ammonium	
bicarbonate,	centrifuging	at	14000	rpm	for	15	minutes	at	room	temperature	between	each	
wash,	 and	 discarding	 the	 flow-through	 each	 time.	 FASP	 filters	 were	 transferred	 to	 fresh	
collection	 tubes	 and	 mass	 spectrometry-grade	 trypsin	 (Promega),	 diluted	 in	 50mM	
ammonium	bicarbonate	to	a	final	volume	of	300μl,	added	to	the	FASP	filters	(1μg	per	filter).	
FASP	 filters	 were	 left	 in	 an	 incubator	 at	 37°C	 overnight.	 To	 collect	 tryptic	 peptides,	 FASP	
filters	were	 centrifuged	 at	 14000	 rpm	 for	 10	minutes	 at	 room	 temperature	 and	 the	 flow-








In	 order	 to	 assess	 in-vitro	protein-protein	 interactions,	 GST	 pull-down	 assays	were	
performed.	10mg	of	cell	lysate	(as	prepared	in	Section	2.3.1)	was	incubated	with	25μg	GST-
fusion	protein	(see	Table	2.5	for	a	list	of	GST-fusion	proteins	used	in	this	study),	rotating	at	
4°C	 for	 3	 hours.	 To	 isolate	 protein-protein	 complexes,	 25μl	 of	 glutathione	 beads	 (Sigma-
Aldrich)	were	then	added	and	incubated	for	a	further	hour	at	4°C.	To	capture	protein-protein	
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complexes,	 glutathione	 beads	 were	 pelleted	 by	 centrifugation	 at	 3000	 rpm	 at	 4°C	 for	 1	
minute,	 and	 the	 supernatant	 discarded.	 Glutathione	 beads	 were	 washed	 in	 NETN	 buffer,	
centrifuged	at	3000	rpm	at	4°C	for	1	minute,	this	was	repeated	4	times.	Samples	were	then	
washed	 in	Buffer	B	 (2mM	EDTA	 in	PBS),	centrifuged	at	3000	rpm	at	4°C	 for	1	minute,	and	
taking	care	to	remove	all	supernatant.	To	elute	protein-protein	complexes	from	the	beads,	
60μl	of	25mM	glutathione	pH	8.2	(BDH	Laboratories)	was	incubated	with	the	samples	for	1	
hour	 at	 4°C.	 Samples	were	 centrifuged	 at	 3000	 rpm	 at	 4°C	 for	 1	minute	 and	 supernatant	
containing	 the	 protein-protein	 complexes	was	 transferred	 into	 a	 fresh	 Eppendorf	 tube.	 A	
further	30μl	of	glutathione	was	added	to	the	beads	and	incubated	at	4°C	for	30	minutes.	The	
samples	were	 centrifuged	again	 at	 3000	 rpm	at	 4°C	 for	 1	minute	 and	 supernatant	pooled	
into	 the	eppendorf	 tube.	Samples	were	 run	on	SDS-PAGE	gels	as	 follows.	25μl	of	 Laemmli	







2.4.3.	After	 the	 final	wash	the	 immunoprecipitates	were	washed	twice	with	deadenylation	
buffer	 (50mM	 Hepes-NaOH	 pH8.0,	 0.15MNaCl,	 2mMMgCl2,	 10%glycerol).	 The	




















that	 time	10µl	of	 supernatant	were	mixed	with	10µl	RNA	 loading	buffer	 (95%	 formamide,	
0.025%	 SDS,	 5mM	 EDTA,	 Blue-orange	 loading	 dye,	 Promega)	 and	 heated	 at	 85oC	 for	 5	
minutes.	RNA	was	analysed	by	electrophoresis	on	a	20%	acrylamide	gel	run	in	the	presence	











membrane	 using	 the	 following	 method.	 The	 gel	 and	 nitrocellulose	 membrane	 (VWR	
Laboratories)	were	 soaked	 in	 transfer	 buffer	 (20%	methanol,	 50mM	Tris,	 190mM	glycine)	









An#gen& An#body& Species& Applica#on& Dilu#on& Source&
53BP1& 53BP1& Rabbit& IF/WB& 1:1000& Novus&
Ad5E1A& M73& Mouse& WB& 1:500& Ed&Harlow&
Ad5E1B55K& 2A6& Mouse& WB/IF& 1:1000& Arnold&Levine&
Ad5E4ORF3& 6A11& Mouse& WB& 1:200& Thomas&Dobner&
Ad5E4ORF6& RSA1& Mouse& WB& 1:200& Thomas&Dobner&
Ad12E1A& M13& Mouse& WB& 1:20& In&house&
Ad12E1B55K& XPH9& Mouse& WB/IF& 1:1000& In&house&
Ad5&Hexon& Ad5&Hexon& Rabbit&& WB& 1:1000&& Vivien&Mautner&
Ad12&Knob& Ad12&Knob& Rabbit& WB& 1:1000& Paul&Freimuth&
ATR& ATR& Goat& WB& 1:1000& Santa&Cruz&
Aurora&kinase& Aurora&kinase& Mouse& WB& 1:1000& Abcam&
βWAcXn& AcXn& Mouse& WB& 1:50000& SigmaWAldrich&
BLM& BLM& Rabbit& WB& 1:1000& Bethyl&
BubR1& BubR1& Mouse& WB& 1:3000& Becton&Dickinson&
Chk1& Chk1& Mouse& WB& 1:1000& Santa&Cruz&
pChk1&S317& pChk1&S317& Rabbit& WB& 1:1000& Bethyl&
pChk1&S345& pChk1&S345& Rabbit&& WB& 1:1000& Cell&Signalling&
Chk2& Chk2& Rabbit& WB& 1:1000& Steve&Elledge&
Claspin& Claspin& Rabbit& WB& 1:1000& Bethyl&
CldU& BrdU& Rat& DNA&ﬁbres& 1:750& AbD&SeroTec&
CNOT3& CNOT3& Rabbit& WB& 1:1000& GeneTex&
CNOT4& CNOT4& Rabbit& WB& 1:1000& GeneTex&
CNOT7& CNOT7& Rabbit& WB& 1:1000& GeneTex&
CtIP& CtIP& Mouse& WB& 1:1000& Baer&Richard&
Cullin&2& Cullin&2& Rabbit&& WB& 1:1000& Abcam&
Cullin&5& Cullin&5& Rabbit& WB& 1:500& Santa&Cruz&
Cyclin&A& Cyclin&A& Rabbit& WB/IF& 1:500& Santa&Cruz&
Cyclin&B& Cyclin&B& Rabbit& WB& 1:500& Santa&Cruz&
Cyclin&E& Cyclin&E& Rabbit& WB& 1:500& Santa&Cruz&
DBP& DBP& Mouse& IF& 1:100& Pieter&van&der&Vliet&
DNAWPK& DNAWPK& Rabbit& WB& 1:1000& Abcam&







An#gen& An#body& Species& Applica#on& Dilu#on& Source&
pHistone)H3)Ser10) pHistone)H3)Ser10) Rabbit) WB/FACS) 1:100) Cell)signalling)
H2AX) H2AX) Rabbit) WB) 1:1000) Millipore)
γH2AX)S139) γH2AX)S139) Mouse) WB/IF) 1:1000) Millipore)
HA) HA)12CAS) Mouse) WB) 1:1000) SigmaCAldrich)
hnRNPUL1) hnRNPUL1) Rabbit) WB) 1:1000) In)house)
IdU) BrdU) Mouse) DNA)ﬁbres) 1:500) Becton)Dickinson)
Ku80) Ku80) Mouse) WB) 1:1000) GeneTex)
MDC1) MDC1) Rabbit) WB) 1:1000) In)house)
MDM2) 2A10) Mouse) WB) 1:200) Arnold)Levine)
Mre11) Mre11) Mouse) WB) 1:1000) Genetex)
NBS1) NBS1) Rabbit) WB) 1:10000) Genetex)
pNBS1)S343) pNBS1)S343) Rabbit) WB) 1:1000) Abcam)
p53) DO1) Mouse) WB) 1:2000) David)Lane)
PCNA) PCNA) Mouse) WB) 1:1000) Santa)Cruz)
Rad9) Rad9) Rabbit) WB) 1:1000) Santa)Cruz)
Rad18) Rad18) Rabbit) WB) 1:1000) Bethyl)
Rad50) Rad50) Mouse) WB) 1:1000) GeneTex)
Rad51) Rad51) Rabbit)) WB) 1:1000) Santa)Cruz)
RNR1) RNR1) Rabbit)) WB) 1:1000) GeneTex)
RNR2) RNR2) Rabbit) WB) 1:1000) GeneTex)
p53R2) p53R2) Rabbit) WB) 1:1000) GeneTex)
RPA)) RPA) Mouse)) WB/IF) 1:1000) Calbiochem)
p21) p21) Mouse) WB) 1:500) Santa)Cruz)
pRPA)S4/8) pRPA)S4/8) Rabbit) WB) 1:1000) Bethyl)
Tab182) Tab182) Rabbit) WB) 1:500) In)house)
Tankyrase)1) Tankyrase)1) Rabbit) WB) 1:1000) GeneTex)
TOPBP1) TOPBP1) Rabbit) WB) 1:1000) Bethyl)
Mouse)IgG) AnYCmouse)HRP) Goat) WB) 1:2000) DAKO)Laboratories)
Rabbit)IgG) AnYCrabbit)HRP) Swine) WB) 1:3000) DAKO)Laboratories)
Rabbit)IgG) Alexa)ﬂuor®)488)anYCrabbit)) Donkey) FACS) 1:50) Invitrogen)
Rabbit)IgG) Alexa)ﬂuor®)546)anYCrabbit)) Goat) IF) 1:1000) Invitrogen)
Mouse)IgG) Alexa)ﬂuor®)488)anYCmouse))Goat) IF) 1:1000) Invitrogen)
Rat)IgG) Alexa)ﬂuor®)488)anYCmouse))Goat) DNA)ﬁbres) 1:500) Invitrogen)











5%	 BSA	 at	 the	 required	 concentration	 (see	 Table	 2.6),	 and	 incubated	 with	 nitrocellulose	
membranes	 overnight	 at	 4°C	 with	 agitation.	 To	 remove	 excess	 primary	 antibodies,	
nitrocellulose	 membranes	 were	 washed	 with	 TBS-T	 three	 times	 for	 10	 minutes	 with	
agitation.	 Nitrocellulose	 membranes	 were	 then	 incubated	 with	 horseradish-peroxidase	
(HRP)-conjugated	secondary	antibodies	(Dako)	for	1	hour	with	agitation.	To	remove	excess	
secondary	antibodies,	nitrocellulose	membranes	were	washed	three	times	with	TBS-T	for	10	
minutes	 each	 time	 with	 agitation.	 Antigens	 were	 detected	 by	 incubation	 in	 enhanced	




To	 assess	 in-vivo	protein-protein	 interactions,	 co-immunoprecipitation	 assays	were	
performed	as	 follows.	5mg	of	cell	 lysate	 (as	prepared	 in	Section	2.3.1)	was	 incubated	with	





rpm	 for	 1	minute	 at	 4°C	 and	 the	 supernatant	 discarded.	 The	 beads	were	 then	washed	 4	
times	 in	 NETN	 buffer,	 centrifuging	 at	 3000	 rpm	 for	 1	 minute	 at	 4°C	 and	 discarding	 the	





Cells	 were	 plated	 onto	 poly-L-lysine	 coated	 coverslips	 and	 incubated	 at	 37°C	
overnight.	Cells	were	washed	twice	 in	 ice-cold	PBS	and	permeabilised	by	 incubation	 in	 ice-
cold	pre-extraction	buffer	 (10mM	pipes	pH	6.8,	300mM	sucrose,	20mM	NaCl,	3mM	MgCl2	
and	0.5%	Triton	X-100)	 for	 5	minutes.	 Cells	were	 fixed	 in	 ice-cold	3.6%	paraformaldehyde	
(PFA)	 in	PBS	for	a	further	10	minutes.	Cover	slips	were	washed	three	times	 in	 ice-cold	PBS	








using	 Vectashield	 Mounting	 medium	 with	 4’,	 6-diamidino-2-phenylindole	 (DAPI)	 (Vector	
Laboratories).	 Upon	 the	 addition	 of	 Vectashield,	 gentle	 pressure	 was	 applied	 to	 the	






Slides	were	washed	 twice	 in	 H20,	 rinsed	 once	 in	 2.5M	 hydrochloric	 acid	 (HCl)	 and	
denatured	in	2.5M	HCl	for	1	hour	15	minutes.	Slides	were	rinsed	twice	in	PBS,	followed	by	
two	washes	in	blocking	solution	(1%	bovine	serum	albumin	(BSA),	0.01%	Tween	20	in	PBS).	
Slides	were	 incubated	 in	blocking	solution	 for	a	 further	30	minutes.	Slides	were	 incubated	
with	rat	anti-BrdU	(AbD	SeroTec)	(which	specifically	cross-reacts	with	CldU)	and	mouse	anti-
BrdU	 (Becton	 Dickinson)	 (which	 specifically	 cross	 reacts	 with	 IdU)	 antibodies	 in	 blocking	
solution	 for	 1	 hour.	 Slides	 were	 washed	 3	 times	 in	 PBS	 and	 incubated	 in	 5%	 PFA	 for	 10	
minutes	 to	 fix	 the	 antibodies.	 Slides	were	washed	 a	 further	 3	 times	 in	 PBS	 followed	 by	 3	
washes	 in	 blocking	 solution.	 Slides	 were	 incubated	 in	 anti-rat	 and	 anti-mouse	 secondary	
antibodies	 (Alexafluor)	 for	 1.5	 hours.	 Slides	were	washed	 twice	 in	 PBS,	 followed	 by	 three	
washes	 in	 blocking	 solution	 and	 twice	 more	 in	 PBS.	 Slides	 were	 mounted	 in	 mounting	






the	 cells	 by	 centrifugation	 at	 1600rpm	 for	 5	 minutes	 between	 each	 wash.	 Cells	 were	
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were	 washed	 once	 in	 1%	 BSA	 in	 PBS	 and	 pelleted	 by	 centrifugation	 at	 1600rpm	 for	 5	








LB-agar	 plates:	1.2%	agar	 (Sigma-Aldrich)	was	added	 to	 LB	prior	 to	 sterilisation.	 Following	
















Colonies	 were	 picked	 from	 LB-agar	 plates	 using	 a	 sterile	 pipette	 tip	 and	 used	 to	
inoculate	3mls	of	LB	supplemented	with	the	appropriate	antibiotic	in	a	shaking	incubator	at	
37°C	at	220rpm	overnight.	Overnight	cultures	were	centrifuged	to	pellet	bacteria	at	12000	








with	 750μl	wash	 solution	 and	 centrifuged	 again	 at	 13000	 rpm	 for	 1	minute.	 The	 columns	
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Large-scale	 preparation	 of	 DNA	 was	 performed	 using	 the	 Invitrogen	 PureLinkTM	 HiPure	




been	 pre-prepared	 by	 the	 addition	 of	 30mls	 of	 equilibration	 buffer,	 and	 allowed	 to	 drip	
through	 the	 column	 by	 gravity.	 Columns	 were	 washed	 with	 50mls	 of	 wash	 buffer	 and	









DNA	 concentrations	 were	 measured	 using	 a	 Nanodrop	 1000	 spectrophotometer	






of	a	normal	 individual)	 (kindly	donated	by	Dr	Phil	Byrd)	was	used	to	amplify	 the	complete	
TAB182	cDNA	using	forward	and	reverse	primers	(shown	in	Table	2.7).	The	polymerase	chain	
reaction	(PCR)	reaction	was	set	up	as	follows:	10-20ng	of	cDNA,	0.5μM	forward	and	reverse	
primers,	 1.5	 units	 of	 Q5	 High-Fidelity	 DNA	 polymerase	 (New	 England	 Biolabs),	 200mM	
dNTPs,	 1	X	Q5	 reaction	buffer	 in	 a	50μl	 reaction.	A	Veriti	 96-well	 Thermal	Cycler	 (Applied	






The	 visualisation	 of	 PCR	 products	 was	 achieved	 by	 running	 the	 product	 on	 0.8%	
agarose	 gels.	 0.8g	 agarose	 (Sigma-Aldrich)	 and	 1μg/ml	 ethidium	 bromide	 (total	
concentration)	was	added	 to	100mls	of	1x	TBE	 (20mM	Na2EDTA,	880mM	Tris	and	890mM	
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orthoboric	 acid)	 and	 heated	 until	 all	 agarose	 was	 dissolved.	 Once	 dissolved,	 the	 agarose	
mixture	was	poured	into	gel	tanks	and	allowed	to	cool.	Once	cooled,	gel	tanks	were	flooded	
with	 1x	 TBE	 buffer.	 1μl	 of	 PCR	 product,	 together	 with	 2μl	 of	 loading	 buffer	 (0.25%	 w/v	
bromophenol	blue,	30%	glycerol)	and	7μl	0.25x	TBE	buffer	was	mixed	and	loaded	onto	the	











of	 linear	molecules	 generated.	 Ligation	 reactions	were	 set	 up	with	 50ng	 Sal	 I-HF	 digested	
and	 phosphatased	 pEGFP-C3	 DNA	 and	 50ng	 of	 Sal	 I-HF	 digested	 TAB182	 cDNA.	 Ligation	
reactions	were	performed	in	12μl	1x	ligation	buffer	containing	1μl	(400	units)	T4	DNA	ligase	
(New	 England	 Biolabs).	 The	 ligation	 reaction	was	 incubated	 at	 16oC	 overnight.	 3μl	 of	 the	
ligation	reaction	was	transformed	into	50μl	of	high	efficiency	NEB	5-alpha	competent	E.coli	






incubated	 with	 0.5μl	 Taq	 polymerase	 (Roche),	 0.75μl	 of	 dNTPs	 (10mM),	 1μl	 forward	 and	
reverse	 primers,	 2.5μl	 5x	 buffer	 +Mg2+,	 into	 a	 final	 volume	of	 25μl.	 The	 reaction	mix	was	






designed	 to	 sequence	 the	 entire	 length	 of	 the	 eGFPC3-TAB182	 gene	 (Table	 2.7).	 Plasmid	




























































During	 adenovirus	 infection,	 the	 viral	 linear	 double-stranded	 genome	 can	 be	
recognised	by	the	DDR	as	DSBs	and	acted	upon	by	the	DSB	repair	machinery	in	an	attempt	to	
‘repair’	 the	adenoviral	 ends.	 The	 result	of	 such	 ‘repair’	 leads	 to	 the	 concatenation	of	 viral	
genomes	 which	 are	 unable	 to	 be	 replicated	 (Weiden	 and	 Ginsberg	 1994).	 To	 avoid	 this,	
adenovirus	has	developed	sophisticated	mechanisms	to	avoid	detection	from	the	DDR	and	
therefore	 replicate	 its	 genome.	 Such	 mechanisms	 include	 the	 degradation	 of	 proteins	
involved	in	the	DDR	and	repair	pathways	including	p53,	Mre11,	DNA	ligase	IV,	BLM,	TOPBP1	
and	Tip60	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	Baker,	Rohleder	et	
al.	 2007,	 Blackford,	 Patel	 et	 al.	 2010,	 Orazio,	 Naeger	 et	 al.	 2011,	 Gupta,	 Jha	 et	 al.	 2013).	
Another	 mechanism	 of	 evading	 the	 cellular	 DDR	 is	 through	 the	 relocalisation	 of	 DDR	
proteins;	 a	 number	 of	 DDR	 proteins	 are	 known	 to	 be	 relocated	 to	 VRCs	 during	 infection	
including	RPA32,	ATR,	ATRIP,	 TOPBP1,	 Rad17	 and	Rad9	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	
Orazio	 et	 al.	 2009).	 Adenovirus	 has	 also	 been	 shown	 to	 relocalise	 DDR	 proteins	 to	 PML	
bodies	or	aggresomes,	such	proteins	include	p53	and	the	MRN	complex	(Carvalho,	Seeler	et	
al.	1995,	Konig,	Roth	et	al.	1999),	(Araujo,	Stracker	et	al.	2005,	Liu,	Shevchenko	et	al.	2005).		
Previous	 preliminary	 studies	 from	 our	 laboratory	 have	 indicated	 that	 TAB182,	 a	
protein	 previously	 shown	 to	 interact	 with	 Tankyrase	 1,	 may	 be	 down-regulated	 during	
adenovirus	 infection	 (Seimiya	 and	 Smith	 2002).	 Such	 preliminary	 studies	 included	 the	
screening	of	a	panel	of	proteins	that	had	been	previously	 implicated	 in	the	DDR	(including	
TAB182),	 to	 determine	 whether	 they	 were	 reduced	 during	 Ad5	 infection.	 Amongst	 the	
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screened	 proteins,	 TAB182	 was	 the	 only	 obvious	 candidate.	 Since	 more	 than	 80%	 of	
adenoviral	cellular	 targets	are	proteins	 involved	 in	 the	DDR,	 it	was	 therefore	hypothesised	
that	 TAB182	 could	 be	 a	 DDR	 protein	 targeted	 for	 proteasomal	 degradation	 during	
adenovirus	infection	in	order	to	promote	viral	replication.	Therefore	the	aim	of	this	chapter	





To	 confirm	 the	 preliminary	 evidence	 obtained	 from	our	 laboratory	 suggesting	 that	
TAB182	is	degraded	during	adenovirus	infection,	HeLa	cells	were	mock-infected	or	infected	
with	 Ad5	 and	 Ad12	 at	 an	MOI	 of	 5	 and	 harvested	 at	 0,	 8,	 24,	 48,	 72	 and	 96	 hours	 post-
infection.	Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	
antibodies	(Figure	3.1).	β-actin	was	used	as	a	loading	control.	Adenovirus	early	proteins	E1A	
and	E1B55K	were	 immunoblotted	along	with	 the	viral	 structural	proteins	Hexon	 (Ad5)	and	
Knob	 (Ad12)	 as	 markers	 of	 adenovirus	 replication.	 As	 expected,	 the	 expression	 of	 E1A,	
E1B55K,	Hexon	(Ad5)	and	Knob	(Ad12)	was	observed	between	8	and	24	hours	post-infection	
in	 both	 Ad5	 and	 Ad12	 infected	 cells.	 Mre11	 and	 p53	 were	 immunoblotted	 as	 positive	
controls	 since	 these	 proteins	 are	 known	 to	 be	 degraded	 during	 adenovirus	 infection	






























controls	 since	 these	 proteins	 are	 known	 to	 be	 degraded	 by	 Ad5	 and	 Ad12.	 β-Actin	 was	




infection,	 respectively.	 Interestingly,	 the	expression	 levels	of	p53	 increased	 following	both	
Ad5	 and	 Ad12	 infection	 before	 it	 was	 degraded.	 This	 is	 believed	 to	 be	 a	 consequence	 of	
adenovirus	 infection	 inducing	 a	 pseudo-S	 phase	 and	 subsequently	 p53	 expression	 is	
increased	 (Boggs	and	Reisman	2006,	Takahashi,	Polson	et	al.	 2011).	 Infection	of	 cells	with	
Ad5	 and	Ad12	 resulted	 in	 the	 reduced	 levels	 of	 TAB182	protein	 at	 72	 and	48	hours	 post-
infection	 respectively,	 confirming	 that	 TAB182	 is	 indeed	 a	 cellular	 target	 for	 certain	
adenovirus	serotypes.	Similarly	to	p53	expression	levels,	the	expression	of	TAB182	increased	





The	 degradation	 of	 DNA	 damage	 proteins	 during	 adenovirus	 infection	 is	 almost	
exclusively	dependent	on	the	proteasome	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	
et	al.	2002,	Baker,	Rohleder	et	al.	2007,	Orazio,	Naeger	et	al.	2011).	To	determine	whether	










Figure	 3.2:	 The	 Down-Regulation	 of	 TAB182	 Protein	 Levels	 during	 Ad5	 and	 Ad12	
Infection	 can	 be	 Rescued	 by	 the	 Proteasomal	 Inhibitor	 Bortezomib.	 HeLa	 cells	 were	
infected	with	Ad5	 (A)	or	Ad12	 (B)	at	an	MOI	of	5.	Cells	were	treated	with	0.5µM	of	the	
proteasome	 inhibitor	 Bortezomib	 24	 hours	 before	 harvesting.	 Cells	 were	 harvested	 at	
various	time-points	(0,	8,	24,	48	and	72	hours)	post-infection.	Cell	lysates	were	subjected	
to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	 was	
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observed	 24	 hours	 post-infection	 in	 DMSO,	 mock-treated	 infected	 cells	 and	 bortezomib	
treated	 infected	 cells.	 Ad5	 infected	 cells	 treated	 with	 bortezomib	 showed	 a	 decrease	 in	
E1B55K	expression	when	compared	to	mock-treated	cells,	possibly	due	to	the	toxic	effects	of	
bortezomib	 on	 the	 transcriptional	machinery	 required	 for	 the	 virus.	Mre11,	 p53	 and	 BLM	
were	 immunoblotted	 as	 controls	 since	 the	 degradation	 of	 these	 proteins	 during	 Ad5	 and	
Ad12	 infection	 is	known	to	be	dependent	on	proteasome	function	(Querido,	Blanchette	et	
al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002,	 Orazio,	 Naeger	 et	 al.	 2011).	 As	 expected,	 in	 cells	
infected	with	Ad5	or	Ad12	and	mock-treated,	Mre11,	p53	and	BLM	were	degraded	during	
the	 course	 of	 infection	 (Figure	 3.2A	 and	 3.2B	 respectively).	 	 In	 cells	 infected	with	 Ad5	 or	
Ad12	 and	 bortezomib	 treated,	 the	 degradation	 of	 Mre11,	 p53	 and	 BLM	 was	 delayed	 in	
comparison	to	mock-treated	control	cells.	 	Similarly,	the	degradation	of	TAB182	in	infected	
(Ad5	 or	 Ad12),	 bortezomib	 treated	 cells	 was	 delayed	 compared	 to	 the	 degradation	 of	
TAB182	 in	 infected,	 mock-treated	 cells.	 These	 data	 indicate	 that	 the	 down-regulation	 of	





in	 order	 to	 degrade	 their	 targets	 (Querido,	 Blanchette	 et	 al.	 2001,	 Baker,	 Rohleder	 et	 al.	
2007,	 Blackford,	 Patel	 et	 al.	 2010,	 Forrester,	 Sedgwick	 et	 al.	 2011,	 Orazio,	 Naeger	 et	 al.	
2011).	 The	 small	molecule	 inhibitor	MLN4924	was	 used	 to	 inhibit	 cellular	 Cullin	 function;	
MLN4924	 inhibits	 the	 NEDD8-activating	 enzyme	 (NAE),	 which	 in	 turn	 inhibits	 Cullin	




after	 infection,	 cells	 were	 also	 incubated	 with	 MLN4924	 until	 harvesting.	 Cells	 were	
harvested	 0,	 8,	 24,	 48	 and	72	hours	 post-infection.	 Cell	 lysates	were	 fractionated	by	 SDS-
PAGE	and	the	filters	were	probed	with	the	indicated	antibodies	(Figure	3.3).	Again,	E1B55K	
was	immunoblotted	as	a	marker	of	infection.	p53	was	immunoblotted	as	a	control	since	the	




treated	 samples.	As	expected,	 the	degradation	of	p53	was	delayed	 in	 adenovirus	 infected	
cells	treated	with	MLN4924	when	compared	to	infected	mock-treated	cells,	confirming	that	
the	degradation	of	this	protein	during	adenovirus	infection	is	dependent	on	Cullin	function.	
Similarly	 to	 the	 degradation	 of	 p53,	 the	 protein	 levels	 of	 TAB182	 were	 unaffected	 in	
adenovirus-infected	 cells	 treated	 with	 MLN4924	 when	 compared	 to	 the	 degradation	
observed	 in	 infected,	mock-treated	 cells,	 showing	 that	 the	 degradation	 of	 TAB182	 during	
Ad12	 infection	 is	 dependent	 on	 Nedd8	 neddylation	 and	 therefore	 Cullin	 function	 (Figure	
3.3).		
To	 confirm	 that	 the	 degradation	 of	 TAB182	 during	 adenovirus	 infection	 is	 indeed	
dependent	on	Cullin	function,	adenovirus	infections	were	also	performed	in	H1299	cells	with	
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Figure	 3.3:	 The	 Degradation	 of	 TAB182	 during	 Ad12	 Infection	 is	 Dependent	 on	 Cullin	
Function.	HeLa	cells	were	infected	with	Ad12	at	an	MOI	of	5.	Cells	were	treated	with	4µM	of	
the	Nedd8	 inhibitor	MLN4924	 immediately	 post-infection.	Cells	were	 harvested	 at	 various	
time-points	 (0,	 8,	 24,	 48	 and	 72	 hours)	post-infection.	Cell	 lysates	were	 subjected	 to	 SDS-
PAGE	and	Western	blotting	using	the	indicated	antibodies.	E1B55K	was	immunoblotted	as	a	
marker	of	infection.	p53	was	immunoblotted	as	a	positive	control	since	this	protein	is	known	
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(Figure	 3.4).	 Induction	 of	 E1B55K	 expression	 confirmed	 successful	 infection.	 Mre11	 was	
immunoblotted	since	its	degradation	during	Ad5	infection	is	known	to	be	dependent	on	Cul5	
function,	 and	 its	 degradation	 during	 Ad12	 infection	 is	 known	 to	 be	 dependent	 on	 Cul2	
function	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	Blackford,	Patel	et	al.	
2010).	 In	 infected	 cells	 lacking	 Cul2	 protein	 expression,	 the	 degradation	 of	 TAB182	 was	
unaffected	during	Ad5	infection,	but	was	inhibited	in	Ad12	infected	cells,	suggesting	that	the	
degradation	of	TAB182	during	Ad12	infection	is	dependent	on	Cul2	function.	In	infected	cells	
lacking	 Cul5	 protein	 expression,	 the	 degradation	 of	 TAB182	was	 partially	 inhibited	 in	 Ad5	





To	 determine	 which	 viral	 proteins	 are	 responsible	 for	 the	 degradation	 of	 TAB182	
during	Ad5	and	Ad12	infection,	infections	were	performed	with	mutant	viruses	which	do	not	










































(Ad5dl1520)	 and	 Knob	 (Ad12dl620)	 were	 immunoblotted	 to	 confirm	 that	 the	 loss	 of	 the	
E1B55K	protein	inhibited	viral	replication.	As	expected,	expression	of	the	E1A	protein	during	
Ad5dl1520	(Figure	3.5A)	and	Ad12dl620	(Figure	3.5B)	infection	was	unaffected	in	the	mutant	
viruses.	 Expression	 of	 E1B55K,	 Hexon	 and	 Knob	 was	 absent	 following	 infection	 with	
Ad5dl1520	(Figure	3.5A)	or	Ad12dl620	(Figure	3.5B)	as	expected.		Mre11	and	p53	were	used	
as	 controls	 since	 the	 degradation	 of	 these	 proteins	 by	 Ad5	 and	 Ad12	 is	 known	 to	 be	
dependent	on	E1B55K	protein	(Querido,	Blanchette	et	al.	2001,	Stracker,	Carson	et	al.	2002,	
Blackford,	 Patel	 et	 al.	 2010).	 As	 anticipated,	 the	 protein	 levels	 of	 Mre11	 and	 p53	 were	




the	 degradation	 of	 TAB182	 during	 Ad5	 and	 Ad12	 infection	 is	 dependent	 on	 adenoviral	
E1B55K	protein.		
Infection	 of	 cells	 with	 Ad5dl155	 (Ad5E4-	 mutant)	 showed	 that	 the	 degradation	 of	
TAB182	was	dependent	on	one	or	more	of	the	adenovirus	E4	proteins	(Figure	3.6).	In	further	
experiments,	HeLa	cells	were	 infected	with	various	Ad5	mutant	viruses	that	 fail	 to	express	
different	 E4	 proteins;	 H5in351	 (E4orf1-	 mutant),	 H5pm4154	 (E4orf6-	 mutant),	 H5pm4155	
(E4orf3-E4orf6-	 mutant),	 H5pm4166	 (E4orf4-	 mutant),	 H5dl356	 (E4orf7-	 mutant),	 H5in352	
(E4orf2-	mutant)	and	H5dl150	(E4orf3-	mutant)	 (Figure	3.7).	As	expected,	the	expression	of	
E1B55K	protein	was	unaffected	following	infection	with	E4	mutant	viruses.	The	expression	of	



















antibodies.	 E1A,	 E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	
Mre11	and	p53	were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	





wt	 virus	 in	 cells	 infected	 with	 H5in351	 (E4orf1-	 mutant),	 H5pm4166	 (E4orf4-	 mutant),	
H5in352	 (E4orf2-	 mutant)	 and	 H5dl150	 (E4orf3-	 mutant),	 suggesting	 that	 E4orf1,	 E4orf2,	
E4orf3	 and	 E4orf4	 are	 not	 essential	 for	 the	 degradation	 of	 TAB182.	 The	 degradation	 of	
TAB182	 was	 inhibited	 following	 infection	 with	 H5pm4154	 (E4orf6-	 mutant),	 H5pm4155	
(E4orf3-E4orf6-	 mutant)	 and	 unexpectedly,	 following	 infection	 with	 H5dl356	 (E4orf7-	






To	 further	 examine	 whether	 the	 degradation	 of	 TAB182	 indeed	 requires	 the	
presence	of	 the	adenovirus	E1B55K	and	E4	proteins	and	to	confirm	that	 they	are	required	
for	Ad12	mediated	degradation,	DNA	 transfections	of	Ad5,	Ad12E1B55K	and	E4	were	also	
performed	 in	 HeLa	 cells.	 The	 DNA	 constructs	 pcDNA3Ad12E1B54K,	 pcDNA3Ad12E4orf6,	
pXC15-Ad5E1B55K,	 pCMV-Ad5E4orf6	 were	 used	 to	 transfect	 the	 cells	 together	 with	 a	
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Figure	3.7:	The	Degradation	of	TAB182	following	 Infection	with	Ad5	is	Dependent	on	the	
Adenovirus	 E4orf6	 Protein.	 HeLa	 cells	 were	 infected	 with	 either	 the	 E4	 mutant	 H5in351	
(E4orf1-	 mutant)	 (A),	 H5pm4154	 (E4orf6-	 mutant)	 (A),	 H5pm4155	 (E4orf3-E4orf6-	mutant)	
(B),	H5pm4166	(E4orf4-	mutant)	(B),	H5dl356	(E4orf7-	mutant)	(C)	H5in352	(E4orf2-	mutant)	
(C)	 and	 H5dl150	 (E4orf3-	 mutant)	 (D)	 	 at	 an	MOI	 of	 5.	 The	 cells	 were	 then	 harvested	 at	
various	 time-points	 (0,	 8,	 24,	 48,	 72,	 96	 and	 120	 hours)	 post-infection.	 Cell	 lysates	were	
subjected	 to	 SDS-PAGE	 and	Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	was	
immunoblotted	 as	 a	 marker	 of	 infection.	 E4orf6	 was	 immunoblotted	 to	 validate	 the	






























marker	 of	 infection.	 E4orf6	was	 immunoblotted	 to	 validate	 the	 expression	 of	 the	mutant	





















































































Figure	3.8:	The	Degradation	of	 TAB182	during	Ad5	 and	Ad12	 Infection	 is	Dependent	on	
the	Adenovirus	E1B55K	and	E4orf6	Proteins.	2μg	of	plasmid	DNA	was	transfected	into	HeLa	
cells	and	48	hours	later,	the	cells	were	harvested	and	the	lysates	subjected	to	SDS-PAGE	and	
Western	 blotting	 using	 the	 indicated	 antibodies.	 E1B55K	 and	 HA	 (E4orf6)	 were	





confirmed	 successful	 transfection	 of	 the	 E1B55K	 plasmid.	 TAB182	 was	 immunoblotted	 to	
assess	which	combination	DNA	plasmid	transfections	affected	the	protein	levels	of	TAB182;	
Mre11	was	immunoblotted	as	a	positive	control.	The	results	demonstrate	that	expression	of	








infected	 or	 infected	 with	 Ad5,	 Ad12,	 Ad5dl1520	 (Ad5E1B55K-	 mutant),	 Ad12dl620	
(Ad12E1B55K-	mutant)	or	H5pm4155	 (Ad5E4-	mutant)	at	an	MOI	of	5.	The	cells	were	 then	
harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection,	 cell	 lysates	 fractionated	by	SDS-
PAGE	and	immunoblotted	with	the	indicated	antibodies	(Figure	3.9).	As	before,	E1A,	E1B55K	
and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 adenovirus	 infection.	 β-actin	 was	
immunoblotted	 as	 a	 loading	 control.	 Mre11	 and	 p53	 were	 immunoblotted	 as	 positive	
controls	 since	 they	 are	 known	 to	 be	 degraded	 during	 adenovirus	 infection	 (Querido,	
Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 TAB182	was	 immunoblotted	 to	 test	
whether	 the	 siRNA-mediated	 knockdown	 of	 TAB182	 was	 effective.	 During	 Ad5	 and	 Ad12	
infection,	the	comparative	levels	of	the	degradation	of	Mre11	and	p53	were	unaffected	by	




Figure	 3.9:	 E1A	Protein	 Expression	 is	 Elevated	 in	Adenovirus	 Infected	 TAB182	 Depleted	
Cells.	 HeLa	cells	were	 transfected	with	 control	or	TAB182	 siRNA.	48	hours	 later,	 the	 cells	
were	 infected	 with	 Ad5	 (A),	 Ad12	 (B),	 Ad5dl1520	 (Ad5E1B55K-	 mutant)	 (C),	 Ad12dl620	
(Ad12E1B55K-	mutant)	(D)	or	Ad5dl4155	(Ad5E4-	mutant)	(E)	at	an	MOI	of	5.	Cells	were	then	
harvested	at	various	time-points	(0,	8,	24,	48,	72	and	96	hours)	post-infection.	Cell	 lysates	
were	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	 indicated	 antibodies.	 E1A,	
E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	 Mre11	 and	 p53	
were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	be	degraded	by	

























































Figure	 3.9	 Cont’d:	 E1A	 Protein	 Expression	 is	 Elevated	 in	 Adenovirus	 Infected	 TAB182	
Depleted	 Cells.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA.	48	hours	 later,	
the	 cells	 were	 infected	 with	 Ad5	 (A),	 Ad12	 (B),	 Ad5dl1520	 (Ad5E1B55K-	 mutant)	 (C),	
Ad12dl620	 (Ad12E1B55K-	mutant)	 (D)	 or	 Ad5dl4155	 (Ad5E4-	mutant)	 (E)	 at	 an	MOI	 of	 5.	
Cells	 were	 then	 harvested	 at	 various	 time-points	 (0,	 8,	 24,	 48,	 72	 and	 96	 hours)	 post-
infection.	Cell	lysates	were	subjected	to	SDS-PAGE	and	Western	blotting	using	the	indicated	
antibodies.	 E1A,	 E1B55K	 and	 Hexon/Knob	 were	 immunoblotted	 as	 markers	 of	 infection.	
Mre11	and	p53	were	immunoblotted	as	positive	controls	since	these	proteins	are	known	to	





Figure	 3.9	 Cont’d:	 E1A	Protein	 Expression	 is	 Elevated	 in	 Adenovirus	 Infected	 TAB182	
Depleted	Cells.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA.	48	hours	later,	
the	 cells	 were	 infected	 with	 Ad5	 (A),	 Ad12	 (B),	 Ad5dl1520	 (Ad5E1B55K-	 mutant)	 (C),	
Ad12dl620	(Ad12E1B55K-	mutant)	(D)	or	Ad5dl4155	(Ad5E4-	mutant)	(E)	at	an	MOI	of	5.	
Cells	were	 then	 harvested	 at	 various	 time-points	 (0,	 8,	 24,	 48,	 72	 and	 96	 hours)	 post-
infection.	 Cell	 lysates	 were	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	
indicated	antibodies.	E1A,	E1B55K	and	Hexon/Knob	were	 immunoblotted	as	markers	of	
infection.	Mre11	and	p53	were	immunoblotted	as	positive	controls	since	these	proteins	
























Since	 the	 protein	 levels	 of	 E1A	 appeared	 earlier	 into	 the	 course	 of	 adenovirus	
infection,	 we	 next	 decided	 to	 determine	 whether	 infection	 of	 cells	 with	 the	 mutant	





mock-infected	 or	 infected	 with	 the	 mutant	 adenoviruses	 Ad5dl1520,	 Ad12dl620	 or	
H5pm4155.	Cells	were	harvested	at	0,	8,	24,	48,	72	and	96	hours	post-infection	and	resolved	
by	 SDS-PAGE	 and	Western	 blotting	 using	 the	 required	 antibodies	 (Figure	 3.9).	 As	 before,	
E1A,	E1B55K	and	Hexon	(Ad5)	or	Knob	(Ad12)	were	immunoblotted	as	markers	of	infection,	
β-Actin	as	a	 loading	control,	TAB182	to	assess	the	efficiency	of	the	knockdown	and	Mre11	
and	 p53	 as	 positive	 controls	 since	 they	 are	 known	 to	 be	 degraded	 during	 the	 course	 of	
adenovirus	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 As	
previously	observed,	 the	degradation	of	Mre11	and	p53	during	mutant	virus	 infection	was	
unaffected	 by	 the	 down-regulation	 of	 TAB182	 levels	 when	 compared	 to	 control	 siRNA	
treated	cells.	Again,	the	total	protein	levels	of	p53	after	TAB182	knockdown	were	decreased	
when	 compared	 to	 cells	 treated	with	 control	 siRNA.	 The	 protein	 levels	 of	 E1B	 and	Hexon	
		 130	
(Ad5)	 or	 Knob	 (Ad12)	were	 also	 unaffected	 by	 TAB182	 depletion	when	 compared	 to	 cells	





Since	 E1A	 expression	 appeared	 to	 be	 elevated	 during	 adenovirus	 infection	 in	 the	
absence	of	TAB182	protein	expression,	we	therefore	hypothesised	that	the	cell	cycle	may	be	
altered	following	TAB182	knockdown	leading	to	more	efficient	adenovirus	infection.	To	test	
this,	 the	expression	of	Cyclin	E	was	examined	during	 the	course	of	adenovirus	 infection	 in	
the	 presence	 and	 absence	 of	 TAB182	 protein	 expression.	 HeLa	 cells	 were	 treated	 with	
TAB182	siRNA	or	with	a	non-targeting	control	siRNA.	48	hours	after	siRNA	treatment,	cells	
were	mock-infected	or	 infected	with	Ad5	or	Ad12	and	harvested	at	0,	8,	24,	48,	72	and	96	
hours	 post-infection.	 Cell	 lysates	were	 subjected	 to	 SDS-PAGE	 and	Western	 blotting	 using	
the	indicated	antibodies	(Figure	3.10).	There	was	no	difference	in	Cyclin	E	expression	in	Ad5	
infected,	 control	 siRNA	 treated	 cells	 when	 compared	 to	 Ad5	 infected	 and	 TAB182	 siRNA	
treated	 cells.	 Interestingly,	 elevated	 Cyclin	 E	 expression	 was	 observed	 in	 Ad12	 infected,	
TAB182	 siRNA	 treated	 cells	when	 compared	 to	Ad12	 infected,	 control	 siRNA	 treated	 cells,	

























Figure	3.10:	Expression	of	Cyclin	E	 is	Elevated	 in	 Infected,	TAB182	Depleted	Cells.	HeLa	




was	 immunoblotted	as	a	marker	of	 infection.	TAB182	was	 immunoblotted	 to	assess	 the	






vitro,	 GST	 pull-down	 assays	 were	 performed.	 Ad5E1HEK293	 and	 Ad12E1HER2	 cell	 lysates	






cell	 lysates	 were	 immunoblotted	 with	 Ad5E1B55K	 antibody.	 Analysis	 showed	 that	 the	 C-
terminal	 fragment	 of	 TAB182	 interacts	 with	 Ad5E1B55K	 in	 vitro	 (Figure	 3.12A).	 Protein	
complexes	 isolated	 using	Ad12E1HER2	 cell	 lysates	were	 immunoblotted	with	Ad12E1B55K	
antibody.	Analysis	showed	that	the	C-terminal	fragment	of	TAB182	also	interacts	with	Ad12	
E1B55K	in	vitro	(Figure	3.12B).		
To	 confirm	 the	 interaction	 between	 TAB182	 and	 Ad5E1B55K/Ad12E1B55K,	 co-
immunoprecipitation	 assays	 were	 performed.	 Ad5E1HEK293	 and	 Ad12E1HER2	 cell	 lysates	
were	 incubated	 with	 antibodies	 against	 TAB182	 along	 with	 IgG	 alone	 as	 a	 non-specific	
binding	 control.	 Immuno-complexes	 were	 isolated	 using	 Protein-G	 agarose	 beads	 and	
subsequently	 resolved	 by	 SDS-PAGE	 and	 Western	 blotting	 using	 antibodies	 against	
Ad5/Ad12	E1B55K	along	with	cell	 lysate	alone	as	a	positive	control.	 	Analysis	 showed	 that	
TAB182	 does	 indeed	 interact	with	 Ad5E1B55K	 and	 Ad12E1B55K	 in	 vivo	 (Figure	 3.12C	 and	





Figure	 3.11:	 Schematic	 of	 the	 GST-TAB182C	 Fragment	 used	 in	 the	 GST	 Pull-Down	
Assays.	 (A)	 Schematic	 of	 full-length	 TAB182.	 Showing	 amino	 acid	 numbers,	 tankyrase	
binding	 domain	 (TBD)	 and	 the	 two	 nuclear	 localisation	 signals	 (NLS)	 it	 contains.	 (B)	
Schematic	of	the	GST-TAB182C	fragment	of	TAB182	provided	as	a	kind	gift	from	Susan	















































































































































































Figure	3.12:	Adenovirus	Early	Region	E1B55K	 Interacts	with	TAB182	 in	Vitro	and	 in	Vivo.	
Ad12E1HER2	(A)	and	Ad5E1HEK293	(B)	cell	lysates	were	incubated	with	either	GST-TAB182C,	
or	with	GST	alone	(non-specific	binding	control)	or	cell	lysate	alone	(positive	control).	Protein	
complexes	 were	 captured	 by	 glutathione-agarose	 beads,	 subjected	 to	 SDS-PAGE	 and	
Western	 blotting.	Ad5E1HEK293	 (C)	 and	Ad12E1HER2	 (D)	 cell	 lysates	were	 incubated	with	
antibodies	 against	 TAB182	 together	 with	 IgG	 (non-specific	 binding	 control).	 Immuno-
complexes	were	isolated	using	Protein-G	agarose	beads	and	subsequently	resolved	by	SDS-
PAGE	 and	Western	 blotting	 using	 antibodies	 against	 Ad5/Ad12	 E1B	 along	with	 cell	 lysate	
alone	 as	 a	 positive	 control.	 (E)	 pEGFPC3-TAB182	 was	 transfected	 into	 Ad5E1HEK293	 and	
Ad12E1HER2	 cell	 lines	 and	 harvested.	 Cell	 lysates	 were	 incubated	 with	 Ad5	 and	 Ad12	
E1B55K	 antibodies	 together	 with	 IgG	 (non-specific	 binding	 control).	 Immuno-complexes	






formed	 isolated	 using	 Protein-G	 agarose	 beads.	 Protein	 complexes	were	 resolved	 by	 SDS-
PAGE	 and	 Western	 blotting	 using	 antibodies	 against	 TAB182.	 Analysis	 confirmed	 that	
TAB182	does	indeed	interact	with	Ad5E1B55K	and	Ad12E1B55K	in	vivo	(Figure	3.12E).		
3.2.8	TAB182	does	not	Localise	to	VRCs	during	Adenovirus	Infection	
Although	 a	 number	 of	 DNA	 damage	 proteins	 are	 degraded	 during	 adenovirus	
infection,	it	is	also	well	established	that	a	number	are	relocalised	to	VRCs	during	adenovirus	
infection	 including	 RPA32,	 ATR,	 ATRIP,	 Rad9,	 TOPBP1	 and	 Rad17	 (Carson,	 Schwartz	 et	 al.	
2003,	Blackford,	Bruton	et	al.	2008,	Carson,	Orazio	et	al.	2009,	Blackford,	Patel	et	al.	2010).	
To	 determine	 whether	 TAB182	 is	 relocalised	 to	 VRCs	 during	 the	 course	 of	 adenovirus	
infection,	immunofluorescence	microscopy	analysis	was	performed	(Figure	3.13).		
HeLa	 cells	 were	 transfected	 with	 pEGFPC3-TAB182	 or	 an	 empty	 pEGFPC3	 construct	 as	 a	
negative	 control	 (see	 Section	 2.5.6	 for	 information	 on	 the	 generation	 of	 the	 pEGFPC3-
TAB182	 construct).	24	hours	 later,	cells	were	re-plated	onto	glass	cover	slips	and,	after	24	
hours,	 infected	with	wild-type	Ad5	or	Ad12	virus	at	an	MOI	of	5.	After	a	 further	24	hours	
cells	were	 fixed,	 permeabilised	 and	 probed	with	 the	 appropriate	 antibodies.	 Ad5	 infected	
cells	were	stained	for	Ad5E1B55K	and	DBP	and	Ad12	infected	cells	stained	with	antibodies	
against	Ad12E1B55K	and	RPA32	which	has	been	shown	previously	to	localise	to	Ad12	VRCs	



























Figure	 3.13:	 TAB182	 does	 not	 Localise	 to	 VRCs	 during	 Adenovirus	 Infection.	 HeLa	 cells	
were	transfected	with	pEGFPC3-TAB182	and	24	hours	later	were	infected	with	Ad5	or	Ad12.	
24	 hours	 following	 infection	 the	 cells	 were	 fixed,	 permeabilised	 and	 probed	 with	 the	






Since	 TAB182	 knockdown	 altered	 the	 expression	 of	 E1A	 and	 Cyclin	 E	 during	
adenovirus	infection,	we	next	wanted	to	examine	the	whether	TAB182	knockdown	had	any	
effect	 on	 the	 formation	 of	 VRCs.	 To	 investigate	 this	 further,	 immunofluorescence	
microscopy	 analysis	 of	 cells	 deficient	 in	 TAB182	 protein	 expression	 was	 performed.	 HeLa	
cells	 were	 treated	 with	 TAB182	 siRNA	 along	 with	 a	 non-targeting	 control	 siRNA.	
Confirmation	 of	 TAB182	 knockdown	was	 achieved	 by	Western	 blotting	 (data	 not	 shown).	
Cells	were	infected	with	wild-type	Ad5	or	Ad12	virus	(MOI	of	5)	for	24	hours	and	were	then	


































































































































































It	 is	 well	 established	 that	 a	 number	 of	 cellular	 proteins	 are	 degraded	 following	
adenovirus	infection.	Most	notably,	a	significant	proportion	of	these	proteins	are	involved	in	
the	 DNA	 damage	 response	 (DDR),	 suggesting	 that	 adenovirus	 degrades	 these	 proteins	 in	
order	to	circumvent	this	pathway	specifically	(Querido,	Blanchette	et	al.	2001,	Stracker,	Lee	
et	 al.	 2005,	Baker,	Rohleder	et	 al.	 2007,	Blackford,	Patel	 et	 al.	 2010,	Orazio,	Naeger	et	 al.	




as	 a	 novel	 degradation	 target	 during	 adenovirus	 infection.	 TAB182	 was	 shown	 to	 be	
degraded	 following	 Ad5	 and	 Ad12	 infection,	 in	 an	 E1B55K	 and	 E4orf6	 dependent	 fashion	
(Figures	3.1,	3.5,	3.6,	3.7	and	3.8).	Furthermore,	using	the	proteasome	inhibitor	bortezomib,	
it	 was	 shown	 that	 the	 degradation	 of	 TAB182	 was	 dependent	 on	 proteasome	 function	
(Figure	3.2),	and	through	the	use	of	the	NEDD8	inhibitor	MLN4924,	this	degradation	was	also	
found	to	be	dependent	on	Cullin	function	(Figure	3.3).	Further	studies	using	Cul2	and	Cul5	
negative	 H1299	 cell	 lines	 showed	 that	 the	 degradation	 of	 TAB182	 during	 Ad5	 infection	 is	
dependent	on	Cul5,	and	TAB182	degradation	following	Ad12	infection	is	dependent	on	Cul2	
(Figure	3.4).	 This	 is	 consistent	with	other	 targets,	 such	as	p53,	which	are	degraded	during	
viral	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Blackford,	 Patel	 et	 al.	 2010).	Using	 siRNA-
mediated	depletion	of	TAB182,	it	was	shown	that	TAB182	suppresses	E1A	protein	expression	
at	early	time	points	post-infection	(Figure	3.9).		From	these	studies	it	was	shown	that	in	the	




in	 vitro	 and	 in	 vivo	 (Figure	 3.12).	 Finally,	 immunofluorescence	 microscopy	 showed	 that	
TAB182	does	not	appear	to	 localise	to	VRCs,	nor	does	the	depletion	of	TAB182	expression	
effect	the	formation	of	VRCs	(Figures	3.13	and	3.14).			
In	 this	 study,	 TAB182	was	 shown	 to	be	degraded	 following	 infection	with	Ad5	and	
Ad12	serotypes	(Figure	3.1).	TAB182	is	also	known	to	be	degraded	following	Ad4	infection,	
but	 not	 following	 infection	 with	 Ad3,	 Ad7,	 Ad9	 and	 Ad11	 (R	 Grand,	 personal	
communication).	 A	 comprehensive	 study	 from	 Forrester	 and	 colleagues	 analysing	 the	
degradation	 patterns	 of	 various	 DDR	 proteins	 following	 infection	 with	 a	 panel	 of	 Ad	
serotypes	showed	that	Mre11	and	p53	are	degraded	following	infection	with	Ad4,	Ad5	and	
Ad12	serotypes,	but	not	following	Ad3,	Ad7,	Ad9	and	Ad11	infection.	In	agreement	with	this,	













degraded	 relatively	 late.	 As	 previously	 discussed,	 there	 are	 large	 variations	 in	 the	 ways	
adenoviruses	 target	DDR	proteins,	 for	 example,	Ad5	and	Ad12	degrade	p53	but	Ad3	does	
not	 (Querido,	Marcellus	 et	 al.	 1997,	 Forrester,	 Sedgwick	 et	 al.	 2011).	 Furthermore,	 some	
proteins	 are	degraded	 later	 than	others,	 for	 example	p53	 is	 normally	degraded	 very	 early	
during	adenovirus	infection	(less	than	24	hours)	whilst	BLM	is	degraded	in	the	later	stages	of	
infection	 (Querido,	 Marcellus	 et	 al.	 1997,	 Orazio,	 Naeger	 et	 al.	 2011).	 Why	 degradation	
targets	 are	 down-regulated	 at	 different	 times	 during	 adenovirus	 infection	 is	 currently	
unknown	 but	 presumably	 is	 linked	 to	 their	 function.	 One	 explanation	 for	 why	 TAB182	 is	
degraded	 so	 late	 in	 the	 virus	 cycle	 could	 be	 that	 TAB182	 expression	 is	 detrimental	 to	
adenovirus	persistent	infection.	There	is	mounting	evidence	to	suggest	that	adenovirus	can	




The	 viral	 proteins	 responsible	 for	 the	 degradation	 of	 adenoviral	 targets	 have	 been	
closely	 studied.	 As	 previously	 discussed,	 the	 degradation	 of	 cellular	 adenovirus	 targets	 is	
thought	to	be	achieved	through	the	viral	proteins	E1B55K	and	E4orf6	proteins,	which	recruit	
a	 Cullin-based	 E3	 ubiquitin	 ligase	 composed	 of	 Rbx1	 and	 Elongins	 B	 and	 C.	 In	 this	
investigation,	through	the	use	of	mutant	viruses	and	the	transfection	of	plasmids	expressing	






2010,	 Forrester,	 Sedgwick	 et	 al.	 2011,	Orazio,	Naeger	 et	 al.	 2011,	Gupta,	 Jha	 et	 al.	 2013).	
Whilst	 the	 degradation	 of	 DDR	 proteins	 during	 adenovirus	 infection	 appeared	 to	 be	
conserved	 amongst	 these	 proteins,	 interestingly,	 the	 degradation	 of	 TOPBP1	 by	 Ad12	 has	
been	 proposed	 to	 be	 dependent	 on	 the	 E4orf6	 protein	 alone,	 together	 with	 a	 cellular	
Cullin2-based	E3	ubiquitin	 ligase,	 suggesting	 there	are	different	mechanisms	employed	 for	
the	 degradation	 of	 proteins	 during	 adenovirus	 infection	 (Blackford,	 Patel	 et	 al.	 2010).	
Similarly,	 Daxx	 proteasome-mediated	 degradation	 by	 Ad5	 appears	 to	 only	 require	 the	
E1B55K	protein	and	not	E4orf6	(Schreiner,	Wimmer	et	al.	2011).		
Whilst	 different	 viral	 proteins	 may	 be	 employed	 for	 the	 degradation	 of	 proteins	
during	adenovirus	infection,	the	general	consensus	during	the	degradation	process	is	that	all	
adenoviral	 targets	 are	 processed	 by	 the	 proteasome.	 All	 DDR	 proteins	 that	 are	 degraded	
during	adenovirus	infection	have	been	shown	to	be	dependent	on	the	proteasome	through	
the	 use	 of	 the	 proteasome	 inhibitor	 MG132	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	
Carson	et	al.	2002,	Baker,	Rohleder	et	al.	2007,	Blackford,	Patel	et	al.	2010,	Orazio,	Naeger	et	
al.	2011,	Gupta,	Jha	et	al.	2013).	In	our	hands,	MG132	(following	only	a	24	hour	incubation)	
was	 highly	 toxic	 to	 HeLa	 cells,	 with	 the	majority	 of	 the	 cells	 dead	 (rounded	 cells	 that	 no	
longer	adhered	to	 the	 tissue	culture	dish),	when	compared	to	mock-treated,	 infected	cells	
(data	not	shown).	For	this	reason	the	proteasome	inhibitor	bortezomib	was	used;	this	was	
found	to	be	much	less	toxic	to	the	cells	which	allowed	incubation	for	longer	time-points.	As	a	
precaution	 bortezomib	 was	 added	 24	 hours	 before	 the	 harvesting	 of	 each	 time	 point	 in	








Furthermore,	 through	 the	 use	 of	 H1299	 cells	 negative	 for	 Cul2	 and	 Cul5	 expression,	 the	
degradation	of	TAB182	during	Ad5	 infection	was	shown	to	be	dependent	on	Cul5,	and	the	
degradation	of	TAB182	during	Ad12	 infection	was	shown	to	be	dependent	on	Cul2	 (Figure	
3.4).	 Interestingly,	 the	degradation	of	p53	during	Ad5	and	Ad12	 infection	 is	dependent	on	






also	 not	 responsible	 for	 the	 degradation	 of	 these	 proteins)	 (Stracker,	 Carson	 et	 al.	 2002,	







From	 studies	 described	 in	 Chapter	 4,	 there	 are	 a	 number	 of	 indications	 that	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	 control	 of	 the	 cell	 cycle.	 It	 was	 therefore	
hypothesised	 that	 TAB182	 may	 hinder	 the	 cell	 cycle	 progression	 which	 is	 induced	 by	
adenovirus.	To	test	this	hypothesis,	the	expression	of	a	panel	of	viral	proteins	was	examined	
in	 infected	 cells	 that	were	deficient	 in	 TAB182	expression.	 Interestingly,	 the	expression	of	
E1A	was	 increased	 in	 infected	cells	 (Ad5	and	Ad12,	along	with	mutant	viruses)	deficient	 in	
TAB182	 expression	 when	 compared	 to	 non-silencing	 controls	 (Figure	 3.9).	 These	 data	




expression	 levels.	Alternatively	 the	 removal	of	 TAB182	expression	may	be	more	beneficial	
during	 Ad5	 than	 Ad12	 infection.	 Interestingly,	 during	 adenovirus	 infection,	 the	 siRNA-
mediated	 knockdown	 of	 Tip60	 expression	 also	 has	 an	 effect	 on	 the	 expression	 of	 viral	
proteins,	with	an	increase	in	the	expression	of	all	early	viral	genes	including	E1A	(measured	
by	 quantitative	 PCR	 and	 immunoblotting)	 (Gupta,	 Jha	 et	 al.	 2013).	 Further	 Tip60	 studies	
showed	that	Tip60	suppresses	viral	early	gene	expression	through	the	acetylation	of	Histone	
H4	at	 the	E1A	promoter	 (Gupta,	 Jha	et	al.	2013).	Since	TAB182	knockdown	also	displays	a	
similar	phenotype	 to	Tip60	with	an	 increase	 in	E1A	expression,	 it	 could	be	 that	TAB182	 is	
also	degraded	to	prevent	suppression	of	the	expression	of	early	viral	proteins.		













this	 is	 the	 case.	 As	 with	 E1A	 expression,	 Cyclin	 E	 expression	 in	 TAB182	 knockdown	 cells	
varies	between	Ad5	and	Ad12	virus	strains	(higher	expression	in	Ad12	than	Ad5).	Again,	virus	
strains	have	different	properties	and	 this	may	explain	 the	differences	 in	expression	 levels.	
Alternatively	the	removal	of	TAB182	expression	may	effect	Cyclin	E	expression	to	a	greater	
extent	during	Ad12	than	Ad5	 infection	as	 there	are	 large	variations	 in	 the	ways	difference	
adenoviruses	target	DDR/cell	cycle	proteins.			
With	 the	exception	of	TOPBP1,	E1B55K	 is	known	to	 interact	directly	with	all	 tested	
DDR	 proteins	 that	 it	 targets	 for	 degradation	 including	 p53,	 DNA	 ligase	 IV,	 BLM	 and	 Tip60	
(Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Lee	 et	 al.	 2005,	 Baker,	 Rohleder	 et	 al.	 2007,	
Blackford,	Patel	et	al.	2010,	Orazio,	Naeger	et	al.	2011,	Gupta,	Jha	et	al.	2013).	Following	GST	





Following	 analysis	 by	 immunofluorescence	 microscopy,	 it	 was	 determined	 that	
TAB182	 does	 not	 localise	 to	 VRCs	 during	 adenovirus	 infection	 (Figure	 3.13).	 Furthermore,	
the	 composition	 of	 VRCs	 were	 analysed	 following	 siRNA-mediated	 TAB182	 knockdown;	 it	
was	found	that	TAB182	deficient	cells	displayed	no	problems	in	VRC	formation	determined	
by	counting	E1B55K,	DBP	and	RPA32	positive	cells	as	a	percentage	of	total	number	of	cells	
following	 infection.	 No	 significant	 differences	 were	 observed	 between	 control	 siRNA	 and	
TAB182	deficient	cells	 (Figure	3.14).	Most	other	DDR	proteins	degraded	during	adenovirus	
infection	have	been	located	at	VRCs.	Prior	to	degradation,	p53	was	shown	to	be	localised	to	





2005,	 Forrester,	 Sedgwick	 et	 al.	 2011).	During	Ad5	and	Ad12	 infection,	Mre11	 is	 found	 to	
localise	 to	 nuclear	 tracks	 and	 VRCs	 respectively	 (Stracker,	 Lee	 et	 al.	 2005,	 Forrester,	
Sedgwick	 et	 al.	 2011).	 During	 Ad3,	 Ad7	 and	 Ad11	 infection	 Mre11	 is	 localised	 to	 VRCs	
whereas	 during	 Ad9	 infection	Mre11	 is	 localised	 to	 nuclear	 tracks.	 During	 Ad3,	 Ad4,	 Ad5,	
Ad7,	Ad9,	Ad11	and	Ad12	infection,	TOPBP1	was	shown	to	be	localised	to	VRCs	(Forrester,	
Sedgwick	 et	 al.	 2011).	 BLM	has	 been	 shown	 to	 be	 localised	 to	 VRCs	 during	 Ad5	 infection	








known	 whether	 the	 protein	 is	 functional	 and	 to	 what	 level	 it	 is	 expressed	 compared	 to	
endogenous	 TAB182	 protein	 levels.	 Further	 investigative	 analysis	 will	 determine	 whether	
TAB182	is	located	at	these	structures.		
In	 conclusion,	 this	 chapter	 presents	 evidence	 to	 suggest	 that	 TAB182	 is	 a	 novel	
protein	degraded	during	adenovirus	infection.	The	degradation	of	which	is	dependent	on	the	
E1B55K	 and	 E4orf6	 proteins,	 together	 with	 a	 cellular	 Cullin	 E3	 ubiquitin	 ligase	 complex.	
These	 data	 suggest	 that	 TAB182	 is	 degraded	 during	 adenovirus	 infection	 to	 prevent	







































The	DDR	and	 repair	pathways	are	a	 complex	and	coordinated	set	of	networks	 that	
detect	and	repair	DNA	damage	with	the	ultimate	aim	to	protect	the	integrity	of	the	genome.	
The	DDR	can	respond	to	a	variety	of	genomic	insults,	including	SSBs,	DSBs,	bulky	lesions	and	
DNA	mismatches.	 In	 addition,	 the	 DDR	 can	 also	 detect	 and	 respond	 to	 replication	 stress	
induced	by	unresolved	DNA	lesions,	DNA-bound	proteins	and	secondary	structures.	The	two	
major	proteins	responsible	for	the	detection	of	DNA	damage	and	replication	stress	are	the	





1.2.1.1).	 If	DNA	damage	 is	not	 repaired	before	DNA	replication,	 this	can	 lead	 to	stalling	of	









2002).	More	 recently,	 TAB182	was	 identified	 in	 a	mass	 spectrometry	 screen	where	 it	was	
identified	as	an	ATM/ATR	substrate	following	DNA	damage	(IR	specifically)	(Matsuoka,	Ballif	
et	 al.	 2007).	 Results	 from	 Chapter	 Three	 showed	 that	 TAB182	 was	 degraded	 following	
infection	with	Ad5	and	Ad12	serotypes.	Since	more	than	80%	of	adenoviral	targets	are	DDR	
proteins,	we	 thus	hypothesised	 that	 TAB182	 could	 also	be	 implicated	 in	 the	DDR.	 Further	
evidence	 obtained	 from	 Chapter	 Three	 suggested	 that	 TAB182	 was	 able	 to	 influence	 the	






Since	 the	 majority	 of	 the	 experiments	 planned	 for	 this	 chapter	 involved	 RNA	
interference	of	TAB182,	 the	optimal	 conditions	 for	 siRNA-mediated	knockdown	of	TAB182	
were	 established.	 HeLa	 cells	 were	 transfected	 with	 increasing	 concentrations	 of	 control	
(non-targeting)	 or	 TAB182	 siRNA	 (20nm,	 45nm,	 90nm	 and	 180nm).	 48	 hours	 following	
transfection,	the	cells	were	harvested,	subjected	to	SDS-PAGE	and	Western	blotting.	TAB182	
was	 immunoblotted	 to	 confirm	 siRNA-mediated	 knockdown	of	 the	 protein	 along	with	 the	
DNA	damage	proteins	NBS1,	 Chk1,	 RPA	and	H2AX	 to	determine	whether	 the	depletion	of	
TAB182	affects	the	expression	of	core	DNA	damage	proteins.	β-Actin	was	immunoblotted	as	
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Figure	 4.1:	 Optimisation	 of	 TAB182	 siRNA	Knockdown.	 HeLa	cells	were	 transfected	with	
increasing	 concentrations	 of	 non-targeting	 control	 or	 TAB182	 siRNA.	 The	 cells	 were	 then	
harvested	 48	 hours	 post-transfection.	 The	 cell	 lysates	 were	 subjected	 to	 SDS-PAGE	 and	
Western	 blotting.	 TAB182	was	 immunoblotted	 to	 assess	 the	 efficiency	 of	 the	 knockdown	
with	 increasing	concentrations	of	siRNA.	β-Actin	was	 immunoblotted	as	a	 loading	control.	
Various	 DDR	 proteins	were	 immunoblotted	 to	 assess	 expression	 levels	 following	 TAB182	




of	 TAB182	 in	 control	 siRNA	 treated	 cells.	Upon	overexposure	of	 the	autoradiography	 film,	
some	 residual	 TAB182	 protein	 expression	 was	 observed	 in	 cells	 treated	 with	 20nm	 of	
TAB182	siRNA.	It	was	therefore	decided	that	the	optimal	concentration	of	TAB182	siRNA	for	
all	 future	experiments	would	be	45nm.	This	was	to	 limit	any	toxicity	and	off-target	effects	
from	 the	use	of	higher	 concentrations	of	 siRNA	 than	necessary.	 The	protein	expression	of	
the	DNA	damage	proteins	NBS1,	 Chk1,	 RPA	and	H2AX	were	unaffected	by	 TAB182	 siRNA-





Since	 results	 from	 the	 Chapter	 Three	 and	 those	 from	 Matsuoka	 and	 colleagues	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	DDR,	 the	 cell	 survival	 of	 TAB182	 deficient	
cells	 was	 assessed	 following	 exposure	 to	 various	 DNA	 damaging	 agents.	 Cells	 previously	














Irradiation	 and	 HU	 Treatment.	 	 Clonogenic	 survival	 assays	 were	 performed	 in	 cells	
depleted	 of	 TAB182,	 along	 with	 non-targeting	 control	 siRNA.	 Following	 the	 indicated	








































































UV-C	 Irradiation	 and	 HU	 Treatment.	 	 Clonogenic	 survival	 assays	were	 performed	 in	 cells	
depleted	of	TAB182,	along	with	non-targeting	control	siRNA.	Following	the	indicated	siRNA	
transfections,	 the	cells	were	exposed	 to	 (A)	 increasing	doses	of	 IR	 (B)	 increasing	doses	of	
UV-C	irradiation	or	(C)	increasing	doses	of	HU	treatment.	Following	exposure,	the	cells	were	
further	 incubated	 in	 fresh	media	 for	 14	 days	 and	 the	 colonies	 formed	were	 stained	with	
0.5%	 crystal	 violet	 in	 20%	 ethanol.	 Colonies	 were	 counted	 and	 the	 data	 was	 plotted	 on	



















levels	 of	 NBS1,	 Chk1,	 RPA	 and	 H2AX	 were	 unaffected	 in	 TAB182	 depleted	 cells	 when	
compared	to	control	cells.	The	protein	levels	of	pNBS1	(S343),	pChk1	(S317	and	S345),	pRPA	
(S4/8)	 and	 γH2AX	 (S139)	 increased	 following	 exposure	 to	 IR	 in	 both	 control	 and	 TAB182	
siRNA	 treated	 cells.	 	 Interestingly,	 the	phosphorylation	of	 pNBS1	 (S343),	 pChk1	 (S317	 and	
S345),	pRPA	(S4/8)	and	γH2AX	(S139)	was	elevated	 in	TAB182	depleted	cells	above	that	of	




In	 cells	 transfected	with	 control	or	TAB182	 siRNA	and	exposed	 to	UV-C	 irradiation,	
the	total	protein	levels	of	NBS1,	Chk1,	RPA	and	H2AX	were	unaffected	by	TAB182	depletion	
when	compared	to	cells	treated	with	control	siRNA.	The	levels	of	pNBS1	(S343),	pChk1	(S317	
and	 S345),	 pRPA	 (S4/8)	 and	 γH2AX	 (S139)	 increased	 following	UV-C	 irradiation	 confirming	
activation	 of	 the	 DDR.	 However,	 there	 was	 little	 observable	 difference	 in	 the	 levels	 of	
phosphorylated	 DNA	 damage	 proteins	 between	 control	 and	 TAB182	 siRNA	 treated	 cells	
apart	 from	 the	 levels	 of	 pChk1	 (S317),	 which	 appeared	 to	 be	 slightly	 elevated	 in	 TAB182	
depleted	 cells	 compared	 to	 control	 cells	 (Figure	 4.3B).	 Therefore,	 the	 siRNA-mediated	
depletion	of	 TAB182	does	not	 impact	on	DNA	damage	 signalling	 after	UV-C	 irradiation,	 at	
least	with	respect	to	the	phosphorylation	events	examined	here.		
In	 cells	 transfected	with	 control	or	 TAB182	 siRNA	and	exposed	 to	2mM	HU	 (wash-
out),	 the	 total	 protein	 levels	 of	 NBS1,	 Chk1,	 RPA	 and	 H2AX	 were	 unaffected	 in	 TAB182	





(S4/8)	and	γH2AX	 (S139)	was	elevated	 in	TAB182	depleted	cells	 compared	 to	 control	 cells	
following	 2mM	 HU	 (Figure	 4.3C).	 This	 suggests	 that	 depletion	 of	 TAB182	 enhances	 DDR	
signalling	following	release	from	HU	exposure.		
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Figure	4.3:	DDR	Signalling	 is	 Increased	 in	 TAB182	Depleted	 Cells	Compared	 to	 Control	
Cells	following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.	50µg	of	
TAB182	 depleted	 or	 control	 siRNA	 treated	 HeLa	 cell	 extracts	 were	 immunoblotted	 for	
proteins	 involved	 in	DDR	signalling	 in	response	to	 (A)	 3	Gy	 IR	exposure,	 (B)	 5	 Jm-2	UV-C	
irradiation	or	(C)	2	hour	treatment	with	2mM	HU,	followed	by	3	washes	in	HU-free	media	
and	 incubation	 in	 fresh	 media	 for	 the	 indicated	 time-points.	 TAB182	 expression	 was	
analysed	 to	 assess	 the	 efficiency	 of	 TAB182	 depletion	 following	 siRNA	 treatment.	 This	
Western	 blot	 is	 representative	 of	 three	 independent	 repeats.	 	 Wash-out	 (WO)	
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and	 incubation	 in	 fresh	 media	 for	 the	 indicated	 time-points.	 TAB182	 expression	 was	
analysed	 to	 assess	 the	 efficiency	 of	 TAB182	 depletion	 following	 siRNA	 treatment.	 This	
Western	 blot	 is	 representative	 of	 three	 independent	 repeats.	 	 Wash-out	 (WO)	
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Figure	 4.3	Cont’d:	DDR	Signalling	 is	 Increased	 in	TAB182	Depleted	 Cells	 Compared	 to	
Control	Cells	following	Exposure	to	IR	and	HU	Treatment,	but	not	after	UV-C	Irradiation.	
50µg	 of	 TAB182	 depleted	 or	 control	 siRNA	 treated	 HeLa	 cell	 extracts	 were	
immunoblotted	 for	 proteins	 involved	 in	 DDR	 signalling	 in	 response	 to	 (A)	 3	 Gy	 IR	
exposure,	(B)	5	Jm-2	UV-C	irradiation	or	(C)	2	hour	treatment	with	2mM	HU,	followed	by	3	
washes	 in	HU-free	media	 and	 incubation	 in	 fresh	media	 for	 the	 indicated	 time-points.	
TAB182	expression	was	analysed	to	assess	the	efficiency	of	TAB182	depletion	following	














ascertain	 whether	 knockdown	 of	 TAB182	 has	 any	 effect	 on	 cell	 cycle	 progression	 in	 the	
absence	 of	 DNA	 damage.	 Confirmation	 of	 TAB182	 knockdown	 was	 achieved	 by	 Western	
blotting	(data	not	shown).	Cells	were	stained	with	the	DNA	stain	PI	and	the	cell	cycle	profile	
analysed	 by	 flow	 cytometry.	 There	was	 no	 observable	 difference	 in	 the	 cell	 cycle	 profiles	
between	control	siRNA	and	TAB182	depleted	cells	(Figure	4.4A).	The	data	are	represented	in	



















































post-transfection.	 (A)	 is	 representative	 of	 a	 typical	 flow	 cytometry	 plot	 observed	 (B)	






following	2	hours	exposure	 (wash-out).	 Samples	were	harvested	and	 fixed	with	ethanol	at	
various	time-points	post-exposure	depending	on	the	DNA	damaging	agent	used.	Cells	were	
stained	 with	 PI	 and	 the	 cell	 cycle	 profile	 analysed	 by	 flow	 cytometry	 (Figure	 4.5).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
Ordinarily,	exposure	to	IR	delays	the	progression	through	the	cell	cycle	through	the	
activation	 of	 cell	 cycle	 checkpoints	 (namely	 the	 G1	 checkpoint,	 the	 S	 checkpoint	 and	 the	
G2/M	checkpoint).	Delay	in	the	progression	through	the	cell	cycle	after	exposure	to	IR	occurs	







IR).	 Similarly	 to	 control	 cells,	 the	G2/M	arrest	 seen	 in	TAB182	 siRNA	 transfected	 cells	was	
also	 alleviated	 24	 hours	 after	 the	 initial	 IR	 exposure,	 and	 the	 cell	 cycle	 profile	 of	 TAB182	






UV-C	 irradiation.	 24	 hours	 post-UV-C	 irradiation,	 a	 release	 from	 the	 cell	 cycle	 arrest	 was	






depletion	was	 also	 noticeable	 24	 hrs	 after	UV-C	 irradiation,	 compared	 to	 control	 cells.	 48	






most	noticeable	as	a	delay	 in	 the	G2	phase	of	 the	cell	 cycle	was	observed.	24	hours	post-
initial	HU	exposure,	cell	cycle	arrest	induced	by	HU	was	alleviated	and	the	cells	continued	to	


















































Figure	 4.5:	Cells	Depleted	of	 TAB182	 Exhibit	Delayed	Cell	Cycle	 Progression	 following	
Exposure	to	Various	DNA	Damaging	Agents.	HeLa	cells	were	transfected	with	either	non-
targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	to	(A)	3	
Gy	of	 IR,	 (B)	5	Jm-2	UV-C	 irradiation	or	 (C)	2	hour	treatment	with	2mM	HU	 for	2	hours,	
followed	by	3	washes	 in	HU-free	media	and	 incubation	 in	 fresh	media	for	the	 indicated	
time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-exposure,	
stained	with	PI	and	the	cell	cycle	profile	analysed	by	flow	cytometry.	 (I)	Representative	













































Figure	 4.5	 Cont’d:	 Cells	 Depleted	 of	 TAB182	 Exhibit	 Delayed	 Cell	 Cycle	 Progression	
following	 Exposure	 to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	
either	non-targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	
to	 (A)	 3	Gy	 of	 IR,	 (B)	 5	 Jm-2	UV-C	 irradiation	or	 (C)	 2	 hour	 treatment	with	2mM	HU	 for	2	
hours,	 followed	 by	 3	 washes	 in	 HU-free	 media	 and	 incubation	 in	 fresh	 media	 for	 the	
indicated	 time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-



























































Figure	 4.5	 Cont’d:	 Cells	 Depleted	 of	 TAB182	 Exhibit	 Delayed	 Cell	 Cycle	 Progression	
following	 Exposure	 to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	
either	non-targeting	control	or	TAB182	siRNA,	and	48	hours	later	mock-exposed	or	exposed	
to	 (A)	 3	Gy	 of	 IR,	 (B)	 5	 Jm-2	UV-C	 irradiation	 or	 (C)	 2	 hour	 treatment	with	 2mM	HU	 for	 2	
hours,	 followed	 by	 3	 washes	 in	 HU-free	 media	 and	 incubation	 in	 fresh	 media	 for	 the	
indicated	 time-points.	 Cells	 were	 harvested	 for	 analysis	 at	 various	 time-points	 post-







Since	 the	 cell	 cycle	 profile	 of	 cells	 deficient	 in	 TAB182	 expression	 revealed	 some	
accumulation	 in	G2/M	phase	of	 the	 cell	 cycle	 following	exposure	 to	 various	 types	of	DNA	
damaging	 agents,	 we	 also	 wanted	 to	 examine	 whether	 the	 G2/M	 checkpoint	 was	 intact.	
HeLa	cells	were	treated	with	either	control	or	TAB182	siRNA,	and	48	hours	later	exposed	to	
either	3	Gy	of	IR,	5	Jm-2	of	UV-C	or	2mM	HU	(wash-out).	Samples	were	harvested	and	fixed	
at	 various	 time-points	 post-exposure	 depending	 on	 the	 DNA	 damaging	 agent	 used.	 Cells	
were	 stained	 with	 an	 antibody	 recognising	 Histone	 H3	 phosphorylated	 on	 Serine	 10	
(phospho-H3	 Ser10)	 as	 a	 marker	 of	 cells	 entering	 mitosis.	 The	 cell	 cycle	 profiles	 of	 the	
samples	 were	 then	 analysed	 by	 flow	 cytometry	 (Figure	 4.6).	 Confirmation	 of	 TAB182	
knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
1-4	 hours	 following	 IR,	 the	 percentage	 of	 control	 cells	 entering	mitosis	 (shown	 by	
phospho-H3	 (Ser10)	 staining)	 was	 steadily	 reduced	 as	 the	 G2/M	 checkpoint	 became	
activated.	24	hours	after	the	initial	IR	exposure,	the	percentage	of	cells	in	mitosis	began	to	
increase	 and	 36	 hours	 later	 it	 reached	 pre-exposure	 levels.	 Importantly,	 there	 was	 no	
significant	 difference	 in	 the	 percentage	 of	 cells	 in	mitosis	 between	 TAB182	 deficient	 and	
control	cells	at	any	of	the	time-points	examined	(Figure	4.6A).	
Within	 4-8	 after	 UV-C	 irradiation	 at	 5	 Jm-2,	 the	 percentage	 of	 cells	 in	 mitosis	
decreased	 as	 a	 consequence	 of	 the	 activation	 of	 the	 G2/M	 checkpoint,	 with	 a	 gradual	


































































to	 Various	 DNA	 Damaging	 Agents.	 HeLa	 cells	 were	 transfected	 with	 either	 control	 or	
TAB182	siRNA	and	48	hours	post-transfection	exposed	to	either	(A)	3	Gy	of	IR,	(B)	5	Jm-2	of	
UV-C	 or	 (C)	 2mM	 HU	 wash-out	 (washed	 out	 after	 2	 hours	 of	 incubation).	 Following	





































Figure	4.6	Cont’d:	The	G2/M	Checkpoint	 is	Proficient	 in	TAB182	Depleted	Cells	 following	
Exposure	to	Various	DNA	Damaging	Agents.	HeLa	cells	were	transfected	with	either	control	
or	TAB182	siRNA	and	48	hours	post-transfection	exposed	to	either	(A)	3	Gy	of	IR,	(B)	5	Jm-2	
of	 UV-C	 or	 (C)	 2mM	 HU	 wash-out	 (washed	 out	 after	 2	 hours	 of	 incubation).	 Following	












the	 percentage	 of	 cells	 in	 mitosis	 increased	 and	 by	 24	 hours,	 the	 percentage	 of	 cells	 in	
mitosis	had	reached	pre-exposure	levels.	 In	cells	depleted	of	TAB182	and	exposed	to	2mM	
HU,	the	same	reduction	in	the	percentage	of	cells	in	mitosis	up	to	4	hours	post-exposure	was	
observed,	 followed	 by	 a	 comparable	 increase	 in	 the	 percentage	 of	 cells	 in	mitosis	 after	 8	
hours	initial	HU	exposure,	recovering	to	pre-exposure	levels	following	24	hours	(Figure	4.6C).	
Taken	 together,	 these	 results	 show	 that	 the	G2/M	 checkpoint	 in	 TAB182	 depleted	
cells	 is	proficient	 following	 IR,	UV-C	 irradiation	and	HU	 treatment.	 	 Since	cells	depleted	of	






Since	 the	 previous	 results	 showed	 potential	 cell	 cycle	 progression	 abnormalities	 in	
TAB182	deficient	 cells	 in	 response	 to	DNA	damage	without	 any	G2/M	checkpoint	defects,	




TAB182	 siRNA	 and	 48	 hours	 later,	 CldU	 was	 added	 to	 the	 cells	 to	 label	 the	 DNA	 during	
replication.	CldU	was	removed	from	the	cells	and	the	cells	were	subsequently	mock-treated	
or	treated	with	2mM	HU	to	induce	replication	stress.	Following	2	hours	of	HU	treatment,	HU	
was	 removed	 from	 the	 cells	 and	 ldU	 was	 added	 in	 HU-free	 media	 to	 label	 nascent	 DNA	
synthesis.	DNA	replication	speed	was	calculated	by	measuring	the	 lengths	of	 the	CldU	and	
IdU	 tracks	 using	 Image	 J	 software.	 The	 lengths	 obtained	 in	 Image	 J	 were	 converted	 into	
micrometers	 using	 the	 scale	bars	 on	 the	microscope	 (Figure	4.7).	 Confirmation	of	 TAB182	
knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
In	control	cells	the	average	fork	speed	before	exposure	to	HU	was	1.45kb	per	minute	
(CldU	 staining).	 In	 TAB182	depleted	 cells,	 there	was	 little	 significant	 difference	 in	 average	
fork	 speed	 (1.22kb	 per	 minute)	 compared	 to	 control	 cells	 before	 exposure	 to	 HU	 (CldU	
staining),	showing	that	knockdown	of	TAB182	alone	does	not	affect	replication	fork	kinetics.	
In	control	siRNA	treated	cells	the	average	fork	speed	following	exposure	to	HU	was	reduced	
to	 0.54	 kb	 per	 minute	 (IdU	 staining),	 showing	 that	 treatment	 with	 HU	 followed	 by	 a	 45	
minute	 incubation	 in	 HU-free	 media	 induces	 replication	 stress	 and	 therefore	 slows	 DNA	
replication.	 Similarly,	 in	 TAB182	 deficient	 cells,	 the	 average	 fork	 speed	 following	 HU	





























































































































followed	 by	 mock-treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours.	 Following	 HU	
treatment,	 cells	 were	 incubated	 with	 IdU	 for	 45	 minutes.	 DNA	 was	 spread	 onto	 slides,	
probed	 with	 the	 appropriate	 antibodies	 and	 visualised	 by	 fluorescence	 microscopy.	 DNA	
fibre	speed	was	calculated	by	measuring	the	lengths	of	the	CldU	and	IdU	tracks	using	Image	J	
software.	 (A)	 Graphs	 represent	 the	 average	 CldU	 fork	 speed	 (before	 HU	 exposure)	 and	
average	 IdU	 fork	 speed	 (HU	 exposure).	 (B)	 Table	 shows	 the	 average	 CldU	 and	 IdU	 fork	









48	 hours	 later	 were	 incubated	 with	 media	 containing	 the	 DNA	 analogue	 CldU.	 Following	
CldU	 incorporation,	 the	cells	were	mock-treated	or	 treated	with	2mM	HU	for	2	hours,	 the	
HU	was	then	removed	and	the	cells	were	further	incubated	with	HU-free	media	containing	
IdU	 for	 45	 minutes.	 Cells	 were	 fixed,	 spread	 onto	 slides	 and	 incubated	 with	 antibodies	
against	 CldU	 and	 IdU.	 DNA	 was	 viewed	 under	 the	 microscope	 and	 the	 observed	 DNA	
structures	 recorded	 (Figure	 4.8).	 Confirmation	 of	 TAB182	 knockdown	 was	 achieved	 by	
Western	blotting	(data	not	shown).	




the	 removal	 of	 HU	 in	 both	 directions,	 these	 are	 denoted	 by	 a	 CldU	 (red)	 track	 with	 IdU	
(green)	 tracks	 on	 either	 side.	 2nd	 label	 origins	 represent	 new	 origins	 of	 replication	 that	
occurred	during	 the	 second	 label	 and	are	denoted	by	an	 IdU	 (green)	 track	alone.	1st	 label	
terminations	represent	forks	that	collapsed	during	the	first	 label	and	did	not	restart	during	
the	 second	 label.	 They	 are	 denoted	 by	 a	 CldU	 (red)	 track	 alone.	 2nd	 label	 terminations	
represent	 two	 forks	 that	 were	 ongoing	 and	 replicating	 during	 the	 first	 label	 and	 have	
converged	and	terminated	during	the	second	label.	They	are	denoted	by	an	IdU	track	(green)	
		 174	
with	 two	 CldU	 (red)	 tracks	 on	 either	 side.	 The	 different	 fibre	 structures	 are	 further	
represented	 in	 Figure	 4.8A.	DNA	 fibre	 structures	were	 calculated	 as	 a	 percentage	of	 total	
number	of	CldU	positive	structures	counted.		
In	 control,	 undamaged	 HeLa	 cells	 subjected	 to	 DNA	 fibre	 structure	 analysis,	 the	
following	 distribution	 of	 structures	 were	 obtained;	 70-80%	 of	 DNA	 fibre	 structures	 were	
‘ongoing	 forks’,	 approximately	 5%	 of	 forks	were	 ‘1st	 label	 origins’,	 10%	 of	 forks	were	 ‘2nd	
label	 origins’,	 10%	 of	 forks	 were	 ‘1st	 label	 terminations’	 and	 5%	 of	 forks	 were	 ‘2nd	 label	
terminations’	(78%,	5%,	8%,	8%	and	5%	respectively	(Figure	4.8B)).	Following	treatment	with	
HU,	 these	 cells	 generally	 displayed	 the	 following	 DNA	 structure	 changes.	 ‘Ongoing	 forks’	
decreased	 to	 approximately	 65%	 due	 to	 an	 increase	 in	 the	 percentages	 of	 other	 DNA	
structures	 in	 response	 to	 HU	 treatment	 (63%	 in	 Figure	 4.8B).	 ‘1st	 label	 origins’	 remained	
unchanged	 at	 approximately	 5%	 of	 DNA	 structures	 (5%	 in	 Figure	 4.8B).	 ‘2nd	 label	 origins’	
decreased	 to	3%	of	 forks	 (3%	 in	 Figure	4.8B),	 this	 is	because	 the	 induction	of	new	origins	
following	 replicative	 stress	 is	 normally	 prevented	 by	 the	 S	 phase	 checkpoint	 to	 prevent	




to	 ongoing	DNA	 replication	 decreasing	 and,	 therefore,	 the	 termination	 of	DNA	 replication	
also	decreasing	as	a	consequence.		











































Figure	 4.8:	 Cells	 Depleted	 of	 TAB182	 Display	 Excessive	 New	Origin	 Firing	 and	 Increased	
Fork	Restart	following	Release	from	HU.	HeLa	cells	were	transfected	with	control	or	TAB182	
siRNA.	 48	 hours	 post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	 minutes,	
followed	 by	 mock-treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours.	 Following	 HU	
treatment,	cells	were	incubated	with	HU-free	media	containing	IdU	for	45	minutes.	DNA	was	
spread	onto	 slides,	probed	with	 the	appropriate	antibodies	and	visualised	by	 fluorescence	






TAB182	 has	 no	 effect	 on	 DNA	 replication	 in	 the	 absence	 of	 replicative	 stress.	 In	 TAB182	
depleted	 cells	 treated	 with	 HU,	 the	 percentage	 of	 ongoing	 forks	 decreased	 from	 79%	 in	
undamaged	 cells	 to	 only	 74%,	 which	 was	 not	 comparable	 to	 control	 cells	 where	 the	
reduction	was	more	significant	(78%	to	63%).	The	percentage	of	1st	 label	origins	in	TAB182	
deficient	 cells	 was	 5%	 and	 was	 similar	 to	 control	 HU	 exposed	 cells.	 Interestingly,	 the	
percentage	of	2nd	label	origins	following	HU	treatment	in	TAB182	deficient	cells	increased	to	
20%,	 in	contrast	 to	control	cells	 in	which	 it	was	3%,	suggesting	that	TAB182	deficient	cells	
excessively	 fire	 new	 origins.	 Furthermore,	 TAB182	 defective	 cells	 displayed	 no	 significant	
increase	 in	the	percentage	of	1st	 label	terminations	following	HU	(11%	in	TAB182	depleted	




Taken	 together,	 these	 results	 demonstrate	 that	 TAB182	 depleted	 cells	 exhibit	
excessive	 new	 origin	 firing	 as	 well	 as	 increased	 fork	 recovery	 following	 release	 from	 HU,	





Since	 TAB182	 deficient	 cells	 exhibit	 irregularities	 during	 DNA	 replication	 in	 the	
presence	of	replication	stress,	the	next	aim	was	to	understand	how	these	defects	occurred.	
		 177	




hours	 later,	 were	 incubated	 in	 media	 containing	 CldU	 and	 subsequently	 mock-treated	 or	
treated	with	HU	or	both	HU	and	1μM	Chk1	inhibitor	for	2	hours.	Following	HU	or	both	HU	
and	Chk1	inhibitor	treatment,	the	cells	were	then	incubated	with	HU-free	media	containing	









al.	 2007,	 Petermann,	Woodcock	 et	 al.	 2010).	 In	 the	 same	 cells	 treated	with	 both	HU	 and	
Chk1	 inhibitor,	 the	percentage	of	2nd	 label	origins	 increased	from	3%	to	41%,	as	expected,	
since	Chk1	activation,	known	to	suppress	new	origin	firing,	was	inhibited.	The	percentage	of	
1st	label	terminations	in	control	cells	increased	with	HU	treatment	from	approximately	9%	to	



































Figure	4.9:	DNA	Fibre	Structures	 in	TAB182	Deficient	Cells	 following	Replication	Stress	 in	
the	Absence	of	Chk1.	HeLa	cells	were	transfected	with	control	or	TAB182	siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	 minutes,	 followed	 by	 mock-
treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours	 together	 with	 1μM	 of	 Chk1	 inhibitor.	
Following	HU	 treatment,	 the	 cells	were	 incubated	 in	HU-free	media	 containing	 IdU	 for	 45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	








(3%	 in	 control	 vs	 28%	 in	 TAB182	 deficient	 cells).	 Furthermore,	 inhibition	 of	 Chk1	 during	
exposure	to	HU	led	to	a	further	increase	in	the	percentage	of	2nd	label	origins	in	both	control	
and	 TAB182	 deficient	 cells,	 but	 more	 importantly,	 the	 difference	 was	 marginal	 (40%	 in	
control	cells	vs	50%	in	TAB182	depleted	cells).	This	suggested	that	1)	inhibiting	Chk1	activity	




percentage	 of	 1st	 label	 terminations	 in	 control	 cells	 compared	 to	 those	 treated	 with	 HU	




the	 ability	 of	 these	 cells	 to	 promote	 replication	 fork	 restart.	 This	 suggests	 that	 TAB182	 is	
required	 for	 fork	 stalling/collapse	 following	 release	 from	 fork	 blocking	 and	 prevents	
replication	fork	restart	even	in	the	absence	of	Chk1	activity	(Figure	4.9).		
To	examine	the	effects	of	ATR	 inhibition	on	TAB182	deficient	cells,	HeLa	cells	were	
treated	with	 either	 control	 or	 TAB182	 siRNA	 and	 48	 hours	 later,	mock-treated	 or	 treated	
with	 HU	 or	 HU	 and	 5μM	 ATR	 inhibitor.	 	 Following	 HU	 or	 both	 HU	 and	 ATR	 inhibitor	
		 180	
treatment,	 the	 cells	were	 incubated	with	 HU-free	media	 containing	 IdU.	 Cells	were	 fixed,	












We	 previously	 observed	 that	 the	 percentage	 of	 2nd	 label	 origins	 increased	 following	 HU	
treatment	in	TAB182	deficient	cells	compared	to	control	cells	following	release	from	HU	(3%	
in	control	cells	vs	28%	in	TAB182	depleted	cells).	Notably,	control	and	TAB182	depleted	cells	
exposed	 to	 both	 HU	 and	 ATR	 inhibitor	 displayed	 a	 similar	 percentage	 of	 2nd	 label	 origins	
(46%	and	47%,	respectively).	Similarly	to	Chk1,	ATR	inhibition	in	response	to	HU	treatment	
completely	abrogated	the	difference	between	the	two	cell	lines	by	increasing	the	percentage	






































the	 Absence	 of	 ATR.	HeLa	cells	were	 transfected	with	 control	 or	 TAB182	 siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	minutes,	 followed	 by	 mock-
treatment	 or	 treatment	 with	 2mM	 HU	 for	 2	 hours	 together	 with	 5μM	 of	 ATR	 inhibitor.	
Following	HU	 treatment,	 the	 cells	were	 incubated	 in	HU-free	media	 containing	 IdU	 for	 45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	




increase	 in	replication	fork	stalling/collapse	of	approximately	50%	 in	both	cell	 lines	 (Figure	
4.10).		
Taken	 together,	 these	 results	 show	 that	 Chk1	 and	 ATR	 activity	 is	 important	 for	
suppressing	new	origin	firing	in	both	control	and	TAB182	defective	cells.	In	addition,	TAB182	




Based	on	 the	DNA	 fibre	 data	 from	Figure	 4.8,	we	wondered	whether	 the	 elevated	
new	 origin	 firing	 observed	 in	 TAB182	 deficient	 cells	 compared	 to	 control	 cells	 following	




CldU	 and	mock-treated	 or	 treated	 with	 HU	 or	 treated	 with	 both	 HU	 and	 25μM	 CDK	 1/2	





origins	 following	 exposure	 to	 HU	 when	 compared	 to	 mock-treated	 cells	 (10%	 to	 2%).	




increase	 in	2nd	 label	origins	 from	2%	to	21%	but	 this	was	completely	suppressed	 following	
incubation	with	 the	 CDK	 inhibitor	 that	 led	 to	 a	marked	 reduction	 down	 to	 control	 levels.	
Thus,	 inhibition	of	 CDK	during	 replication	 stress	 almost	 completely	 suppressed	new	origin	




The	 1st	 label	 termination	 percentage	 in	 untreated	 control	 cells	 was	 11%	 and	
increased	to	34%	following	HU	treatment	and	remained	unaltered	following	CDK	inhibition	
(Figure	4.11).	 This	was	not	unexpected	 since	CDK	 inhibition	has	no	documented	effect	 on	
replication	restart	(Petermann,	Orta	et	al.	2010).	More	importantly,	since	the	percentage	of	
1st	 label	 terminations	 in	TAB182	deficient	cells	exposed	 to	both	HU	and	CDK	 inhibitor	was	
comparable	to	TAB182	deficient	cells	treated	with	HU	alone	(15%),	it	can	be	concluded	that	










































the	 Absence	 of	 CDK.	HeLa	cells	were	 transfected	with	 control	or	TAB182	 siRNA.	48	hours	
post-transfection,	 the	 cells	 were	 incubated	 with	 CldU	 for	 20	minutes,	 followed	 by	 mock-
treatment	or	treatment	with	2mM	HU	for	2	hours	together	with	25μM	of	CDK	1/2	inhibitor	
III.	Following	HU	treatment,	the	cells	were	incubated	in	HU-free	media	containing	IdU	for	45	
minutes.	 DNA	 was	 spread	 onto	 slides	 and	 staining	 processed	 as	 in	 Figure	 4.8.	 The	 graph	










acids	1221-1729	of	TAB182	 (Figure	1.16)	 (Seimiya	and	Smith	2002).	 	Cell	 lysates	were	also	
incubated	with	GST	alone	as	a	non-specific	binding	control,	and	cell	lysate	alone	was	run	as	a	
positive	 control.	 Protein	 complexes	 were	 captured	 using	 glutathione-agarose	 beads,	
subjected	to	SDS-PAGE	and	Western	blotting	(Figure	4.12).	Protein	complexes	isolated	using	
HeLa	cell	 lysates	were	 immunoblotted	with	a	panel	of	antibodies	 involved	 in	 the	DDR	and	





It	 is	 well	 established	 that	 DNA	 damage	 can	 be	 indirectly	 observed	 through	 the	
detection	 of	 the	 accumulation	 of	 proteins	 at	 regions	 of	 DNA	 damage	which	 form	 distinct	
sites	 known	 as	 foci.	 To	 determine	 whether	 TAB182	 is	 relocalised	 to	 DNA	 damage	 foci	
following	 DNA	 damage,	 immunofluorescence	 analysis	 was	 performed.	 A	 TAB182	 DNA	







































































































































Table	 4.1:	 GST-TAB182C	 Non-Interacting	 Proteins.	 Table	 to	
illustrate	the	proteins	that	do	not	interact	with	the	C-terminal	





transfection,	 the	 cells	 were	 exposed	 to	 2mM	 HU	 (left-in	 throughout	 the	 course	 of	 the	
experiment)	or	3	Gy	of	 IR.	2	hours	post-exposure,	the	cells	were	then	fixed,	permeabilised	
and	probed	with	antibodies	against	γH2AX	(Figure	4.13).			
Mock-exposed,	 GFP-TAB182	 transfected	 cells	 exhibited	 a	 pan-cellular	 staining	
pattern	 that	 appeared	 to	 be	 concentrated	 around	 the	 nucleus.	 	 It	 can	 be	 seen	 from	 the	
γH2AX	staining	that	DNA	damage	foci	are	formed	in	both	HU	and	IR	exposed	cells.	Following	
exposure	to	either	IR	or	HU,	the	staining	pattern	of	GFP-TAB182	did	not	change,	suggesting	











were	 analysed	 by	 fluorescence	 microscopy,	 γH2AX	 and	 53BP1	 foci	 positive	 cells	 were	






























Exposure.	 HeLa	 cells	 were	 transfected	 with	 eGFPC3-TAB182	 and	 48	 hours	 later,	 mock-
exposed	 or	 exposed	 to	 2mM	 HU	 (left-in	 throughout	 the	 duration	 of	 the	 experiment)	 or	
irradiated	at	3	Gy	IR.	2	hours	post-treatment	the	cells	were	then	fixed,	permeabilised	and	




In	 the	absence	of	any	DNA	damage,	 there	was	a	basal	 level	of	γH2AX	 foci	positive	control	
cells	 (approximately	 12%).	 Following	2	hours	 incubation	with	2mM	HU,	 the	percentage	of	
γH2AX	foci	positive	cells	increased	to	approximately	20%,	this	is	indicative	of	the	initiation	of	
formation	of	DNA	damage	following	the	addition	of	HU.	1	hour	after	release	from	HU,	the	
percentage	 of	 γH2AX	 foci	 positive	 cells	 was	 approximately	 49%,	 representing	 the	 highest	
percentage	of	 γH2AX	 foci	 positive	 cells	 throughout	 the	 course	 of	 the	 experiment.	 2	 to	 24	
hours	 post-release	 from	 HU,	 the	 percentage	 of	 γH2AX	 foci	 positive	 cells	 was	 reduced	 to	
around	21	to	30%,	indicating	that	there	was	dissolution	of	γH2AX	foci	and	possibly	clearance	
of	DNA	damage.	Upon	TAB182	depletion,	the	basal	 levels	of	γH2AX	foci	positive	cells	were	
similar	 to	 control	 siRNA	 treated	 cells	 (approximately	 10%).	 The	 percentage	 of	 γH2AX	 foci	
positive	cells	at	 the	point	of	HU	removal	 in	 the	absence	of	TAB182	was	also	equivalent	 to	
control	 siRNA	 treated	 cells	 (approximately	 20%).	 This	 was	 not	 the	 case	 1	 hour	 post-HU	
release	where	only	14%	of	TAB182	depleted	cells	displayed	γH2AX	foci	when	compared	to	
50%	of	control	cells.	This	reduction	in	the	percentage	of	cells	with	γH2AX	positive	foci	was	
evident	 in	 all	 the	 other	 time-points	 examined	 (Figure	 4.14A).	 This	 suggested	 that	 there	 is	
either	less	DNA	damage/faster	clearance	of	damage	or	fork	recovery	following	release	from	
HU	 in	 TAB182	 deficient	 cells	 in	 agreement	 with	 the	 observation	 that	 there	 is	 less	 fork	
stalling,	 or	 that	 the	 phosphorylation/dephosphorylation	 equilibrium	 of	 γH2AX	 in	 TAB182	
defective	cells	is	compromised	(Figure	4.14A).		
To	ascertain	whether	there	is	less	DNA	damage	in	the	form	of	DSBs	in	TAB182	cells,	
we	 also	 examined	 the	 levels	 of	 53BP1	 foci	 positive	 cells.	 The	 percentage	 of	 cells	 with	



































































point	 of	 release,	 1,	 2,	 4	 and	 24	 hours	 post-HU	 treatment.	 Fixed	 cells	 were	 probed	 with	
antibodies	 against	 ΥH2AX	 or	 53BP1.	 Cells	 were	 analysed	 by	 fluorescence	 microscopy	 and	
ΥH2AX+	or	53BP1+	cells	scored	as	those	having	more	than	7	foci	per	cell.	(A)	Graph	shows	the	
percentage	of	cells	with	γH2AX+	foci	across	various	time-points	after	2mM	HU	exposure.	(B)	
Graph	depicts	the	percentage	of	 cells	with	53BP1+	foci	 across	various	time-points	 following	





the	percentage	of	 cells	with	53BP1	positive	 foci	was	 approximately	24%,	 representing	 the	
maximal	 percentage	 of	 53BP1	 positive	 cells	 throughout	 the	 course	 of	 the	 experiment.	 At	
later	 time-points	 the	 levels	 of	 53BP1	positive	 cells	 reduced	 suggesting	 that	 the	DNA	DSBs	
were	 resolved/repaired.	 In	 TAB182	 depleted	 cells	 the	 percentage	 of	 cells	 displaying	
constitutive	53BP1	positive	foci	was	equivalent	to	control	cells.	At	the	point	of	HU	removal,	
the	 percentage	 of	 cells	 with	 53BP1	 positive	 foci	 was	 approximately	 17%	 and	 slightly	
decreased	 compared	 to	 control	 cells	 (20%).	 Strikingly,	 1	 hour	 after	 HU	 release	 the	
percentage	of	TAB182	depleted	cells	with	53BP1	positive	foci	was	approximately	8%,	which	
was	 significantly	 lower	 than	 the	 percentage	 of	 control	 cells	 with	 53BP1	 positive	 foci	
(approximately	 24%).	 The	 levels	 of	 53BP1	 foci	 remained	 relatively	 constant	 thereafter	 but	
were	 always	 reduced	 compared	 to	 control	 cells.	 These	 data	 suggest	 that	 DNA	 DSBs	 or	
collapsed	forks	marked	by	53BP1	formed	with	HU	treatment	are	resolved	faster	 in	TAB182	





Unresolved	 replication	 intermediates	 or	 under-replicated	 DNA	 transmitted	 to	
daughter	 cells	 in	 G1	 phase,	 is	 sequestered	 in	 nuclear	 compartments	 that	 are	 marked	 by	
53BP1	 (Harrigan,	 Belotserkovskaya	 et	 al.	 2011,	 Lukas,	 Savic	 et	 al.	 2011).	 These	 53BP1	











the	 following	 categories;	 1-2	 53BP1	 bodies	 per	 cell,	 3-4	 53BP1	 bodies	 per	 cell,	 5-6	 53BP1	
bodies	 per	 cell,	 7-8	 53BP1	 bodies	 per	 cell	 or	 9+	 53BP1	 bodies	 per	 cell	 (Figure	 4.15).	
Confirmation	of	TAB182	knockdown	was	achieved	by	Western	blotting	(data	not	shown).	
In	 the	 HeLa	 cells	 that	 were	 utilised	 for	 this	 experiment,	 there	 was	 a	 high	 level	 of	
background	53BP1	bodies	in	G1	in	both	control	and	TAB182	depleted,	untreated	cells	(Figure	
4.15A).	 4	 hours	 post-HU	 release	 there	was	 a	mild	 induction	 of	 1-2	 53BP1	 bodies	 in	 both	
control	 cells	and	TAB182	depleted	cells.	24	hours	 following	 release	 from	HU	there	was	an	
increase	 in	 the	 percentage	 of	 cells	 containing	 1-2	 53BP1	 bodies	 that	 were	 deficient	 in	
TAB182	compared	to	controls	(37%	of	TAB182	knockdown	cells	vs	27%	of	control	cells).	This	
suggested	that	after	release	from	replication	blocking	with	HU,	 in	particular	24	hours	after	







Figure	 4.15:	 TAB182	 Depleted	 Cells	 Exhibit	 Elevated	 Levels	 of	 53BP1	 Bodies	 in	 G1	
following	Release	 from	HU.	HeLa	cells	were	treated	with	control	or	TAB182	siRNA	and	48	
hrs	 later,	were	mock-exposed	 (A)	or	exposed	 to	 2mM	HU	 for	 2	 hrs.	Cells	were	 fixed	 and	
permeabilised	 at	 4	 (B)	 and	 24	 hrs	 (C)	 post-HU	 treatment.	 Fixed	 cells	 were	 probed	 with	
antibodies	against	Cyclin	A	and	53BP1.	The	cells	were	analysed	by	fluorescence	microscopy	
and	the	number	of	53BP1	bodies	in	G1	counted.	Graphs	illustrate	the	percentage	of	G1	cells	






















































































2.2%	 of	 cells	 had	 1	 micronucleus,	 0.4%	 of	 cells	 had	 2-5	 micronuclei,	 no	 cells	 had	 5+	
micronuclei	 and	 0.2%	 of	 cells	 exhibited	 mitotic	 catastrophe	 but	 there	 were	 no	 observed	
anaphase	 bridges.	 In	 TAB182	 depleted	 cells	 48	 hours	 after	 HU	 release,	 the	 percentage	 of	
cells	 with	 micronuclei	 was	 slightly	 higher	 than	 that	 of	 control	 cells;	 4.9%	 of	 cells	 had	 1	
micronucleus,	 1.0%	 of	 cells	 had	 2-5	micronuclei	 and	 0.3%	 of	 cells	 had	 5+	micronuclei.	 In	
addition,	 0.7%	 of	 cells	 exhibited	mitotic	 catastrophes	 and	 0.1%	 of	 cells	 showed	 anaphase	





































Since	TAB182	deficient	 cells	 displayed	elevated	numbers	of	micronuclei	 and	53BP1	
bodies	 in	 response	 to	 replication	stress,	metaphase	spread	analysis	was	also	performed	 in	
order	 to	 analyse	 chromosomal	 damage	 of	 metaphase	 chromosomes.	 HeLa	 cells	 were	
transfected	with	control	or	TAB182	siRNA	and	48	hours	later	were	either	mock-exposed	or	
incubated	 in	media	 containing	 2mM	HU	 for	 2	 hours.	 48	 hours	 after	 HU	 release,	 the	 cells	
were	treated	with	colcemid	to	block	cells	in	mitosis.	The	cells	were	then	fixed	and	dropped	
onto	slides,	 followed	by	Giemsa	staining	 to	allow	visualisation	of	 chromosomal	damage	of	
metaphase	chromosomes.	The	total	number	of	chromatid	gaps/breaks	was	scored	in	a	total	
of	50	metaphase	spreads	in	both	control	and	TAB182	depleted	cells.	Confirmation	of	TAB182	
knockdown	was	 achieved	 by	Western	 blotting	 (data	 not	 shown).	 In	 control	 siRNA	 treated	
cells,	 the	 total	 number	 of	 chromatid	 gaps/breaks	was	 0.67	 per	metaphase,	 in	 contrast	 to	
TAB182	 deficient	 cells	 where	 the	 total	 number	 of	 chromatid	 gaps/breaks	 following	 HU	






































were	 exposed	 to	 2mM	HU	 for	 2	 hours	 and	 then	 incubated	 in	HU-free	media.	 48	 hours	
later,	 the	 cells	 were	 treated	 with	 colcemid	 to	 block	 cells	 in	 mitosis.	 Cells	 were	 fixed,	
dropped	onto	slides	and	stained	with	Giemsa	ready	for	analysis.	Metaphase	spreads	were	
visualised	 by	 light	 microscopy	 and	 counted	 for	 the	 number	 of	 chromatid	 gaps/breaks.	





hours	 later.	 Budding	 uninhibited	 by	 benzimidazoles-related	 1	 (BubR1)	 and	 Cdc27	 were	
immunoblotted	 since	 they	 are	 highly	 phosphorylated	 in	 mitosis	 but	 become	 gradually	
dephosphorylated	as	the	cells	exit	M	phase	and	proceed	into	G1.	Claspin	and	Cyclin	A	levels	
are	high	during	S	phase	but	are	 largely	diminished	during	mitosis	and	G1.	Cyclin	B	and	H3	





modified	 during	 mitosis.	 During	 the	 release	 from	 nocodazole	 block	 (between	 1	 and	 24	
hours),	the	phosphorylation	(denoted	by	retarded	migration	on	the	gel)	of	BubR1	and	Cdc27	
was	diminished	as	 the	cells	progress	 through	G1	and	 into	S	phase.	The	protein	expression	
levels	of	Claspin	and	Cyclin	A	(between	1	and	24	hours)	started	to	increase	at	approximately	
6-8	hours	after	nocodazole	release	as	the	cells	were	going	from	G1	into	S	phase.	Finally,	the	



































treated	 but	 not	 released	 control.	 Cells	 lysates	 were	 subjected	 to	 SDS-PAGE	 and	 Western	





To	 date,	 very	 little	 is	 known	 about	 the	 function	 of	 TAB182.	 It	 has	 been	 previously	
established	 that	 it	 interacts	 with	 Tankyrase	 1,	 and	 that	 Tankyrase	 1	 is	 able	 to	 ribosylate	
TAB182	 in	 vitro	 (Seimiya	 and	 Smith	 2002).	 In	 addition	 to	 this	 interaction,	 it	 has	 been	
suggested	 that	 TAB182	may	 be	 involved	 in	 the	DDR	pathways,	 since	 it	 is	 thought	 to	 be	 a	
substrate	of	ATM/ATR	phosphorylation	(Matsuoka,	Ballif	et	al.	2007).	Work	presented	in	this	
chapter	 has	 implicated	 TAB182	 in	 the	 DDR	 for	 several	 reasons.	 Firstly,	 cells	 deficient	 in	
TAB182	are	sensitive	to	agents	that	induce	replicative	stress	(UV-C	irradiation	and	HU),	but	
not	IR	(Figure	4.2).	Secondly,	following	exposure	to	various	DNA	damaging	agents	such	as	IR	
and	 HU,	 TAB182	 deficient	 cells	 exhibited	 an	 increase	 in	 DDR	 signalling	 measured	 by	 the	
elevated	levels	of	phosphorylated	DDR	proteins	such	a	pChk1	(S317	and	S345),	pRPA	(S4/8)	
and	γH2AX	(Figure	4.3).	Furthermore,	a	minor	delay	in	the	progression	through	G2/M	after	
IR	 or	 HU	 treatment,	 or	 in	 the	 progression	 through	 S	 phase	 after	 UV-C	 irradiation	 was	
observed	in	TAB182	depleted	cells	(Figure	4.5).	Further	analysis	of	the	G2/M	checkpoint	by	








stalling	 observed	 in	 TAB182	 deficient	 cells	 following	 HU	 treatment	 was	 shown	 to	 be	
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dependent	 on	 ATR	 but	 not	 on	 Chk1	 or	 CDK	 function,	 suggesting	 that	 in	 the	 absence	 of	
TAB182,	 ATR	 is	 important	 for	 replication	 resumption	 (Figures	 4.10,	 4.9	 and	 4.11,	
respectively).		
It	was	shown	that	TAB182	does	not	 localise	to	DNA	damage	foci	 following	exposure	to	HU	
(Figure	4.13).	Further	analyses	revealed	that	TAB182	depletion	 leads	to	a	reduction	 in	 	the	
numbers	 of	 γH2AX	 and	 53BP1	 foci	 positive	 cells	 following	 1hr	 release	 from	 2mM	 HU	





associated	 micronuclei	 following	 exposure	 to	 HU	 in	 TAB182	 deficient	 cells	 (Figure	 4.16).	
Interestingly,	 metaphase	 spread	 analysis	 showed	 that	 TAB182	 depleted	 cells	 have	 less	
chromatid	 gaps/breaks	 following	 exposure	 to	 HU,	 the	 reason	 for	 this	 result	 is	 unclear	 at	
present	 (Figure	 4.17).	 Finally,	 using	 nocodazole	 release	 assays,	 TAB182	 was	 shown	 to	 be	
down-regulated	during	G1	and	its	expression	increased	as	the	cells	progressed	through	the	
cell	 cycle,	 further	 suggesting	 that	 TAB182	may	be	 important	 during	 S	 phase	 (Figure	 4.18).	
Similarly,	 it	was	observed	that	as	adenovirus	 infection	progressed	there	was	an	increase	in	





Clonogenic	 Survival,	 DNA	Damage	 Response	 Signalling	 and	 Cell	 Cycle	 Control	 in	 TAB182	
Deficient	Cells	
Clonogenic	survival	assays	demonstrated	that	TAB182	depleted	cells	are	sensitive	to	






pNBS1	 S343,	 pChk1	 S317/S345,	 pRPA	 S4/8	 and	 γH2AX	 S139	 were	 determined.	 ATM	 is	
responsible	for	the	phosphorylation	of	NBS1	on	S343,	which	is	indicative	of	the	activation	of	
the	 S	 phase	 checkpoint	 (Lim,	 Kim	 et	 al.	 2000).	 ATM	 and	 ATR	 have	 been	 shown	 to	
phosphorylate	 Chk1	 on	 S317	 or	 S345	 (Zhao	 and	 Piwnica-Worms	 2001,	Gatei,	 Sloper	 et	 al.	
2003).	 Phosphorylation	 of	 Chk1	 at	 S317	 is	 required	 for	 cell	 cycle	 re-entry	 after	 stalled	
replication	(Martin	and	Ouchi	2008).	Phosphorylation	of	Chk1	on	S345	is	required	for	Chk1	
localisation	to	the	nucleus	following	activation	of	the	checkpoint	(Jiang,	Pereira	et	al.	2003).	
Phosphorylation	 on	 S4/8	 of	 RPA	 is	 indicative	 of	 RPA-bound	 ssDNA	 formed	 as	 a	 result	 of	







mild	 and	 there	may	be	 compensatory	pathways	 to	promote	 cellular	 survival	 in	 these	 cells	
following	exposure	to	IR.	Following	exposure	to	2mM	HU,	TAB182	defective	cells	displayed	
slightly	elevated	levels	of	pRPA	(S4/8)	and	γH2AX	(S139)	and	elevated	levels	of	pChk1	(S317	




can	 account	 for	 the	 UV-C	 hypersensitivity	 observed	 is	 unclear.	 Significantly,	 however,	
TAB182	depleted	cells	appeared	to	progress	through	S	phase	slower	than	control	cells	after	
UV-C	 irradiation,	 indicating	that	there	may	be	a	role	for	TAB182	in	replication	progression.	
Progression	 through	 S	 phase	 in	 the	 presence	 of	 other	 types	 of	DNA	damage/stress	 under	
conditions	 of	 down-regulation	 of	 TAB182	 expression,	 appeared	 to	 be	 intact,	 but	 with	 a	
bigger	fraction	of	cells	accumulating	in	G2/M	compared	to	control	cells.			
Using	 nocodazole	 release	 assays,	 it	 was	 shown	 that	 TAB182	 was	 down-regulated	
during	G1	phase	of	the	cell	cycle	(Figure	4.18).	The	reason	for	this	down-regulation	is	unclear	
at	present.	 Interestingly,	 during	mitosis	 TAB182	appeared	 to	migrate	more	 slowly	by	 SDS-
PAGE,	 suggesting	 that	 TAB182	 may	 undergo	 post-translational	 modifications	 such	 as	
phosphorylation	 or	 ribosylation	 during	 mitosis.	 Indeed,	 studies	 from	 Matsuoka	 and	









molecules	 during	 DNA	 replication	 following	 release	 from	 replication	 stress	 (Jackson	 and	
Pombo	1998).	This	technique	was	therefore	employed	to	analyse	the	replication	dynamics	in	
TAB182	 deficient	 cells.	 In	 both	 unperturbed	 cells	 as	 well	 as	 cells	 released	 from	 2mM	HU	
treatment,	 the	 speed	 of	 replication	 fork	 progression	 in	 TAB182	 depleted	 cells	 was	
comparable	 to	 control	 siRNA	 cells,	 suggesting	 that	 TAB182	depletion	has	no	effect	on	 the	
progression	 of	 actively	 replicating	 forks	 (Figure	 4.7).	 Interestingly,	 TAB182	 depleted	 cells	
exhibited	 excessive	 new	 origin	 firing	 (measured	 by	 the	 elevated	 percentage	 of	 2nd	 label	
origins	compared	to	control	siRNA	treated	cells),	as	well	as	an	increase	in	fork	restart	events	
(measured	 by	 decreased	 fork	 stalling	 compared	 to	 control	 siRNA	 treated	 cells),	 following	
release	from	HU	(Figure	4.8).	This	suggested	that	TAB182	deficient	cells	may	fire	new	origins	




employed	 to	 ablate	 new	 origin	 firing	 and	 the	 effect	 on	 fork	 restart	 was	 assessed	 (Figure	
4.11).	The	CDK	 I/II	 inhibitor	abolished	new	origin	 firing	as	expected,	but	strikingly,	 this	did	
not	 impact	 on	 the	 percentage	 of	 fork	 restart	 events	 in	 TAB182	 knockdown	 cells,	 showing	
that	the	increased	fork	restart	observed	in	these	cells	is	not	a	result	of	elevated	new	origin	
firing.	Interestingly,	DT40	cells	lines	that	do	not	express	the	FANCM	helicase,	a	protein	which	
has	previously	been	 implicated	 in	fork	restart,	display	both	 increased	new	origin	firing	and	
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elevated	 fork	 restart	 following	 release	 from	 replication	 blocks	 (Schwab,	 Blackford	 et	 al.	
2010).	However,	 the	 increased	fork	restart	observed	 in	FANCM	negative	cells	 is	a	result	of	
new	 origin	 firing,	 as	 upon	 CDK	 inhibition,	 increased	 fork	 restart	 reaches	 control	 levels.	
Furthermore,	in	contrast	to	TAB182	depleted	cells	that	replicate	their	DNA	at	similar	rates	to	
control	 cells,	 FANCM	 deficient	 HeLa	 cells	 show	 increased	 fork	 replication	 speeds	 in	 both	
unperturbed	and	replication	stressed	cells	(Luke-Glaser,	Luke	et	al.	2010).	This	suggests	that	
FANCM	 is	 able	 to	 slow	 down	 replication	 fork	 progression.	 Nethertheless,	 in	 this	 study,	














checkpoint	 roles	 outside	 the	 ATR/Chk1	 pathways	 or	 2)	 that	 it	 does	 not	 have	 a	 role	 in	
checkpoint	function.		
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Taken	 together,	 we	 hypothesise	 that	 TAB182	 may	 be	 involved	 in	 promoting	 fork	












specific	 antibodies	 against	 TAB182	 that	 could	 be	 utilised	 to	 allow	 the	 visualisation	 of	 the	
localisation	of	the	endogenous	protein	within	the	cell,	we	made	use	of	a	pEGFPC3-TAB182	
construct	 to	 perform	 this	 analysis.	 GFP-TAB182	 exhibited	 pan-cellular	 localisation	 that	
remained	unaltered	upon	the	induction	of	replication	stress.	However,	due	to	the	fact	that	







in	 cells	 exhibiting	 γH2AX	 and	 53BP1	 foci	 upon	 TAB182	 depletion,	 suggesting	 that	 TAB182	
may	be	promoting	the	stalling/collapsing	of	forks	into	DSBs	(Figure	4.14).	We	do	not	know	if	
TAB182	 acts	 directly	 at	 the	 fork	 but	 since	 in	 silico	analysis	 has	 not	 revealed	 any	 nuclease	









bodies)	 in	 G1	 following	 replication	 stress	 (Harrigan,	 Belotserkovskaya	 et	 al.	 2011,	 Lukas,	
Savic	et	al.	2011).	Knockdown	of	TAB182	slightly	increased	the	levels	of	53BP1	bodies	above	
those	 observed	 in	 control	 cells	 indicative	 of	 elevated	 levels	 of	 under-replicated	 DNA	 or	
replication	stress	(Figure	4.15).	Another	example	of	unresolved	replication	stress	leading	to	
genomic	 instability	 is	 the	presence	of	chromatid	gaps	and	breaks	that	can	be	visualised	by	
chromosomal	 metaphase	 spreads	 following	 replication	 stress.	 Our	 analysis	 showed	 that	
knockdown	 of	 TAB182	 lead	 to	 a	 reduction	 in	 the	 average	 number	 of	 gaps	 and	 breaks	
following	release	from	HU.	Nevertheless,	an	increase	in	micronuclei	was	observed	in	TAB182	
defective	cells	upon	replication	stress.	
Taken	 together,	 in	 the	 absence	 of	 TAB182,	 cells	 are	 sensitive	 to	 replication	 stress,	
with	more	 replication	 forks	 restarting	 following	 release	 from	HU.	Finally,	TAB182	depleted	
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Three,	 where	 TAB182	 was	 shown	 to	 be	 degraded	 following	 infection	 with	 a	 number	 of	
adenovirus	serotypes.	More	than	80%	of	proteins	known	to	be	degraded	by	adenovirus	are	
involved	 in	 the	 DDR,	 therefore	 adenoviral	 targets	 are	 likely	 to	 be	 DDR	 proteins	 (Querido,	
Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002,	 Baker,	 Rohleder	 et	 al.	 2007,	 Orazio,	
Naeger	et	al.	2011,	Gupta,	Jha	et	al.	2013).	Furthermore,	work	presented	in	Chapter	Three	
showed	that	TAB182	depletion	enhanced	the	expression	of	 the	cell	cycle	protein,	Cyclin	E,	
and	 elevated	 the	 expression	 of	 the	 adenoviral	 E1A	 protein	 (Figures	 3.10	 and	 3.9,	
respectively).	This	suggested	that,	firstly,	TAB182	may	be	involved	in	cell	cycle	control	or	the	
regulation	of	 replication,	and	 secondly,	 that	 the	degradation	of	TAB182	during	adenovirus	
infection	is	beneficial	for	both	viral	replication	and	the	production	of	viral	progeny.	
A	potential	role	for	TAB182	in	the	DDR	was	further	indicated	in	Chapter	Four.	Using	
cell	 survival	 assays,	 TAB182	depleted	 cells	 appeared	 to	 be	 sensitive	 to	 agents	 that	 induce	
replication	 stress	 (Figure	 4.2).	 Moreover,	 TAB182	 deficient	 cells	 displayed	 increased	 DDR	
signalling	 following	 exposure	 to	 various	 DNA	 damaging	 agents	 (Figure	 4.3).	 Cell	 cycle	
analyses	 revealed	 that	 TAB182	 deficient	 cells	 exhibit	 a	 delay	 in	 cell	 cycle	 progression	
following	exposure	 to	DNA	damaging	agents	 (especially	 after	UV-C	 irradiation),	which	was	
not	due	to	a	defective	G2/M	checkpoint	(Figures	4.5	and	4.6,	respectively).	
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Using	DNA	fibre	assays,	 the	replication	checkpoint	 in	TAB182	deficient	cells	both	 in	
the	absence	of	stress	and	following	HU	release	was	shown	to	be	proficient,	since	replication	
elongation	 speeds	 were	 comparable	 to	 control	 cells	 (also	 shown	 by	 proficient	 Chk1	
phosphorylation)	(Figures	4.7	and	4.3,	respectively).	However,	DNA	fibre	structures	following	
replication	 stress	demonstrated	 that	TAB182	deficient	 cells	displayed	excessive	new	origin	
firing	 and	 increased	 fork	 restart	 following	 release	 from	 replication	 blocks	 induced	 by	 HU	
(Figure	4.8).	A	CDK	I/II	 inhibitor	was	used	to	 inhibit	new	origin	firing	 in	order	to	determine	
whether	 the	 elevated	 new	 origin	 firing	 and	 increased	 fork	 restart	 observed	 in	 TAB182	




with	 γH2AX	 and	 53BP1	 foci	 and	 less	 chromatid	 gaps/breaks	 are	 formed	 after	 replication	
stress	upon	TAB182	depletion,	suggests	 that	 less	replication	 forks	stall	 in	TAB182	deficient	
cells	 and	 therefore	 less	 DSBs	 may	 be	 accumulating	 (Figures	 4.14	 and	 4.17,	 respectively).	
However,	 TAB182	 deficient	 cells	 displayed	 increased	 levels	 of	 micronuclei	 as	 well	 as	
increased	numbers	of	 cells	with	1-2	53BP1	bodies	 in	G1,	 suggesting	 that	TAB182	deficient	
cells	may	also	exhibit	phenotypes	of	genomic	instability	(Figures	4.16	and	4.15,	respectively).	
Taken	 together,	 the	 work	 presented	 in	 Chapters	 Three	 and	 Four	 indicates	 that	
TAB182	may	be	involved	in	the	response	to	replication	stress	as	well	as	in	the	maintenance	
of	genome	stability.	However,	no	precise	mechanism	for	the	involvement	of	TAB182	in	the	
DDR	has	been	elucidated	thus	 far.	The	aim	of	 this	chapter	was	 therefore	 to	 try	 to	 identify	
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GST	 pull-down	 assays	 previously	 performed	 in	 Chapter	 Four	 revealed	 that	 TAB182	
interacted	with	Tankyrase	1,	Chk1	and	Aurora	 kinase	 (Figure	4.12).	 To	gain	 further	 insight	
into	the	function	of	TAB182,	co-immunoprecipitation	experiments	were	performed	in	HeLa	
cell	 lysates,	 along	 with	 Ad5	 and	 Ad12	 infected	 HeLas	 and	 the	 resulting	 TAB182-protein	
complexes	were	analysed	by	mass	spectrometry.	After	immunoprecipitation,	proteins	were	
digested	with	 trypsin	as	described	 in	Section	2.3.5.	 The	 resulting	peptides	were	 separated	
using	a	Bruker	amaZon	ion	trap	mass	spectrometer	and	processed	and	analysed	by	using	the	
ProteinScape	 central	 bioinformatic	 platform	 (Bruker). Protein	 names,	 peptide	 number,	
percentage	coverage	and	Mascot	score	were	all	determined	(Table	5.1).	
TAB182	 co-immunoprecipitations	 performed	 in	 uninfected	 HeLa	 cells	 revealed	 a	










Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 68! 49.4! 3491!
CNOT1! 38! 17.4! 1472!
CNOT3! 7! 10.2! 237!
CNOT7! 6! 28.8! 211!
CNOT2! 5! 12.2! 245!
CNOT6L! 1! 1.8! 21!
CNOT10! 1! 1.3! 29!
CNOT11! 1! 2.4! 56!
CNOT9! 6! 20.4! 224!
!! !! !! !!
PRMT3! 9! 18.5! 377!
FHL2! 12! 52.3! 470!
!! !! !! !!
(B)$Ad5$Infected$
HeLas$(24hr):$
Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 70! 47.2! 4302!
CNOT1! 51! 22.6! 2423!
CNOT3! 15! 19.1! 607!
CNOT2! 7! 15.4! 343!
CNOT10! 5! 10.2! 219!
CNOT6L! 2! 4.1! 90!
CNOT8! 1! 4.8! 45!
CNOT11! 3! 8! 122!
CNOT9! 10! 36.5! 470!
!! !! !! !!
PRMT3! 8! 17.3! 356!
FHL2! 18! 60.6! 707!
!! !! !! !!
(C)$Ad12$Infected$HeLas$(24hr):$
Protein$ Pep6de$number$ Percentage$coverage$ Mascot$Score$$
!! !! !! !!
TAB182! 68! 49.4! 3491!
CNOT1! 38! 17.4! 1472!
CNOT2! 5! 12.2! 245!
CNOT3! 7! 10.2! 237!
CNOT7! 6! 28.8! 211!
CNOT10! 1! 1.3! 29!
CNOT6L! 1! 1.8! 21!
CNOT11! 1! 2.4! 56!
CNOT9! 6! 20.4! 234!
!! !! !! !!
PRMT3! 9! 18.5! 376.8!
FHL2! 12! 52.3! 470!
!! !! !! !!
Table	 5.1:	 TAB182	 Interacts	 with	 the	 CNOT	 Complex	 in	 Vivo.	 TAB182	 was	
immunoprecipitated	from	(A)	uninfected,	(B)	Ad5	or	(C)	Ad12	infected	HeLa	cell	lysates	and	






CNOT7	 (Ad12	 only),	 CNOT8	 (Ad5	 only),	 CNOT9,	 CNOT10	 and	 CNOT11.	 Again,	 PRMT3	 and	
FHL2	proteins	were	found	to	interact	with	TAB182	in	this	screen	(Table	5.1B	and	Table	5.1C).	
These	 results	 are	 representative	 of	 10	 independent	 mass	 spectrometry	 screens	
performed	 throughout	 the	 duration	 of	 this	 study.	 Taken	 together	 these	 data	 show	 that	
TAB182	 is	 likely	 to	 interact	with	various	 components	of	 the	CNOT	complex,	as	well	 as	 the	
proteins	 PRMT3	 and	 FHL2.	 Interestingly,	 CNOT4	 was	 never	 identified	 in	 any	 of	 the	 co-
immunoprecipitations.	 It	 is	 assumed	 that	 the	peptides	 identified	 as	deriving	 from	CNOT6L	
could	 have	 also	 been	 components	 of	 CNOT6	 due	 to	 the	 high	 similarity	 between	 the	 two	
proteins.	When	the	TAB182	immunoprecipitation	was	performed	in	the	presence	of	Ad5	and	








between	 TAB182	 and	 various	 components	 of	 the	 CNOT	 complex	 (namely	 CNOT1,	 CNOT2,	


































subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 with	 the	 required	 antibodies.	 	 β-actin	 was	
immunoblotted	 as	 a	 loading	 control.	 Adenovirus	 early	 proteins	 E1A	 and	 E1B55K	 were	
immunoblotted	 along	 with	 the	 viral	 structural	 proteins	 Hexon	 (Ad5)	 and	 Knob	 (Ad12)	 as	
markers	of	adenovirus	 infection.	As	expected,	the	expression	of	E1A,	E1B55K,	Hexon	(Ad5)	
and	Knob	(Ad12)	was	observed	between	8	and	24	hours	post-infection	in	both	Ad5	and	Ad12	
infected	 cells	 confirming	 infection	 with	 these	 serotypes.	 Mre11	 and	 p53	 were	
immunoblotted	as	positive	controls	since	these	proteins	are	known	to	be	degraded	during	
adenovirus	 infection	 (Querido,	 Blanchette	 et	 al.	 2001,	 Stracker,	 Carson	 et	 al.	 2002).	 As	
anticipated,	Mre11	and	p53	were	degraded	in	both	Ad5	and	Ad12	infected	cells	by	72	hours	
post-infection.	CNOT4	expression	was	unaffected	during	 the	course	of	both	Ad5	and	Ad12	





		 Two	 of	 the	 major	 enzyme	 activities	 associated	 with	 the	 CCR4-NOT	 complex	 are	
deadenylation	 and	 E3	 ubiquitin	 ligase	 activity,	 which	 have	 been	 attributed	 to	 CNOT6	 and	
CNOT4	respectively	(Albert,	Hanzawa	et	al.	2002,	Chen,	Chiang	et	al.	2002).	Since	CNOT4	and	
CNOT6	are	 the	 two	most	 characterised	CNOT	subunits,	we	decided	 to	 focus	on	 these	 two	
proteins	for	the	following	experiments.	To	examine	to	what	extent	these	proteins	impacted	
on	 the	 DDR	 and	 adenovirus	 infection,	 siRNA	 knockdown	 experiments	 were	 undertaken.	
Therefore	 optimal	 conditions	 for	 siRNA-mediated	 knockdown	 of	 these	 protein	 were	
established.	 HeLa	 cells	 were	 transfected	 with	 increasing	 concentrations	 of	 control	 (non-
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targeting),	 CNOT4	 or	 CNOT6	 siRNA	 (20nm,	 45nm	 and	 90nm).	 48	 hours	 post-transfection,	
cells	 were	 harvested,	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting.	 CNOT4	 was	




The	 expression	 of	 CNOT4	 was	 significantly	 down-regulated	 in	 all	 CNOT4	 siRNA	
concentrations	 used	 (20nm,	 45nm	 and	 90nm)	 when	 compared	 to	 control	 siRNA	 treated	
samples.	 Upon	 overexposure	 of	 autoradiography	 film,	 there	 was	 some	 residual	 CNOT4	
expression	 in	 the	 cell	 lysate	 treated	with	20nm	of	CNOT4	 siRNA.	 It	was	 therefore	decided	
that	 the	 45nm	 CNOT4	 siRNA	 concentration	 would	 be	 used	 for	 all	 future	 experiments.	 A	
number	 of	 known	 commercial	 CNOT6	 antibodies	 were	 tested	 but	 in	 each	 case	 the	
expression	 of	 CNOT6	was	 seen	 to	 be	 unaffected	 in	 all	 CNOT6	 siRNA	 concentrations	 used	
(data	 not	 shown)	 (Figure	 5.2A).	 The	 reason	 for	 this	 could	 be	 either	 that	 none	 of	 the	
commercial	antibodies	detected	CNOT6	or	the	CNOT6	siRNA	does	not	work.	
TAB182	was	also	immunoblotted	in	cells	transfected	with	control,	CNOT4	or	CNOT6	
siRNA	 to	 determine	 whether	 the	 knockdown	 of	 these	 proteins	 had	 any	 effect	 on	 the	
expression	 of	 TAB182.	 siRNA	 mediated	 knockdown	 of	 CNOT6	 had	 no	 effect	 on	 the	
expression	of	TAB182	when	compared	to	control	cells.	Interestingly,	the	depletion	of	CNOT4	
appeared	 to	 slightly	down-regulate	 the	 levels	of	TAB182	when	compared	 to	control	 siRNA	






































































































































































































U20S	 cells	were	 transfected	with	 2μg	 of	 either	HA-CNOT6	 or	HA-CNOT6L	 or	 pcDNA3.1	 or	
pEGFP-C3	only	as	negative	controls.	48	hours	later,	the	cells	were	harvested,	fractionated	by	
SDS-PAGE	 and	 subjected	 to	 Western	 blotting.	 HA	 was	 immunoblotted	 to	 assess	 the	
efficiency	 of	 the	 transfection.	 (C)	 CNOT6	 siRNA	 optimisation.	 HeLa	 or	 U20S	 cells	 were	
transfected	 with	 control,	 CNOT6,	 CNOT6L	 or	 CNOT6/CNOT6L	 siRNA	 and	 48	 hours	 later	
transfected	with	2μg	of	either	HA-CNOT6,	HA-CNOT6L,	both	HA-CNOT6	and	HA-CNOT6L	or	
pcDNA3.1	 or	 pEGFP-C3	 only	 as	 negative	 controls.	 48	 hours	 post-transfection	 cells	 were	
harvested	 and	 the	 cell	 lysates	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 HA	
antibodies.		
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Since	 it	 had	 not	 been	 determined	 whether	 the	 lack	 of	 down-regulation	 of	 CNOT6	
expression	 after	 the	 use	 of	 increasing	 concentrations	 of	 CNOT6	 siRNA	was	 due	 to	 a	 non-
specific	antibody	or	a	failure	of	the	CNOT6	siRNA	to	effectively	knockdown	the	expression	of		
the	protein,	the	following	experiment	was	carried	out.	Figure	5.3B	shows	validation	of	HA-
CNOT6	 and	 HA-CNOT6L	 plasmids	 received	 from	 Dr	 Sebastian	 Winkler	 (University	 of	
Nottingham).	U20S	and	HeLa	cells	were	transfected	with	HA-CNOT6	and	HA-CNOT6L	along	
with	 pEGFP-C3	 and	 pcDNA3.1	 as	 controls.	 48	 hours	 later	 the	 cells	 were	 harvested,	
fractionated	by	SDS-PAGE	and	subjected	to	Western	blotting	using	a	HA	antibody	to	assess	





Western	 blotting	with	 the	 required	 antibodies.	Western	 blot	 analysis	 showed	 that	 CNOT6	
siRNA	 does	 indeed	 reduce	 the	 levels	 of	 ectopically	 expressed	 CNOT6	 (Figure	 5.2C).	










blotting	 using	 the	 appropriate	 antibodies.	 CNOT4	 was	 immunoblotted	 to	 assess	 the	
efficiency	of	the	CNOT4	siRNA,	CNOT6	was	not	immunoblotted	since	no	known	commercial	
antibodies	 are	 specific	 for	 this	 protein	 (see	 Section	 5.2.3).	 E1A,	 E1B55K,	Hexon	 (Ad5)	 and	
Knob	 (Ad12)	were	 immunoblotted	as	markers	of	adenovirus	 infection,	Mre11	as	a	protein	
known	 to	 be	 degraded	 during	 Ad5	 and	Ad12	 infection	 and	 β-Actin	was	 used	 as	 a	 loading	
control	(Figure	5.3)	(Stracker,	Carson	et	al.	2002).			











In	control	 siRNA	treated	cells	 infected	with	Ad12,	 the	expression	of	 the	adenovirus	
early	protein	E1A	appeared	8	hours	post-infection,	whilst	the	expression	of	the	adenovirus	
early	protein	E1B55K	and	the	viral	structural	protein	Knob	appeared	24	hours	post-infection.	
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48	 and	 72	 hours	 post-infection,	 subjected	 to	 SDS-PAGE	 and	 Western	 blotting	 using	 the	







siRNA	 treated	 cells	 was	 also	 comparable	 to	 control	 siRNA	 treated	 cells,	 where	 it	 was	
degraded	24	hours	post-infection	(Figure	5.3B).	










2009).	 To	 investigate	 this	 further,	 DNA	 fibre	 structure	 analysis	 was	 performed	 in	 cells	
depleted	of	CNOT4	and	CNOT6.		HeLa	cells	were	transfected	with	control,	CNOT4	or	CNOT6	
siRNA	 and	 48	 hours	 later,	 labelled	with	 the	DNA	 analogue	 CldU.	 Following	 CldU	 labelling,	
cells	were	mock-treated	or	treated	with	2mM	HU	for	2	hours,	and	subsequently	 incubated	



















































































percentages	 of	 the	 different	DNA	 structures	were	 all	 similar	 to	 control,	HU	exposed	 cells.	
Again,	in	CNOT6	transfected,	undamaged	cells,	the	percentages	of	DNA	fibre	structures	were	
all	 similar	 to	 control,	 undamaged	 cells.	 However,	 even	 though	 ‘ongoing	 forks’,	 ‘1st	 label	
origins’,	 ‘1st	 label	 terminations’	 and	 ‘2nd	 label	 terminations	 were	 similar	 in	 CNOT6	 and	
control	 siRNA	 transfected	 cells	 after	 release	 from	HU	block,	 this	was	not	 the	 case	 for	 ‘2nd	
label	 origins’	 that	 were	 significantly	 increased	 in	 CNOT6	 siRNA	 treated	 cells	 by	 34%	
compared	to	control	cells	(Figure	5.4).		
Taken	together,	these	results	showed	that	CNOT4	knockdown	has	no	effect	on	DNA	
replication	progression	 following	HU	 treatment.	However,	 the	depletion	of	CNOT6	 in	 cells	
exposed	to	HU	caused	a	similar	effect	on	‘2nd	 label	origins’	as	the	one	previously	observed	






and	 the	 DNA	 fibre	 structures	 determined.	 HeLa	 cells	 were	 transfected	with	 the	 following	
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combinations;	control;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	or	TAB182	and	CNOT6.	
48	 hours	 later,	 cells	were	 labelled	with	 the	 DNA	 analogue	 CldU.	 Following	 CldU	 labelling,	
cells	were	mock-treated	or	treated	with	2mM	HU	for	2	hours,	and	subsequently	 incubated	
with	 IdU	 in	 HU-free	media.	 	 Cells	 were	 then	 processed	 for	 DNA	 fibre	 analysis	 as	 before.	
Double	knockdowns	were	validated	by	Western	blotting,	note	there	was	no	specific	CNOT6	
antibody	 available	 in	 this	 study	 and	 therefore	 CNOT6	 knockdown	 could	 not	 be	 validated		
(Figures	5.2	and	5.5C).	
Since	we	are	purely	interested	in	‘2nd	label	origins’	and	‘1st	label	terminations’	at	this	
stage	 none	 of	 the	 other	 structures	will	 be	 referred	 to	 in	 this	 section	 (see	 Figure	 5.5A	 for	
more	 detailed	 results).	 As	 previously	 discussed,	 the	 percentage	 of	 ‘2nd	 label	 origins’	 in	
control	siRNA	treated	undamaged	cells	was	approximately	11%,	decreasing	to	3%	upon	the	
addition	 of	 HU	 treatment.	 As	 previously	 seen	 in	 Figure	 4.8,	 the	 percentage	 of	 ‘2nd	 label	
origins’	in	TAB182	siRNA	treated	undamaged	cells	was	also	approximately	10%,	but	upon	the	
addition	of	HU	treatment	was	increased	to	approximately	18%.	The	percentage	of	‘2nd	label	
origins’	 in	 CNOT4	 siRNA	 treated,	 undamaged	 cells	 was	 approximately	 11%,	 decreasing	 to	
approximately	3%	upon	the	addition	of	HU,	which	was	similar	to	control	siRNA	treated	cells	
(Figure	5.5A).	In	TAB182/CNOT4	double	knockdown	cells	this	percentage	was	approximately	
11%	 in	 undamaged	 cells	 and	 upon	 the	 addition	 of	 HU,	 remains	 similar,	 suggesting	 that	
CNOT4	 may	 be	 able	 to	 partially	 rescue	 elevated	 new	 origin	 firing	 observed	 in	 TAB182	
deficient	cells	alone	(Figure	5.5A).	In	contrast	to	CNOT4,	the	percentage	of	‘2nd	label	origins’	



































































































































or	 CNOT6.	 HeLa	 cells	 were	 transfected	 with	 control,	 TAB182,	 CNOT4,	 CNOT6,	
TAB182/CNOT4	 or	 TAB182/CNOT6	 siRNA	 and	 were	 then	 treated	 as	 in	 Figure	 5.4.	 Graphs	
show	 the	 fibre	 structures	 as	 a	 percentage	 of	 all	 CldU	 structures.	 (A)	DNA	 fibre	 structures	
after	 TAB182/CNOT4	 double	 knockdown.	 (B)	 DNA	 fibre	 structures	 after	 TAB182/CNOT6	
double	knockdown.	Error	bars	represent	SEM.	(C)	Western	blot	shows	validation	of	TAB182,	









and	 increased	to	28%	upon	the	addition	of	HU.	 In	TAB182	defective,	undamaged	cells,	 the	
percentage	of	‘1st	label	terminations’	was	approximately	10%	increasing	up	to	14%	upon	the	
addition	 of	 HU.	 In	 CNOT4	 depleted,	 undamaged	 cells	 the	 percentage	 of	 ‘1st	 label	
terminations’	 was	 approximately	 12%	 and	 increased	 up	 to	 31%	 upon	 the	 addition	 of	 HU	
similarly	 to	 control	 cells.	 In	 TAB182/CNOT4	 double	 knockdown	 undamaged	 cells	 the	
percentage	 of	 ‘1st	 label	 terminations’	 was	 approximately	 12%	 and	 following	 HU	 release	
increased	 up	 to	 29%.	 This	 suggests	 that	 CNOT4	 depletion	 can	 restore	 the	 ‘1st	 label	
termination’	 defect	 observed	 in	 TAB182	 deficient	 cells	 to	 control	 levels	 following	 HU	
treatment	(Figure	5.5A).	
In	CNOT6	deficient,	undamaged	cells	 the	percentage	of	 ‘1st	 label	 terminations’	was	
9%,	increasing	to	approximately	27%	after	HU	release,	as	in	control	cells.	In	TAB182/CNOT6	







Since	 TAB182	was	 shown	 to	 associate	with	 components	 of	 the	 CNOT	 complex,	we	
also	aimed	 to	examine	how	CNOT4	and	CNOT6	 impacts	on	cellular	 survival	 in	 response	 to	
replication	 stress.	 To	 this	 end,	 HeLa	 cells	 were	 transfected	 with	 the	 following	 siRNA	
combinations;	control;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	or	TAB182	and	CNOT6.		
48	 hours	 later,	 the	 cells	were	 plated	 at	 various	 densities	 and	were	 exposed	 to	 increasing	
concentrations	 of	 HU	 (0-10mM	HU).	 Following	 exposure,	 the	 cells	 were	 incubated	 for	 14	
days	and	the	colonies	formed	were	stained	and	counted.	Colony	numbers	were	plotted	on	
survival	 graphs	and	analysed	 (Figure	5.6).	Confirmation	of	 TAB182	and	CNOT4	knockdown	
was	achieved	by	Western	blotting	(Figure	5.5C).	
As	 previously	 shown	 (Figure	 4.2),	 TAB182	 deficient	 cells	 are	 sensitive	 to	 HU.	
Interestingly,	CNOT4	and	CNOT6	are	also	similarly	sensitive	to	HU	as	TAB182.	When	double	
knockdowns	 of	 TAB182	 and	 CNOT4,	 or	 TAB182	 and	 CNOT6	 were	 performed,	 the	 HU	
sensitivity	 was	 additive	 in	 all	 cases	 compared	 to	 single	 knockdowns	 of	 these	 proteins,	





complex	were	 able	 to	 affect	 the	 expression	 of	 components	 of	 the	 RNR	 complex	 (Mulder,	

























Figure	 5.6:	 Depletion	 of	 CNOT4	 or	 CNOT6	 Results	 in	 Hypersensitivity	 to	 HU	 which	 is	
Additive	 Upon	 Co-Depletion	 of	 TAB182.	 HeLa	 cells	 were	 transfected	 with	 one	 of	 the	
following	combinations;	TAB182;	CNOT4;	CNOT6;	TAB182	and	CNOT4;	TAB182	and	CNOT6	
TAB182,	along	with	non-targeting	control	siRNA.	48	hours	later,	the	cells	were	then	exposed	
















































R1,	R2	or	p53R2.	Slightly	 reduced	 levels	of	R1	and	R2	expression	were	observed	 in	CNOT4	
deficient	 cells,	 whilst	 the	 expression	 of	 p53R2	 remained	 unaltered	 following	 CNOT4	






To	 ascertain	 whether	 TAB182	 is	 associated	 with	 an	 enzymatically	 active	 CNOT	
complex,	 simple	 deadenylation	 assays	were	 carried	 out.	 TAB182	was	 immunoprecipitated	




































































Figure	 5.8:	 TAB182	 is	 Associated	 with	 Deadenylase	 Activity.	 (A)	 TAB182	 and	 adenovirus	
E1B55K	proteins	were	 immunoprecipitated	from	HeLa	and	adenovirus	E1	transformed	cells,	
respectively.	 Antibody/antigen	 complexes	 were	 incubated	 at	 37ᵒC	 in	 appropriate	 buffer	
containing	a	target	 fluorescein-labelled	ribonucleotide	as	described	 in	Section	2.3.7.	After	1	
hour	 the	 reaction	 supernatant	 was	 mixed	 with	 RNA	 loading	 buffer,	 heated	 at	 85ᵒC	 and	
subjected	 to	electrophoresis	on	a	20%	 acrylamide	gel	 run	 in	 the	presence	of	8M	urea/TBE.	
Fluoroscein-labelled	 ribonucleotide	 was	 visualised	 using	 a	 Fusion	 SL	 chemiluminescence	
imaging	system.	‘Control’	lane	represents	untreated	ribonucleotide.	(B)	Cell	lysates	from	Ad5	
and	 Ad12	 infected	 HeLa	 cells	 were	 incubated	 with	 fluorescein-labelled	 ribonucleotide	 as	








associated	 with	 a	 number	 of	 subunits	 of	 the	 CNOT	 complex	 including	 CNOT1,	 CNOT2,	
CNOT3,	CNOT6L,	CNOT7,	CNOT8,	CNOT9,	CNOT10	and	CNOT11	in	both	uninfected	HeLa	cells	
and	Ad5	and	Ad12	 infected	cells	 (Table	5.1).	CNOT3	and	CNOT7	were	 shown	 to	be	down-
regulated	following	both	Ad5	and	Ad12	infection,	suggesting	that	components	of	the	CNOT	
complex	may	also	be	targeted	by	adenovirus	for	degradation	(Figure	5.1).	DNA	fibre	analysis	
revealed	 that	CNOT4	depleted	 cells	 exhibited	 replication	dynamics	 similar	 to	 control	 cells,	
but	 interestingly,	CNOT4	knockdown	 in	TAB182	deficient	 cells	was	able	 to	partially	 rescue	
the	 new	origin	 firing	 defect	 observed	 and	 to	 completely	 rescue	 the	 increased	 fork	 restart	
observed	in	TAB182	deficient	cells	following	release	from	replication	block	(Figures	5.4	and	
5.5).	CNOT6	depleted	cells	showed	firstly,	an	increase	in	new	origin	firing	after	release	from	
HU	 that	was	 comparable	 to	 that	 observed	 in	 TAB182	depleted	 cells,	 and	 secondly,	 a	mild	
increase	 in	fork	restart	 (Figure	5.4).	 Interestingly,	CNOT6	and	TAB182	were	epistatic	 in	the	
new	 origin	 defect	 observed	 following	 release	 from	 HU.	 However,	 CNOT6	 knockdown	 in	
TAB182	 deficient	 cells	 had	 no	 effect	 on	 the	 increased	 fork	 restart	 observed	 in	 these	 cells	
(Figure	 5.5).	 Interestingly,	 colony	 survival	 assays	 of	 single	 or	 double	 knockdowns	 showed	
that	 CNOT4	 or	 CNOT6	 were	 not	 epistatic	 with	 TAB182	 (Figure	 5.6).	 Defects	 observed	 in	
TAB182,	 CNOT4	 and	 CNOT6	 proteins	 were	 shown	 to	 not	 be	 a	 product	 of	 affecting	 RNR	
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expression,	although	depletion	of	CNOT4	was	 shown	 to	mildly	affect	 the	expression	of	R1	
and	R2	 (Figure	5.7).	 Finally,	 TAB182	was	 shown	 to	have	associated	deadenylase	activity	 in	
vivo	(Figure	5.8).		
There	 is	 limited	 information	about	the	function	of	TAB182,	but	some	reports	 in	the	
literature	have	suggested	that	TAB182	interacts	with	a	large,	multi-subunit	complex	known	
as	 the	 CCR4-NOT	 complex	 in	 yeast,	 and	 the	 CNOT	 complex	 in	 mammalian	 cells	 (Morita,	
Suzuki	et	al.	2007,	Lau,	Kolkman	et	al.	2009).	Our	mass	spectrometry	data	have	confirmed	




the	CNOT	 complex.	 Interestingly,	 neither	CNOT4	nor	CNOT6	were	detected	 in	 TAB182	 co-
immunoprecipitates.	The	explanation	for	the	lack	of	detection	of	CNOT6	may	be	due	to	the	
high	amino	acid	sequence	similarity	(79%)	between	CNOT6	and	CNOT6L,	and	so	CNOT6	may	
be	 identified	 as	 CNOT6L.	 The	 CNOT	 complex	 is	 a	 highly	 conserved,	multi-subunit	 complex	
with	roles	in	the	regulation	of	gene	expression.	It	has	been	implicated	in	mRNA	regulation,	





Lau	 and	 colleagues	 in	 HeLa	 cells	 has	 helped	 to	 elucidate	 the	 composition	 of	 the	 CNOT	
complex	 and	 its	 interacting	 proteins	 in	 human	 cells.	 Also	 using	 mass	 spectrometry,	 this	
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group	 found	 the	 core	 components	 of	 the	 CNOT	 complex	 to	 be	 CNOT1,	 CNOT2,	 CNOT3,	
CNOT9,	 CNOT10	 and	 the	 two	previously	 unidentified	CNOT	 complex	 components	 CNOT11	
and	 TAB182.	 Interestingly,	 the	 deadenylases	 CNOT6,	 CNOT6L,	 CNOT7	 and	 CNOT8	 were	
found	 to	 be	 variable	 subunits	 of	 the	 CNOT	 complex.	 CNOT7	 was	 not	 found	 in	 CNOT8	
purifications,	nor	CNOT8	 found	 in	CNOT7	purifications,	 suggesting	 that	CNOT7	and	CNOT8	
exist	 in	 separate	complexes.	Furthermore,	both	CNOT6/CNOT6L	were	 identified	 in	CNOT7,	
but	not	CNOT8	purifications,	 suggesting	 that	CNOT6/CNOT6L	does	not	 stably	 interact	with	
CNOT8	(Figure	1.15)	(Lau,	Kolkman	et	al.	2009).	In	the	TAB182	purifications	presented	in	this	




these	 subunits	are	not	 thought	 to	 stably	 interact	with	 the	core	CNOT	complex,	 suggesting	
that	 either	 CNOT7/CNOT8	 transiently	 associate	 with	 TAB182	 and/or	 TAB182	may	 be	 in	 a	
complex	 with	 CNOT7/CNOT8	 (Table	 5.1).	 PRMT3	 and	 FHL2	 were	 also	 identified	 in	 the	
TAB182	 mass	 spectrometry	 screen.	 PRMT3	 is	 a	 type	 I	 arginine	 methyltransferase	 which	
catalyses	 the	methylation	 of	 guanidine	 nitrogens	 of	 arginine	 residues	 of	 proteins.	 Protein	
arginine	methylation	has	a	 role	 in	a	number	of	 cellular	 functions	 including	protein-protein	







Aurora	 kinase	 that	were	 identified	 in	 the	 GST	 pull-downs	 performed	 in	 this	 study	 (Figure	
4.12),	 were	 not	 identified	 in	 the	 mass	 spectrometry	 screen.	 There	 are	 a	 number	 of	
explanations	 for	 the	different	 interacting	proteins	 identified	between	experiments.	 Firstly,	
the	mass	spectrometry	screen	was	performed	following	co-immunoprecipitation	assays	and	
not	GST	pull-downs,	and	so	could	yield	different	results.	Secondly,	the	GST	pull-downs	were	
performed	 using	 a	 C-terminal	 fragment	 (Figure	 3.11)	 of	 TAB182	 only	 and	 may	 not	 be	
representative	of	the	entire	TAB182	protein	as	in	the	mass	spectrometry	experiment.	Finally,	
the	mass	spectrometry	experiment	was	performed	in	whole	cell	lysates	and	thus	a	large	pool	
of	 TAB182	 interacting	proteins	were	 identified,	whereas	 the	GST	pull-downs	were	only	an	
examination	 of	 TAB182	 interaction	 with	 one	 protein.	 For	 this	 reason	 less	 abundant	
interactions,	 for	example,	 Tankyrase	1,	Chk1	and	Aurora	kinase,	may	be	masked	by	 larger	
protein	pools,	for	example,	such	as	those	with	the	CNOT	complex.			
Results	 from	 Table	 5.1	 showed	 that	 adenovirus	 infection	 had	 no	 effect	 on	 the	
interaction	between	TAB182	and	components	of	the	CNOT	complex.	Since	TAB182	appeared	
to	 be	 a	 stable	 core	 component	 of	 the	 CNOT	 complex,	 and	 TAB182	 is	 degraded	 during	
infection	with	 a	 number	 of	 different	 adenovirus	 serotypes,	 it	 was	 next	 hypothesised	 that	
components	of	the	CNOT	complex	may	also	be	targeted	for	degradation	during	adenovirus	
infection	 (Figure	 5.1).	 CNOT4	was	not	 down-regulated	 following	 infection	with	 adenovirus	
serotypes	 5	 or	 12.	 Interestingly,	 CNOT3	 and	CNOT7	were	 down-regulated	during	Ad5	 and	









for	 the	 changes	 in	 E1A	 protein	 expression	 observed	 in	 TAB182	 deficient	 cells	 in	 Chapter	
Three	(Figures	3.9	and	5.3).		
DNA	 fibre	 analysis	 revealed	 that	 cells	 depleted	 of	 CNOT4	 exhibit	 replication	





the	 new	 origin	 firing	 defect	 and	 completely	 rescued	 the	 increased	 fork	 restart	 present	 in	
TAB182	 deficient	 cells	 alone	 (Figure	 5.5).	 This	 suggests	 that	 the	 new	 origin	 firing	 defect	
observed	in	TAB182	depleted	cells	following	release	from	HU	is	partially	dependent	on	the	
activity	 of	 the	 CNOT4	 protein,	 and	 the	 increased	 fork	 restart	 observed	 in	 these	 cells	 is	
completely	dependent	on	CNOT4	activity.	This	leads	to	the	question	of	whether	the	defects	
in	 new	 origin	 firing	 and	 fork	 restart	 are	 dependent	 on	 the	 E3	 ubiquitin	 ligase	 activity	 of	









and	 AT-rich	 interaction	 domain	 1C	 (JARID1C)	 protein	 for	 degradation.	 This	 function	 is	
thought	to	achieve	a	balance	between	histone	demethylase	and	histone	methyltransferases	
and	therefore	H3K4	methylation	and	transcription	(Mersman,	Du	et	al.	2009).	Since	only	two	
NOT4/hCNOT4	 substrates	 have	 been	 identified	 to	 date,	 it	 is	 difficult	 to	 speculate	 why	
knockdown	 of	 CNOT4	 is	 able	 to	 rescue	 the	 defects	 observed	 in	 TAB182	 depleted	 cells	
following	release	from	HU.	Since	CNOT4	has	been	shown	to	exist	in	a	complex	distinct	from	
the	core	CNOT	complex,	it	is	likely	that	CNOT4	interacts	with	other	proteins	that	are	yet	to	
be	 identified.	 Identification	of	 such	proteins	may	help	 to	elucidate	 the	 role	of	CNOT4	and	
TAB182	in	response	to	replication	stress.		
Double	 knockdown	of	CNOT6/TAB182	 revealed	 that	 the	excessive	new	origin	 firing	
observed	 following	 release	 from	HU	 in	 these	cells	was	epistatic	 (Figure	5.5).	However,	 the	
double	knockdown	of	CNOT6/TAB182	had	no	effect	on	the	increased	fork	restart	observed	
in	TAB182	deficient	cells	alone,	suggesting	that	CNOT6	cannot	rescue	this	defect.	Reports	in	
the	 literature	 have	 suggested	 that	 sensitivity	 to	 DNA	 damaging	 agents	 in	 CCR4	 (hCNOT6)	
mutant	yeast	strains	is	due	to	the	loss	of	deadenylation	activity	(Traven,	Hammet	et	al.	2005,	
Woolstencroft,	Beilharz	et	al.	2006).	Indeed,	CCR4	has	been	shown	to	regulate	compromised	






not	 deadenylated,	 thus	 explaining	 why	 these	 cells	 display	 elevated	 new	 origin	 firing	
following	release	from	HU.	
Since	 the	 CNOT	 complex	 component	 TAB182	was	 shown	 to	 be	 sensitive	 to	 agents	
that	induced	replication	stress,	and	studies	in	yeast	mutant	strains	had	shown	a	number	of	






to	 a	 similar	 extent	 to	 the	 observed	 sensitivity	 of	 TAB182	 depleted	 cells.	 However,	 double	
knockdown	of	TAB182/CNOT4	or	TAB182/CNOT6	revealed	that	TAB182	and	CNOT4/CNOT6	
act	 independently	 of	 one	 another	 (Figure	 5.6).	 These	 data	 suggest	 the	 mechanisms	 of	
promoting	survival	 in	TAB182	depleted	cells	and	CNOT4/CNOT6	depleted	cells	are	distinct.	
Thorough	studies	have	been	performed	 in	yeast	mutant	strains	 to	address	 the	mechanism	





to	 be	 sensitive	 to	 IR,	 HU,	 4-NQO,	 camptothecin,	 MMS	 (Mulder,	 Winkler	 et	 al.	 2005,	
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Woolstencroft,	 Beilharz	 et	 al.	 2006,	 Deshpande,	 Hayles	 et	 al.	 2009).	 NOT1,	 NOT2,	 NOT3,	
NOT4	 and	 NOT5	 mutant	 yeast	 strains	 have	 been	 shown	 to	 be	 sensitive	 to	 HU	 (Mulder,	
Winkler	 et	 al.	 2005).	 A	 number	 of	 mechanisms	 of	 sensitivity	 have	 been	 postulated.	
Interestingly,	 Woolstencroft	 and	 colleagues	 demonstrated	 that	 CCR4	 (hCNOT6/hCNOT6L)	
yeast	strains	with	mutations	in	the	region	responsible	for	deadenylase	activity	also	displayed	
sensitivity	to	HU,	but	not	to	the	same	extent	as	the	CCR4	deletion	yeast	strain,	suggesting	
that	 the	 sensitivity	 to	 HU	 observed	 in	 CCR4	 mutants	 operates	 via	 both	 deadenylation-
dependent	 and	 independent	 mechanisms.	 Studies	 from	 Traven	 and	 colleagues	 also	
suggested	 that	 the	deadenylase	activity	of	 the	CCR4-NOT	complex	 is	 required	 for	 the	DDR	
(Traven,	 Hammet	 et	 al.	 2005,	 Woolstencroft,	 Beilharz	 et	 al.	 2006).	 Further	 studies	 from	
these	groups	revealed	that	CCR4	and	Chk1	cooperate	 in	 the	same	pathway	 in	 response	to	
replication	stress	induced	by	HU.	CCR4	was	later	found	to	regulate	CRT1	mRNA	poly(A)	tail	
length,	 CRT	 is	 a	 transcriptional	 repressor	 of	 a	 number	 of	 DNA	 damage-related	 genes	 and	
therefore	 the	 sensitivity	 of	 CCR4	 yeast	mutants	was	 attributed	 to	 deregulated	 CRT	mRNA	
poly(A)	 tail	 length	 (Woolstencroft,	 Beilharz	 et	 al.	 2006).	 Another	 study	 by	 Mulder	 and	




(hCNOT7/hCNOT8)	 component	 of	 the	 CNOT	 complex	 is	 responsible	 for	 Spd1	 degradation	
and	 Suc22	 translocation	 (Spd1	 is	 the	 RNR	 inhibitory	 protein	 that	 holds	 Suc22,	 the	 RNR	
regulatory	subunit	in	the	nucleoplasm),	and	therefore	is	sensitive	to	HU	(Takahashi,	Kontani	
et	 al.	 2007).	 It	 therefore	 remains	unclear	what	 the	exact	mechanism	 for	 the	 sensitivity	 to	
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various	 DNA	 damaging	 agents	 is	 in	 cells	 depleted	 of	 various	 CCR4-NOT	 components,	





DNA	 agents	 observed	 in	 CCR4-NOT	 mutant	 yeast	 strains	 (Mulder,	 Winkler	 et	 al.	 2005,	
Traven,	Hammet	et	al.	2005,	Takahashi,	Kontani	et	al.	2007).	RNR	catalyses	the	conversion	of	
NDPs	 into	 dNDPs,	 which	 is	 the	 rate	 limiting	 step	 in	 the	 production	 of	 dNTPs	 which	 are	
necessary	 for	 DNA	 replication	 (Jordan	 and	 Reichard	 1998).	 RNR	 activity	 is	 also	 important	





1997).	 In	 mammalian	 cells,	 three	 RNR	 subunits	 exist,	 R1	 and	 R2,	 which	 become	
transcriptionally	 activated	 during	 S	 phase	 in	 order	 to	 allow	 dNTP	 production	 during	 DNA	
replication	 (Chabes,	 Bjorklund	 et	 al.	 2004,	 Hakansson,	 Hofer	 et	 al.	 2006).	 The	 third	
mammalian	 RNR	 subunit,	 known	 as	 p53R2,	 becomes	 transcriptionally	 activated	 by	 p53	
following	DNA	damage	(Tanaka,	Arakawa	et	al.	2000).	Since	the	sensitivity	to	DNA	damaging	
agents	observed	 in	CCR4-NOT	complex	mutants	has	been	 linked	to	RNR	expression,	 it	was	
thought	 that	 TAB182	 depletion	 may	 have	 an	 effect	 on	 mammalian	 RNR	 expression.	




In	 mammalian	 cells,	 the	 deadenylase	 activity	 of	 the	 CNOT	 complex	 is	 achieved	
through	 the	 CNOT6,	 CNOT6L,	 CNOT7	 and	 CNOT8	 components,	 which	 are	 thought	 to	
transiently	associate	with	the	CNOT	complex	(Figure	1.14)(Lau,	Kolkman	et	al.	2009).	In	this	






used	 as	 bait,	 TAB182	would	 not	 always	 be	 identified	 in	 the	 purifications,	 suggesting	 that	
TAB182	 is	 not	 a	 core	 component	 of	 the	 CNOT	 complex,	 however,	 this	 would	 be	
contradictory	 to	 the	 results	 obtained	 from	 Lau	 and	 colleagues	 (Lau,	 Kolkman	et	 al.	 2009).	
Furthermore,	 deadenylation	 activity	 (or	 lack	 of)	 was	 thought	 to	 be	 responsible	 for	 the	
observed	sensitivities	of	CCR4,	NOT4	and	Caf1	to	DNA	damaging	agents	in	the	yeast	studies	
(Mulder,	Winkler	et	al.	2005,	Woolstencroft,	Beilharz	et	al.	2006,	Takahashi,	Kontani	et	al.	
2007).	 If	 defective	 deadenylation	 activity	 was	 responsible	 for	 the	 sensitivity	 of	 TAB182	
depleted	cells	following	HU,	it	would	be	expected	that	TAB182	and	CNOT6	would	appear	to	
be	epistatic,	 that	 is	of	course	assuming	both	sensitivities	seen	 in	TAB182	and	CNOT6	were	























Previous	 to	 this	 study,	 little	was	 known	about	 the	 function	of	 TAB182.	 Preliminary	
evidence	from	our	laboratory	suggested	that	TAB182	may	be	degraded	following	adenovirus	
infection.	 Furthermore,	 TAB182	 was	 thought	 to	 be	 a	 potential	 substrate	 of	 ATM/ATR	
phosphorylation	 (Matsuoka,	Ballif	 et	 al.	 2007).	 Taken	 together	 these	observations	pointed	
towards	a	role	for	TAB182	in	the	DNA	damage	response	(DDR).		




expression	 to	 a	 limited	 extent	 following	 Ad5	 and	 Ad12	 infection,	 suggesting	 that	 its	
expression	 has	 an	 inhibitory	 effect	 on	 viral	 infection.	 This	 is	 also	 the	 case	 for	 Cyclin	 E	
expression	 following	 Ad12	 infection	 in	 TAB182	 depleted	 cells,	 where	 its	 expression	 was	
increased,	 but	 whether	 this	 is	 directly	 regulated	 by	 TAB182,	 or	 via	 transcriptional	
hyperactivation	 mediated	 by	 the	 upregulation	 of	 E1A	 levels	 is	 unclear.	 TAB182	 did	 not	
localise	 to	 VRCs	 following	Ad	 infection,	 but	may	 localise	 to	 nuclear	 tracks	 or	 aggresomes,	
something	that	is	yet	to	be	examined.		
TAB182	 is	 a	 component	 of	 the	 CNOT	 complex,	 which	 in	 yeast,	 has	 roles	 in	mRNA	








no	effect	on	E1A	expression	 following	 infection,	although	 the	CNOT	subunits	used	 for	 this	





We	 can	 envisage	 a	 number	 of	 reasons	 why	 adenovirus	 may	 degrade	 TAB182.	 Firstly,	 if	
TAB182	 is	 indeed	 a	 cell	 cycle	 regulatory	 protein,	 its	 degradation	will	 be	 advantageous	 to	
promote	viral	 infection.	Removal	of	 cell	 cycle	 regulatory	proteins	 (such	as	p53)	allows	 the	
cell	 cycle	 to	 proceed	 thus	 allowing	 viral	 DNA	 replication.	 If	 TAB182	 is	 also	 a	 cell	 cycle	
regulatory	protein	this	could	be	the	reason	for	its	degradation	during	adenovirus	infection.		
Secondly,	 it	 is	 also	 plausible	 that	 the	 effects	 on	 the	 cell	 cycle	 observed	 upon	 TAB182	
depletion	are	indirectly	linked	to	a	potential	role	of	TAB182	in	the	DDR.	To	further	examine	
whether	adenovirus	degrades	TAB182	to	promote	viral	infection,	cell	cycle	analysis	could	be	







Adenovirus	 is	 known	 to	 relocalise	 some	 components	 of	 the	 DDR	 to	 VRCs,	 nuclear	
tracks	and	aggresomes,	which,	at	least	in	the	case	of	VRCs,	is	thought	to	inhibit	the	function	
of	 the	 DDR	 proteins	 to	 promote	 viral	 DNA	 replication	 (Stracker,	 Lee	 et	 al.	 2005,	 Carson,	
Orazio	et	al.	2009).	In	this	study,	TAB182	was	not	found	to	localise	to	VRCs.	Further	analysis	
of	 TAB182	 localisation	 to	 nuclear	 tracks	 and	 aggresomes	 will	 establish	 whether	 it	 is	
advantageous	for	adenovirus	to	sequester	TAB182	within	these	structures.		
Components	of	 the	core	CNOT	complex	are	also	down-regulated	during	adenovirus	
infection	 (CNOT3	 and	 CNOT7),	 but	 it	 is	 unknown	 whether	 the	 down-regulation	 of	 these	
proteins	has	any	effect	on	the	efficiency	of	adenovirus	infection.	If	similar	phenotypes	were	
observed	 for	 TAB182	 and	 the	 CNOT	 complex,	 this	 would	 suggest	 that	 adenovirus	 may	
degrade	 these	 proteins	 to	 compromise	 a	 common	 pathway	 in	 order	 to	 promote	 viral	











suggests	 that	 TAB182	 prevents	 fork	 restart	 and	 suppresses	 new	 origin	 firing	 following	
release	 from	 replication	 stress	 even	 though	 the	 mechanism	 through	 which	 this	 occurs	 is	
unknown.	 In	 silico	 analysis	 did	 not	 reveal	 any	 predicted	 functional	 domains	 in	 TAB182.	
Therefore,	 the	 question	 arises	 as	 to	 how	 does	 TAB182	 regulate	 fork	 recovery	 and	 origin	
firing	upon	 release	 from	 replication	blocking.	One	possibility	 could	be	 that	 it	 is	 present	 at	
stalled	forks	where	it	associates	with	proteins	involved	in	the	response	to	replication	stress.	
In	 support	of	 this,	TAB182	was	 found	 to	directly	 interact	with	Chk1	 (Figure	4.12),	which	 is	
necessary	 for	 checkpoint	activation	and	suppression	of	new	origin	 firing	during	 replication	
stress	 (Maya-Mendoza,	 Petermann	 et	 al.	 2007,	 Petermann,	 Woodcock	 et	 al.	 2010).	
Furthermore,	TAB182	may	be	associated	with	fork	remodelling	complexes	at	the	fork.	In	this	
respect,	FANCM,	a	helicase	mutated	in	the	Fanconi	anaemia	M	group,	displays	a	very	similar	
phenotype	 to	 TAB182.	 In	 fact,	 amongst	 the	 helicases	 implicated	 in	 the	 regulation	 of	
replication	fork	restart,	such	as	BLM,	WRN,	SMARCAL1	and	FBH1,	it	is	only	FANCM	depletion	
that	 leads	 to	 elevated	 fork	 restart,	 something	we	 also	 observed	 in	 TAB182	 deficient	 cells	
(Schwab,	Blackford	et	al.	2010).	However,	FANCM	deficient	cells	exhibit	an	increase	in	DSB	
formation,	something	that	was	not	observed	in	TAB182	deficient	cells	(Blackford,	Schwab	et	
al.	 2012).	Another	possibility	 is	 that	TAB182	may	be	 required	 for	 fork	 collapse	 in	order	 to	
facilitate	 an	 alternative	 pathway	 of	 replication	 intermediate	 resolution	 at	 sites	 of	 stalled	
replication.	 If	 TAB182	 is	 necessary	 for	 fork	 collapse,	 it	may	 act	 in	 concert	with	 structure-
specific	 endonucleases	 at	 the	 fork.	 Interestingly,	 similarly	 to	 TAB182	 deficient	 cells,	
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depletion	 of	 the	 structure-specific	 endonuclease	 MUS81	 leads	 to	 a	 minor	 increase	 in	
micronuclei	formation	as	well	as	a	reduction	in	gaps	and	breaks	following	replication	stress	
(Ying,	 Minocherhomji	 et	 al.	 2013,	 Pepe	 and	 West	 2014,	 Sarbajna,	 Davies	 et	 al.	 2014).	
Moreover,	MUS81	depleted	cells	show	reduced	DSB	formation	following	replication	stress	as	
measured	 by	 pulse-field	 gel	 electrophoresis	 (PFGE),	 a	 phenotype	 also	 present	 in	 TAB182	
deficient	 cells	 as	 indicated	 by	 the	 reduction	 of	 53BP1	 foci	 positive	 cells	 following	 release	
from	 HU	 (Pepe	 and	 West	 2014).	 Similarly	 to	 TAB182,	 MUS81	 depleted	 cells	 show	 no	
differences	in	fork	speed	both	during	unperturbed	replication	as	well	as	following	replication	
stress,	 but	 display	 elevated	 new	 origin	 firing	 following	 release	 from	HU	 (Fu,	Martin	 et	 al.	










fork	 stability	 and	 restart	 in	 TAB182	 knockdown	 cells.	 A	 number	 of	 different	 experiments	




fork,	 iPOND	 followed	 by	 mass	 spectrometry	 could	 be	 performed.	 iPOND	 involves	 the	
labelling	 of	 nascent	 DNA	 using	 the	 nucleoside	 analogue	 5-ethynyl-2’-deoxyuridine	 (EdU).	
Biotin	 can	be	conjugated	 to	EdU-labelled	DNA	using	click	 chemistry	and	allows	a	one-step	
purification	 of	 nascent	 DNA-bound	 proteins.	 Using	 this	 technique,	 it	 can	 be	 determined	
whether	 TAB182	 is	 associated	 with	 active,	 stalled	 or	 collapsed	 replication	 forks	 (Sirbu,	
McDonald	et	al.	2013).	Furthermore,	performing	TAB182	immunoprecipitation	experiments	
in	human	cells	before	and	after	replication	stress	would	give	insight	about	the	proteins	that	
TAB182	 associates	 with.	 DNA	 damage	 signalling	 in	 TAB182	 deficient	 cells	 can	 be	 further	
examined	 by	 monitoring	 the	 activation	 of	 additional	 factors	 activated	 upon	 replication	
stress.	 To	 better	 characterise	 the	 phenotypes	 observed	 after	 release	 from	 HU,	 we	 could	
examine	the	ability	of	cells	to	form	Rad51	foci	to	see	whether	homologous	recombination	is	
the	 pathway	 that	 facilitates	 replication	 fork	 restart	 in	 the	 absence	 of	 TAB182.	 To	 confirm	
whether	the	decreased	γH2AX	and	53BP1	foci	observed	in	TAB182	deficient	cells	 following	
release	 from	 HU	 are	 a	 consequence	 of	 fork	 collapse	 into	 DSBs,	 we	 could	 perform	 PFGE	
and/or	comet	assays	to	measure	the	amount	of	DNA	breaks	resulting	from	collapsed	forks.	
Whether	 structure-specific	 endonucleases	 and/or	 helicases	 are	 important	 for	 fork	 restart	
after	HU	 in	TAB182	deficient	cells	 is	also	an	 important	question	that	could	be	 investigated	









replication	 fork	 dynamics,	 but	 cells	 depleted	 of	 the	 CNOT	 deadenylation	 subunit,	 CNOT6,	





cells	 alone	 was	 epistatic,	 suggesting	 that	 they	may	 be	 acting	 in	 a	 common	 pathway	 that	
regulates	 new	 origin	 firing.	 However,	 CNOT6	 and	 TAB182	 depletion	 had	 no	 effect	 on	 the	
increased	fork	restart	observed	following	replication	stress	in	TAB182	cells	alone.	This	leads	
to	 the	 question	 as	 to	 whether	 the	 phenotypes	 observed	 in	 TAB182	 deficient	 cells	 is	
dependent	on	the	E3	ubiquitin	ligase	and	deadenylation	activity	of	the	CNOT	complex.	In	our	
hands,	 TAB182	 was	 shown	 to	 have	 associated	 deadenylase	 activity.	 Interestingly,	 the	
sensitivity	 to	 HU	 observed	 in	 TAB182	 and	 CNOT4/6	 deficient	 cells	 was	 shown	 to	 be	
independent	 of	 one	 another,	 perhaps	 suggesting	 that	 the	 sensitivity	 and	 replication	 fork	
dynamics	of	TAB182	deficient	cells	operate	by	 independent	mechanisms.	To	address	these	
questions,	co-depletions	of	TAB182	together	with	CNOT4	or	CNOT6	could	be	performed	to	
see	 whether	 the	 replication	 functions	 of	 TAB182	 are	 linked	 to	 the	 CNOT	 complex.	 For	
example,	 the	 formation	 of	 γH2AX	 and	 53BP1	 foci,	 levels	 of	 53BP1	 bodies	 in	 G1	 and	
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micronuclei	could	be	assessed	following	replication	stress	 in	cells	depleted	of	both	TAB182	





The	 identification	 of	 novel	 proteins	 involved	 in	 the	 DDR	 and	 replication	 stress	
pathways	 has	 important	 implications	 for	 the	 understanding	 of	 genomic	 instability,	 a	
hallmark	 of	 cancer	 (Hanahan	 and	 Weinberg	 2011).	 	 Work	 presented	 in	 this	 thesis	 has	
demonstrated	TAB182	to	be	degraded	during	adenovirus	infection,	implicating	a	role	for	this	
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